- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株1-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
//
ID 66 [Human iPSC]
AC CVCL_C919
DR ISCR; 328
RX PubMed=19252478;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID 66 [Mouse mammary tumor]
AC CVCL_9722
AS CVCL_B393
SY Line 66; Clone 66; Cl-66; Cl66
DR BTO; BTO:0004309
RX PubMed=210930;
RX PubMed=2413152;
RX PubMed=2790822;
RX PubMed=3940214;
RX PubMed=6871851;
RX PubMed=10651311;
CC Doubling time: 30.8 +- 4.2 hours (PubMed=10651311).
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0I84 ! 168
OI CVCL_W343 ! 410.4
OI CVCL_0I87 ! 67 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID 6606PDA
AC CVCL_HX26
RX PubMed=21276229;
RX PubMed=21720167;
RX PubMed=26322225;
CC Breed/subspecies: C57BL/6 transgenic for Mist1KrasG12D.
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 6613
AC CVCL_EQ45
SY 6603
DR GEO; GSM666036
DR GEO; GSM666037
RX PubMed=22033105;
CC Omics: Transcriptome analysis.
DI NCIt; C98994; NADH dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 661W
AC CVCL_6240
SY 661w; 661 W
DR BTO; BTO:0001554
DR Lonza; 336
RX PubMed=11243878;
RX PubMed=14985288;
RX PubMed=23975727;
RX PubMed=26854824;
WW http://otm.illinois.edu/technologies/mouse-retinal-photoreceptor-derived-cell-line-661
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6N transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 6647
AC CVCL_H722
SY #6647
DR Cosmic; 1078384
DR Cosmic; 1082508
DR Cosmic; 1718435
DR Cosmic; 2228212
RX PubMed=327080;
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=8617485;
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 665A1
AC CVCL_DQ18
DR GEO; GSM1040292
DR GEO; GSM1040362
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ13 ! 610A2
OI CVCL_DQ14 ! 610B1
OI CVCL_DQ19 ! 665A7
SX Male
CA Induced pluripotent stem cell
//
ID 665A7
AC CVCL_DQ19
DR GEO; GSM1040293
DR GEO; GSM1040363
DR GEO; GSM1489238
DR GEO; GSM1489444
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ13 ! 610A2
OI CVCL_DQ14 ! 610B1
OI CVCL_DQ18 ! 665A1
SX Male
CA Induced pluripotent stem cell
//
ID 66cl-4
AC CVCL_9721
SY 66cl4; Line 66 clone 4
DR EFO; EFO_0002038
RX PubMed=1993557;
RX PubMed=3940214;
RX PubMed=6871851;
RX PubMed=10411109;
RX PubMed=15671244;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9722 ! 66 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID 67 [Human iPSC]
AC CVCL_C920
DR ISCR; 327
RX PubMed=19252478;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID 67 [Mouse mammary tumor]
AC CVCL_0I87
SY Line 67
RX PubMed=210930;
RX PubMed=1540948;
RX PubMed=2413152;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0I84 ! 168
OI CVCL_W343 ! 410.4
OI CVCL_9722 ! 66 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID 67-1
AC CVCL_8165
SY 67-I
RX PubMed=8525373;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 677-mel
AC CVCL_8055
SY 677-MEL; 677 mel; 677
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 67BR
AC CVCL_HF27
RX PubMed=2973075;
RX PubMed=6600729;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 67I
AC CVCL_8166
RX PubMed=1845822;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Breed/subspecies: Fischer.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID 67j25D
AC CVCL_Z425
SY 67J25D; 67j 25D; 67j25 D; DM
DR CLO; CLO_0001454
DR CLDB; cl116
DR DGRC; 173
RX CelloPub=CLPUB00185;
RX DOI=10.1016/B978-012229460-0/50004-X;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/s67j_25d.htm
CC Group: Insect cell line.
CC Breed/subspecies: Oregon R-C.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Female
CA Spontaneously immortalized cell line
//
ID 67j25D-G
AC CVCL_Z426
RX DOI=10.1099/0022-1317-54-1-23;
CC Group: Insect cell line.
CC Breed/subspecies: Oregon R-C.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z425 ! 67j25D
SX Female
CA Spontaneously immortalized cell line
//
ID 67j25D-P
AC CVCL_Z427
RX DOI=10.1099/0022-1317-54-1-23;
CC Group: Insect cell line.
CC Breed/subspecies: Oregon R-C.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z425 ! 67j25D
SX Female
CA Spontaneously immortalized cell line
//
ID 67NR
AC CVCL_9723
DR EFO; EFO_0002039
RX PubMed=1540948;
RX PubMed=10411109;
RX PubMed=15671244;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0I87 ! 67 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID 67T
AC CVCL_8167
RX PubMed=1845822;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Breed/subspecies: Fischer.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8166 ! 67I
CA Transformed cell line
//
ID 68-1-2
AC CVCL_3273
DR CLO; CLO_0001455
DR ATCC; CRL-1712
RX PubMed=6090455;
CC Monoclonal antibody target: UniProtKB; P10443; Escherichia coli polC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 686LN-M3e
AC CVCL_D099
SY M3e
RX PubMed=17028921;
CC Derived from metastatic site: Lymph node.
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6984 ! MDA-686Ln
SX Male
CA Cancer cell line
//
ID 686LN-M4e
AC CVCL_D097
SY M4e
RX PubMed=17028921;
CC Derived from metastatic site: Lymph node.
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6984 ! MDA-686Ln
SX Male
CA Cancer cell line
//
ID 686LN-R30
AC CVCL_D098
SY R30
RX PubMed=18473353;
CC Derived from metastatic site: Lymph node.
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6984 ! MDA-686Ln
SX Male
CA Cancer cell line
//
ID 692D2
AC CVCL_DQ20
DR GEO; GSM1489209
DR GEO; GSM1489232
DR GEO; GSM1489256
DR GEO; GSM1489449
DR GEO; GSM1942573
RX PubMed=25665923;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ06 ! 585A1
OI CVCL_DQ07 ! 585B1
OI CVCL_DQ21 ! 703A1
OI CVCL_DQ22 ! 703B1
SX Male
CA Induced pluripotent stem cell
//
ID 697
AC CVCL_0079
AS CVCL_8861
SY Line 697; EU-3
DR BTO; BTO:0001969
DR CLO; CLO_0001008
DR CLDB; cl117
DR BioSample; SAMN03473591
DR CCLE; 697_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308147
DR ChEMBL-Targets; CHEMBL2366253
DR Cosmic; 906800
DR Cosmic; 1037742
DR Cosmic; 1130252
DR Cosmic; 1191693
DR Cosmic; 1524788
DR Cosmic; 2396142
DR Cosmic; 2427693
DR Cosmic-CLP; 906800
DR DSMZ; ACC-42
DR GDSC; 906800
DR GEO; GSM236777
DR GEO; GSM236813
DR GEO; GSM886843
DR GEO; GSM887907
DR GEO; GSM1669562
DR IZSLER; BS TCL 241
DR Lonza; 235
RX PubMed=6982733;
RX PubMed=7888679;
RX PubMed=9108419;
RX PubMed=10490826;
RX PubMed=11021758;
RX PubMed=15843827;
RX PubMed=20519628;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Emory University; USA.
CC Doubling time: 40 hours (PubMed=25984343); ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 697-mel
AC CVCL_8056
SY 697-MEL; 697 Mel; 697 mel; 697mel; 697
DR CGH-DB; 9302-4
DR Cosmic; 905215
RX PubMed=8081556;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=15467732;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 6A-HS-MYC
AC CVCL_5A27
RX Patent=EP0232845A2;
RX PubMed=3526329;
CC Transfected with: MGI; MGI:97250; Myc.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID 6A7M
AC CVCL_G621
SY 6A7
DR CLO; CLO_0001456
DR ATCC; HB-8159
RX Patent=US4767710;
RX PubMed=6197636;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with S-20 and G-24; recognizes M blood group antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 6A8.6F10.1A6
AC CVCL_J914
SY 6F10
DR CLO; CLO_0001457
DR ATCC; CRL-2743
DR ATCC; JHU-27
CC Discontinued: ATCC; CRL-2743; true.
CC Discontinued: ATCC; JHU-27; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 6B [Mouse embryonal carcinoma]
AC CVCL_1N72
SY 6BTG; AG13178
DR CLO; CLO_0022097
DR Coriell; AG13178
RX PubMed=2791350;
CC Breed/subspecies: CBA.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1N70 ! H6
CA Cancer cell line
//
ID 6B [Salmon]
AC CVCL_S159
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 6B(NG)C25
AC CVCL_1N74
SY AG13179
DR CLO; CLO_0022098
DR Coriell; AG13179
RX PubMed=2321096;
RX PubMed=2791350;
CC Breed/subspecies: CBA.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1N72 ! 6B [Mouse embryonal carcinoma]
CA Cancer cell line
//
ID 6B2
AC CVCL_X862
DR ATCC; PTA-5261
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 6B3
AC CVCL_X863
DR ATCC; PTA-5262
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 6C12
AC CVCL_X864
DR ATCC; PTA-5597
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 6C3HED-OG
AC CVCL_F966
SY 6C3HED/OG
DR TKG; TKG 0146
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 6CFSMEo-
AC CVCL_IN62
SY 6CFSMEO
RX PubMed=1375758;
RX PubMed=15463957;
CC Characteristics: Heterozygous for the CFTR p.Phe508del and p.Gln2Ter mutations.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN60 ! 2CFSMEo-
CA Transformed cell line
//
ID 6D11.3.1
AC CVCL_J989
DR ATCC; PTA-4299
RX Patent=US20080171036;
CC Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
CC Discontinued: ATCC; PTA-4299; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 6D3.4.4
AC CVCL_J930
DR ATCC; HB-9573
RX Patent=US5194593;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 6D6
AC CVCL_4T76
DR ATCC; CRL-9171
RX Patent=US5662905;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-9171; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 6D8MB4
AC CVCL_G094
SY 6D8 MB4
DR CLO; CLO_0001458
DR ATCC; CRL-1842
DR ECACC; 95022201
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 6E6
AC CVCL_4582
DR CLO; CLO_0001459
DR ATCC; CRL-11398
RX Patent=US5854070;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Transformed cell line
//
ID 6F11
AC CVCL_L106
DR ATCC; CRL-8562
RX Patent=US4834975;
RX Patent=US5662905;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-8562; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 6F2.1.1
AC CVCL_U724
SY anti-FcRH3-6F2
DR ATCC; PTA-6337
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 6F4C5
AC CVCL_J150
DR CLO; CLO_0001460
DR ATCC; CRL-1869
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 6G4.2.5
AC CVCL_J003
DR CLO; CLO_0001461
DR ATCC; HB-11722
RX Patent=US5677426;
CC Monoclonal antibody target: UniProtKB; P19874; Rabbit IL8.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 6G5(AAT) Clone 1C9
AC CVCL_U076
DR ECACC; 02043017
CC Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 6H
AC CVCL_J418
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 6H4
AC CVCL_IQ39
RX Patent=US7259246;
RX PubMed=9363892;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2295.
CC Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (also reacts with hamster, human, mouse, pig and sheep).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 6H7(PGM1) Clone D10
AC CVCL_U077
DR ECACC; 02043022
CC Monoclonal antibody target: UniProtKB; P36871; Human PGM1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 6LBLN
AC CVCL_3638
DR CLO; CLO_0001462
DR ATCC; CRL-6050
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6050; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID 6R081Cl1
AC CVCL_6A83
RX PubMed=286129;
OX NCBI_TaxID=10047; ! Meriones unguiculatus
SX Female
CA Cancer cell line
//
ID 6T-CEM
AC CVCL_6869
SY 6-T CEM
DR ATCC; CRL-8296
DR BioSample; SAMN03471201
DR CCRID; 3131C0001000700002
RX Patent=US4705687;
RX Patent=US4728614;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 10,13
ST D5S818: 11,12,13
ST D7S820: 9,14
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID 6T-CEM20
AC CVCL_U293
SY 6T-CEM-20; 6-T CEM-20; 6TCEM20
DR ATCC; CRL-8295
RX Patent=US4705687;
RX Patent=US4728614;
RX PubMed=6234996;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Discontinued: ATCC; CRL-8295; probable.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6869 ! 6T-CEM
SX Female
CA Cancer cell line
//
ID 7-17
AC CVCL_6241
DR Lonza; 1468
RX PubMed=2885757;
RX PubMed=8759735;
CC Characteristics: IL2 or IL7 dependent.
CC Caution: Erroneously indicated as originating from human in Lonza 1468.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID 7-34-1
AC CVCL_G622
DR CLO; CLO_0001472
DR ATCC; CRL-1945
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7-TD-1
AC CVCL_1935
SY 7TD1; 7TDI
DR CLO; CLO_0001502
DR CLO; CLO_0001503
DR CLO; CLO_0050386
DR CLDB; cl118
DR ATCC; CRL-1851
DR ChEMBL-Cells; CHEMBL3307673
DR ChEMBL-Targets; CHEMBL614646
DR DSMZ; ACC-23
DR ICLC; HYL96001
DR IZSLER; BS Hy 54
DR RCB; RCB1190
WW http://www.atcc.org/support/faqs/cc5e9/7TD1%20ATCC%20CRL1851-1078.aspx
WW http://www.cells-talk.com/index.php/page/copelibrary?key=7TD1
CC Doubling time: ~24-25 hours (DSMZ).
CC Discontinued: ATCC; CRL-1851; true.
CC Discontinued: ICLC; HYL96001; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7.107 pRSV-T
AC CVCL_L074
SY 7.107
DR ATCC; CRL-11136
RX Patent=US5672498;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
CC Discontinued: ATCC; CRL-11136; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 7.16.4
AC CVCL_X742
DR ATCC; HB-10493
RX Patent=US5824311;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 7.4.C4
AC CVCL_M029
DR ECACC; 92092321
CC Monoclonal antibody target: Cell surface components expressed on leukocytes, red blood cells and vascular endothelial cells of fish.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 701-LCL
AC CVCL_8072
DR CLO; CLO_0051015
DR BioSample; SAMN03471952
DR RCB; RCB2282
DR TKG; TKG 0610
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 6,9
ST TPOX: 11 (RCB)
ST TPOX: 7,11 (TKG)
ST vWA: 16,17,18 (RCB)
ST vWA: 16,18 (TKG)
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 703A1
AC CVCL_DQ21
DR GEO; GSM1040290
DR GEO; GSM1040360
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ06 ! 585A1
OI CVCL_DQ07 ! 585B1
OI CVCL_DQ20 ! 692D2
OI CVCL_DQ22 ! 703B1
SX Male
CA Induced pluripotent stem cell
//
ID 703B1
AC CVCL_DQ22
DR GEO; GSM1040291
DR GEO; GSM1040361
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ06 ! 585A1
OI CVCL_DQ07 ! 585B1
OI CVCL_DQ20 ! 692D2
OI CVCL_DQ21 ! 703A1
SX Male
CA Induced pluripotent stem cell
//
ID 703D4
AC CVCL_J151
DR CLO; CLO_0001465
DR ATCC; HB-8301
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 707.fl
AC CVCL_H711
DR CLO; CLO_0050779
DR ECACC; 99072807
DR RCB; RCB0569
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID 707B1011C3
AC CVCL_4094
DR CLO; CLO_0001467
DR CLDB; cl122
DR ECACC; 87120401
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4145 ! Clone 707
CA Cancer cell line
//
ID 70Z/3
AC CVCL_0127
SY 70 Z/3; 70 z/3; 70Z3; 70Z/3.12; 7OZ/3
DR BTO; BTO:0000788
DR CLO; CLO_0001468
DR MCCL; MCC:0000019
DR CLDB; cl123
DR ATCC; TIB-158
DR ECACC; 91092002
DR TOKU-E; 406
RX PubMed=308074;
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Misspelling: Occasionally '702/3'.
CC Breed/subspecies: C57BL/6 x DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 71 BLCL
AC CVCL_E410
DR ECACC; 94031611
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 71-31
AC CVCL_9V05
RX Patent=US5731189;
RX PubMed=2922401;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 711A1
AC CVCL_DQ23
DR GEO; GSM1040294
DR GEO; GSM1040364
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ11 ! 606A1
OI CVCL_DQ12 ! 606B1
OI CVCL_DR11 ! 711A5
OI CVCL_DQ24 ! 711A6
OI CVCL_DQ25 ! 711C1
SX Female
CA Induced pluripotent stem cell
//
ID 711A5
AC CVCL_DR11
DR GEO; GSM2152678
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ11 ! 606A1
OI CVCL_DQ12 ! 606B1
OI CVCL_DQ23 ! 711A1
OI CVCL_DQ24 ! 711A6
OI CVCL_DQ25 ! 711C1
SX Female
CA Induced pluripotent stem cell
//
ID 711A6
AC CVCL_DQ24
DR GEO; GSM1040295
DR GEO; GSM1040365
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ11 ! 606A1
OI CVCL_DQ12 ! 606B1
OI CVCL_DQ23 ! 711A1
OI CVCL_DR11 ! 711A5
OI CVCL_DQ25 ! 711C1
SX Female
CA Induced pluripotent stem cell
//
ID 711C1
AC CVCL_DQ25
DR GEO; GSM1040296
DR GEO; GSM1040366
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ11 ! 606A1
OI CVCL_DQ12 ! 606B1
OI CVCL_DQ23 ! 711A1
OI CVCL_DR11 ! 711A5
OI CVCL_DQ24 ! 711A6
SX Female
CA Induced pluripotent stem cell
//
ID 71A7
AC CVCL_J049
DR CLO; CLO_0001469
DR ATCC; TIB-147
RX PubMed=6161967;
CC Monoclonal antibody target: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 720
AC CVCL_6242
DR Lonza; 1033
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 725.1
AC CVCL_0I08
DR ATCC; PTA-5124
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7265PDA
AC CVCL_HX27
RX PubMed=26322225;
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 729-mel
AC CVCL_S561
SY 729mel
DR CGH-DB; 9303-4
DR Cosmic; 905216
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 72A1
AC CVCL_1936
SY 72 A1
DR CLO; CLO_0001470
DR CLDB; cl124
DR CLDB; cl5143
DR ATCC; HB-168
DR DSMZ; ACC-89
DR IZSLER; BS Hy 35
RX PubMed=6248876;
CC Monoclonal antibody target: UniProtKB; P03200; Epstein-Barr virus envelope glycoprotein GP350 (BLLF1).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 73/1
AC CVCL_G623
DR CLO; CLO_0001471
DR ATCC; HB-66
DR IZSLER; BS Hy 56
CC Monoclonal antibody target: UniProtKB; P03441; Influenza A/Bangkok/1/1979 HA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 731-mel
AC CVCL_S562
SY 731mel
DR CGH-DB; 9304-4
DR Cosmic; 905217
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 7316A
AC CVCL_3944
SY Morris hepatoma 7316A; Morris hepatoma-7316A
DR BTO; BTO:0001941
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 73B
AC CVCL_M030
DR ECACC; 91060554
CC Monoclonal antibody target: UniProtKB; W5Q2E5; Sheep PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 74 BLCL
AC CVCL_E411
DR ECACC; 94031612
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 74-11-10
AC CVCL_4467
DR CLO; CLO_0001473
DR CLDB; cl5150
DR ATCC; HB-139
DR IZSLER; BS Hy 19
RX PubMed=6609988;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 74-12-4
AC CVCL_4468
DR CLO; CLO_0001474
DR CLDB; cl5152
DR ATCC; HB-147
DR IZSLER; BS Hy 20
RX PubMed=6609988;
CC Monoclonal antibody target: UniProtKB; Q6R3N4; Pig CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 74-22-15
AC CVCL_4469
DR CLO; CLO_0001475
DR CLDB; cl5153
DR ATCC; HB-142
DR IZSLER; BS Hy 21
RX PubMed=6609988;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 74-22-15A
AC CVCL_4470
DR CLO; CLO_0001476
DR ATCC; HB-142.1
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4469 ! 74-22-15
CA Hybridoma
//
ID 74-9-3
AC CVCL_4471
DR CLO; CLO_0001478
DR CLDB; cl5144
DR ATCC; HB-156
DR IZSLER; BS Hy 15
RX PubMed=6609988;
CC Monoclonal antibody target: UniProtKB; K7GMW0; Pig PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 741F8-2B9
AC CVCL_N286
SY 741F8
DR ATCC; HB-10807
RX Patent=US5169774;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 743E
AC CVCL_7944
RX PubMed=66978;
RX PubMed=6244232;
CC Derived from metastatic site: Brain.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 744A2
AC CVCL_DQ26
DR GEO; GSM936066
DR GEO; GSM1489210
DR GEO; GSM1489236
DR GEO; GSM1489450
DR GEO; GSM1942572
DR GEO; GSM1942588
DR GEO; GSM1942589
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ27 ! 744B9
OI CVCL_DQ28 ! 751A3
OI CVCL_DQ29 ! 751B4
SX Male
CA Induced pluripotent stem cell
//
ID 744B9
AC CVCL_DQ27
DR GEO; GSM936067
DR GEO; GSM1489211
DR GEO; GSM1489235
DR GEO; GSM1489451
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ26 ! 744A2
OI CVCL_DQ28 ! 751A3
OI CVCL_DQ29 ! 751B4
SX Male
CA Induced pluripotent stem cell
//
ID 745C2
AC CVCL_4095
DR CLO; CLO_0001477
DR CLDB; cl125
DR ECACC; 87030901
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 7501
AC CVCL_B991
SY A7501
DR CLO; CLO_0050403
DR RCB; RCB0116
RX PubMed=2828049;
CC Monoclonal antibody target: UniProtKB; P0CS90; Yeast SSC1/ENS1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 751A3
AC CVCL_DQ28
DR GEO; GSM936064
DR GEO; GSM1489212
DR GEO; GSM1489228
DR GEO; GSM1489452
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ26 ! 744A2
OI CVCL_DQ27 ! 744B9
OI CVCL_DQ29 ! 751B4
SX Male
CA Induced pluripotent stem cell
//
ID 751B4
AC CVCL_DQ29
DR GEO; GSM936065
DR GEO; GSM1489213
DR GEO; GSM1489229
DR GEO; GSM1489453
DR GEO; GSM1493701
DR GEO; GSM1942577
DR GEO; GSM1942578
DR GEO; GSM1942579
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ26 ! 744A2
OI CVCL_DQ27 ! 744B9
OI CVCL_DQ28 ! 751A3
SX Male
CA Induced pluripotent stem cell
//
ID 751G
AC CVCL_7945
RX PubMed=66978;
RX PubMed=6244232;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 751-NA-15
AC CVCL_M361
SY 751
DR ATCC; CRL-10992
DR ATCC; CRL-12160
RX Patent=US5981708;
CC Discontinued: ATCC; CRL-10992; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 75e7vg1
AC CVCL_Z927
SY 75e 7vg1; 75 e 7 vg1
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 75e7vg2
AC CVCL_Z917
SY 75e 7vg2; 75 e 7 vg2
DR CLO; CLO_0001479
DR CLDB; cl126
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/s75_e_7_vg_2.htm
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 75e7vg3
AC CVCL_Z928
SY 75e 7vg3; 75 e 7 vg3
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 75e7vg4
AC CVCL_Z929
SY 75e 7vg4; 75 e 7 vg4
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 75e7vg5
AC CVCL_Z918
SY 75e 7vg5; 75 e 7 vg5
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Female
CA Spontaneously immortalized cell line
//
ID 75e7vg6
AC CVCL_Z930
SY 75e 7vg6; 75 e 7 vg6
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 75e7vg7
AC CVCL_Z919
SY 75e 7vg7; 75 e 7 vg7
RX CelloPub=CLPUB00208;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Male
CA Spontaneously immortalized cell line
//
ID 75j23pe34
AC CVCL_Z926
DR CLO; CLO_0001480
DR CLDB; cl127
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 76 BLCL
AC CVCL_E412
DR ECACC; 94031613
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 76-2
AC CVCL_Z022
RX PubMed=7817386;
RX PubMed=9163851;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 76-2-11
AC CVCL_4472
DR CLO; CLO_0001481
DR ATCC; HB-143
RX PubMed=6609988;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 76-5-28
AC CVCL_4473
DR CLO; CLO_0001482
DR ATCC; HB-153
RX PubMed=6609988;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 76-6-7
AC CVCL_4474
DR CLO; CLO_0001483
DR ATCC; HB-141
RX PubMed=6609988;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 76-7-4
AC CVCL_4475
DR CLO; CLO_0001484
DR CLDB; cl5154
DR ATCC; HB-140
DR IZSLER; BS Hy 22
RX PubMed=6609988;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7603830
AC CVCL_E931
RX PubMed=11528123;
WW http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC Group: Non-human primate cell line.
CC Breed/subspecies: Bolivian/Peruvian hybrid.
OX NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis
CA Finite cell line
//
ID 769-P
AC CVCL_1050
SY 769P; 769-p
DR CLO; CLO_0001485
DR EFO; EFO_0002099
DR ATCC; CRL-1933
DR BioSample; SAMN03473275
DR CCLE; 769P_KIDNEY
DR CCRID; 3111C0001CCC000333
DR CCRID; 3131C0001001200020
DR CCRID; 3142C0001000000087
DR ChEMBL-Cells; CHEMBL3308705
DR ChEMBL-Targets; CHEMBL1075385
DR CLS; 300106/p490_769-P
DR Cosmic; 687935
DR Cosmic; 801355
DR Cosmic; 910922
DR Cosmic; 982280
DR Cosmic; 1779197
DR Cosmic; 2520640
DR Cosmic-CLP; 910922
DR GDSC; 910922
DR GEO; GSM374479
DR GEO; GSM827256
DR GEO; GSM886844
DR GEO; GSM887908
DR GEO; GSM1669571
DR IGRhCellID; 769P
DR IZSLER; BS TCL 123
DR KCB; KCB 2013031YJ
RX PubMed=721102;
RX PubMed=1010528;
RX PubMed=6244232;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27993170;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 35 hours (PubMed=721102).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,14
ST D16S539: 9,13
ST D18S51: 14,17
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 12,16
ST FGA: 20,22
ST Penta D: 12,16
ST Penta E: 7,18
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 76NE6
AC CVCL_S909
SY 76E6
RX PubMed=1658367;
RX PubMed=7537374;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S910 ! 76NE7
CA Transformed cell line
//
ID 76NE7
AC CVCL_S910
SY 76E7
RX PubMed=1658367;
RX PubMed=7537374;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S909 ! 76NE6
CA Transformed cell line
//
ID 77-4
AC CVCL_Z023
RX PubMed=7817386;
RX PubMed=9163851;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 776.1
AC CVCL_0I09
DR ATCC; PTA-4570
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7777-14b-aza
AC CVCL_0F78
SY 7777-14b-AZA
RX PubMed=3859464;
RX PubMed=6604949;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_0444 ! McA-RH7777
OI CVCL_2113 ! MH-7777A
SX Female
CA Cancer cell line
//
ID 77N1
AC CVCL_6810
DR IFO; IFO50280
CC Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) [Strain Bratislava-77 (B77)].
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Transformed cell line
//
ID 78 BLCL
AC CVCL_E413
DR ECACC; 94031614
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 78-5
AC CVCL_1Q52
RX PubMed=2595451;
RX PubMed=4332008;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U406 ! CHO-glyA
CA Hybrid cell line
//
ID 78-5j1
AC CVCL_1Q53
SY J1; J1(glyA)
RX PubMed=2595451;
RX PubMed=4332008;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1Q52 ! 78-5
CA Hybrid cell line
//
ID 7800C1
AC CVCL_3870
SY 7800 C1; Morris hepatoma 7800C1
DR BTO; BTO:0002535
DR ChEMBL-Cells; CHEMBL3308566
DR ChEMBL-Targets; CHEMBL614742
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 786-O
AC CVCL_1051
SY 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT
DR BTO; BTO:0003781
DR CLO; CLO_0001486
DR EFO; EFO_0005707
DR ATCC; CRL-1932
DR BCRC; 60243
DR BioSample; SAMN03471906
DR CCLE; 786O_KIDNEY
DR CCRID; 3111C0001CCC000243
DR CCRID; 3131C0001000700003
DR ChEMBL-Cells; CHEMBL3307284
DR ChEMBL-Cells; CHEMBL3308018
DR ChEMBL-Cells; CHEMBL3308645
DR ChEMBL-Targets; CHEMBL613102
DR ChEMBL-Targets; CHEMBL614043
DR ChEMBL-Targets; CHEMBL614776
DR CLS; 300107/p747_786-O
DR Cosmic; 687936
DR Cosmic; 875874
DR Cosmic; 897461
DR Cosmic; 905947
DR Cosmic; 972929
DR Cosmic; 974305
DR Cosmic; 982276
DR Cosmic; 1044259
DR Cosmic; 1092589
DR Cosmic; 1175848
DR Cosmic; 1305372
DR Cosmic; 1312360
DR Cosmic; 1481416
DR Cosmic; 1998431
DR Cosmic; 2036676
DR Cosmic; 2520637
DR Cosmic-CLP; 905947
DR ENCODE; ENCBS261AAA
DR ENCODE; ENCBS413VCR
DR ENCODE; ENCBS807WMR
DR GDSC; 905947
DR GEO; GSM50226
DR GEO; GSM50290
DR GEO; GSM482711
DR GEO; GSM750838
DR GEO; GSM799371
DR GEO; GSM799377
DR GEO; GSM799434
DR GEO; GSM843437
DR GEO; GSM846283
DR GEO; GSM886845
DR GEO; GSM887909
DR GEO; GSM1153444
DR GEO; GSM1181296
DR GEO; GSM1181322
DR GEO; GSM1669572
DR IZSLER; BS TCL 124
DR KCB; KCB 200941YJ
DR Lonza; 1087
DR PRIDE; PXD000335
DR PRIDE; PXD000589
DR PRIDE; PXD001493
DR PRIDE; PXD003105
DR SKY/M-FISH/CGH; 2782
RX PubMed=721102;
RX PubMed=1010528;
RX PubMed=2041050;
RX PubMed=6244232;
RX PubMed=7915601;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=27993170;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=40
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/RCC7860_Crawford_protocol.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 45 hours (PubMed=721102); 24 hours (PubMed=25984343); 22.4 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: '768-0' in ChEMBL CHEMBL614043 and CHEMBL3307284.
CC Misspelling: '796-0' in ChEMBL CHEMBL614776 and CHEMBL3308645.
ST Source(s): ATCC; CLS; Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12
ST D18S51: 13,14
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 17,18
ST D3S1358: 16
ST D5S818: 9
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 24,25 (CLS)
ST FGA: 24 (PubMed=19372543; PubMed=25877200)
ST Penta D: 9,12
ST Penta E: 7,16
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 786-O-Luc
AC CVCL_J240
SY 786-0-Luc
DR JCRB; JCRB1397
DR JCRB; NIHS0651
CC Transfected with: UniProtKB; P08659; Firefly luciferase (pMSCV-luc).
CC Discontinued: JCRB; NIHS0651; true.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1051 ! 786-O
SX Male
CA Cancer cell line
//
ID 786-O/Luc
AC CVCL_AS74
SY 786-0/Luciferase
RX PubMed=20443133;
CC Transfected with: UniProtKB; P08659; Firefly luciferase (pRev_CMV_Luc2).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1051 ! 786-O
SX Male
CA Cancer cell line
//
ID 7898
AC CVCL_EQ46
SY 5260
DR GEO; GSM666038
DR GEO; GSM666039
RX PubMed=22033105;
CC Omics: Transcriptome analysis.
DI NCIt; C98994; NADH dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 791T
AC CVCL_D535
DR ChEMBL-Cells; CHEMBL3307892
DR ChEMBL-Targets; CHEMBL614254
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 7926
AC CVCL_1937
DR DSMZ; ACC-587
RX PubMed=11747540;
RX PubMed=20638124;
CC From: Yoshida K.; National Institute of Radiological Sciences; Chiba-shi; Japan.
CC Doubling time: ~50-80 hours (DSMZ).
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 794CSF
AC CVCL_EJ06
DR Cosmic; 1751978
RX PubMed=22082607;
CC Derived from metastatic site: Cerebrospinal fluid.
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 798-mel
AC CVCL_S563
SY 798mel
DR CGH-DB; 9305-4
DR Cosmic; 905218
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 798A3
AC CVCL_DQ38
DR GEO; GSM2152679
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DQ50 ! DP94
SX Female
CA Induced pluripotent stem cell
//
ID 798B2
AC CVCL_DQ39
DR GEO; GSM2152680
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DQ50 ! DP94
SX Female
CA Induced pluripotent stem cell
//
ID 79f7Dv3g
AC CVCL_Z280
SY 79 f7 Dv 3g
DR CLO; CLO_0001487
DR CLDB; cl130
RX DOI=10.1007/BF02623449;
RX DOI=10.1016/B978-012229460-0/50004-X;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/s79f7dv3g.htm
CC Group: Insect cell line.
OX NCBI_TaxID=7244; ! Drosophila virilis
SX Male
CA Spontaneously immortalized cell line
//
ID 7A11
AC CVCL_0I10
DR ATCC; PTA-5110
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7A2.4.1
AC CVCL_U725
SY anti-FcRH1,2,3-7A2
DR ATCC; PTA-6335
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7A9
AC CVCL_J152
DR CLO; CLO_0001488
DR ATCC; HB-10135
RX Patent=US5011778;
CC Monoclonal antibody target: Human IL1-activated endothelial cells.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7B6.15.11
AC CVCL_J990
DR ATCC; PTA-5000
RX Patent=US20080171036;
CC Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
CC Discontinued: ATCC; PTA-5000; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 7C2
AC CVCL_M052
DR ECACC; 91060550
CC Monoclonal antibody target: UniProtKB; W5QHT2; Sheep CD8A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7C2C5C12
AC CVCL_4496
SY 7C2C5; 7C2 C5
DR CLO; CLO_0001490
DR CLDB; cl5111
DR ATCC; HB-8678
DR IZSLER; BS Hy 48
RX Patent=US4670384;
CC Monoclonal antibody target: Trichinella spiralis antigens Ts.45, Ts.49 and Ts.53.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7C6
AC CVCL_0I11
DR ATCC; PTA-5111
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7C6.5.4
AC CVCL_J931
DR CLO; CLO_0001491
DR ATCC; HB-9574
RX Patent=US5194593;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7C8
AC CVCL_J156
DR CLO; CLO_0001492
DR ATCC; HB-8465
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 7D10
AC CVCL_IQ48
RX Patent=EP0162812A2;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-418.
CC Monoclonal antibody target: UniProtKB; P14174; Mouse Mif.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7D11.1.1
AC CVCL_U726
SY anti-FcRH5c-7D11
DR ATCC; PTA-6340
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7D2-1.4.1.5
AC CVCL_8829
DR CLO; CLO_0001493
DR ATCC; HB-92
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7D3A.2
AC CVCL_J932
DR CLO; CLO_0001494
DR ATCC; CRL-1886
RX PubMed=6186076;
CC Monoclonal antibody target: UniProtKB; P18609; Bluetongue virus 17 VP7.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7D4
AC CVCL_4497
SY 7 D4
DR CLO; CLO_0001463
DR CLO; CLO_0001495
DR CLDB; cl5110
DR ATCC; CRL-1698
DR BCRJ; 0028
DR ECACC; 88111402
DR IZSLER; BS Hy 24
DR JCRB; JCRB9092
RX PubMed=6412230;
CC Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7E10(GC) Clone A
AC CVCL_U078
DR ECACC; 02043021
CC Monoclonal antibody target: UniProtKB; P02774; Human GC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7E11C5
AC CVCL_J934
SY 7E11-C5; 7E11.C5
DR CLO; CLO_0001496
DR ATCC; HB-10494
RX Patent=US5763202;
RX PubMed=2449118;
CC Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7E12H12
AC CVCL_G696
DR CLO; CLO_0001497
DR ATCC; HB-9397
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 7E2
AC CVCL_9V27
RX PubMed=2264287;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybrid cell line
//
ID 7E3
AC CVCL_J935
DR CLO; CLO_0001498
DR ATCC; HB-8832
RX Patent=US5976532;
CC Discontinued: ATCC; HB-8832; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7E4.1.1
AC CVCL_U727
SY anti-FcRH1,2,3,5-7E4
DR ATCC; PTA-6338
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7E9
AC CVCL_N024
DR ATCC; PTA-7313
RX Patent=US7737259;
CC Monoclonal antibody target: UniProtKB; Q8N6P7; Human IL22RA1.
CC Discontinued: ATCC; PTA-7313; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 7F10
AC CVCL_0I12
DR ATCC; PTA-5112
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7F2
AC CVCL_6558
DR CLO; CLO_0001499
DR ATCC; CRL-12557
DR BCRC; 60453
RX Patent=US5830682;
RX PubMed=9495512;
CC Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID 7F2-6D4-8E7
AC CVCL_G624
DR CLO; CLO_0001500
DR ATCC; HB-11945
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7F8.C7
AC CVCL_IV64
DR ATCC; PTA-8335
RX Patent=US8022175;
CC Monoclonal antibody target: Newcastle disease viruses HN protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7F9
AC CVCL_U638
DR CLO; CLO_0050404
DR RCB; RCB2811
RX PubMed=17207026;
CC Monoclonal antibody target: UniProtKB; D4A9Q5; Rat Cpm.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID 7G10
AC CVCL_0I13
DR ATCC; PTA-5245
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7G5.3B6
AC CVCL_IQ65
RX Patent=US9221910;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2921.
CC Monoclonal antibody target: UniProtKB; P07333; Human CSF1R/CD115.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7G7.7.8
AC CVCL_U728
SY anti-FcRH2-7G7
DR ATCC; PTA-6336
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 7G7B6
AC CVCL_J731
SY 7G7/B6
DR CLO; CLO_0001501
DR ATCC; HB-8784
DR NCBI_Iran; H161
RX Patent=US4707443;
CC Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7GP
AC CVCL_8331
RX PubMed=8125107;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8337 ! M4Beu
CA Cancer cell line
//
ID 7GP122
AC CVCL_8332
SY 7Gp122
RX PubMed=11059782;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8331 ! 7GP
CA Cancer cell line
//
ID 7H1
AC CVCL_0I14
DR ATCC; PTA-5114
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 7KE2
AC CVCL_DR15
DR GEO; GSM1489216
DR GEO; GSM1489456
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 7LBLN
AC CVCL_S345
DR ATCC; CRL-6051
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6051; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID 7R2/A4
AC CVCL_J052
DR ECACC; 92030601
DR NCBI_Iran; H116
CC Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 7SA
AC CVCL_HA77
RX PubMed=1737362;
RX PubMed=1973007;
RX PubMed=2496488;
RX PubMed=2505924;
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0190 ! C3H/10T1/2 clone 8
CA Transformed cell line
//
ID 7T1
AC CVCL_4E63
DR RCB; RCB0171
RX DOI=10.1247/csf.4.267;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID 8-MG-BA
AC CVCL_1052
SY 8MGBA
DR CLO; CLO_0001523
DR BioSample; SAMN03473597
DR CCLE; 8MGBA_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308251
DR ChEMBL-Targets; CHEMBL2366115
DR Cosmic; 687562
DR Cosmic; 1746945
DR Cosmic; 2302327
DR Cosmic; 2367505
DR Cosmic-CLP; 687562
DR DSMZ; ACC-432
DR GDSC; 687562
DR GEO; GSM326211
DR GEO; GSM886848
DR GEO; GSM887912
DR GEO; GSM1669575
RX PubMed=9604998;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 8.03
AC CVCL_J170
SY 8.03.4
DR ATCC; HB-8388
RX Patent=US4650676;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 8.2
AC CVCL_K252
RX PubMed=8566067;
CC Characteristics: IL4 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K251 ! LD8
CA Factor-dependent cell line
//
ID 80 V 5B4
AC CVCL_J732
DR CLO; CLO_0001504
DR ATCC; TIB-132
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 80-1
AC CVCL_N033
DR ATCC; HB-11871
RX Patent=US5675063;
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_J972 ! 240E1-1-2
CA Hybridoma
//
ID 8016
AC CVCL_HF00
RX PubMed=20638124;
CC From: Yoshida K.; National Institute of Radiological Sciences; Chiba-shi; Japan.
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 8029 DDP4
AC CVCL_7001
SY 8029 DDP
RX PubMed=8679156;
RX PubMed=20947470;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7000 ! 8029 NA
SX Male
CA Cancer cell line
//
ID 8029 NA
AC CVCL_7000
RX PubMed=8679156;
RX PubMed=20947470;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6648 ! HLaC-79
SX Male
CA Cancer cell line
//
ID 802C11
AC CVCL_C475
DR CLO; CLO_0050278
DR RCB; RCB2308
RX PubMed=9758151;
CC Monoclonal antibody target: UniProtKB; Q61490; Mouse Alcam/Cd166.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 803-15.6
AC CVCL_J936
DR CLO; CLO_0001505
DR ATCC; CRL-2395
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 804 G
AC CVCL_J122
SY 804G
RX PubMed=7448785;
RX PubMed=1986003;
CC Transformant: ChEBI; CHEBI:91112; N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN).
CC Breed/subspecies: ACI.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID 807.15
AC CVCL_J937
DR CLO; CLO_0001506
DR ATCC; CRL-2287
RX PubMed=7101727;
CC Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse GP (recognizes glycoprotein GC/G1).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 807.31
AC CVCL_J938
DR CLO; CLO_0001507
DR ATCC; CRL-2282
RX PubMed=7101727;
CC Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse GP (recognizes glycoprotein GC/G1).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 807.33
AC CVCL_J939
DR CLO; CLO_0001508
DR ATCC; CRL-2290
RX PubMed=7101727;
CC Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse GP (recognizes glycoprotein GC/G1).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 80T
AC CVCL_6359
DR CLO; CLO_0001509
DR ATCC; CRL-7901
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7901; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Finite cell line
//
ID 81.3
AC CVCL_0602
DR CLO; CLO_0001001
DR CLDB; cl131
DR ECACC; 85100105
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 82-132
AC CVCL_5U99
SY Clara M
RX PubMed=6850563;
RX PubMed=9347924;
CC Breed/subspecies: Swiss Webster.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 82-6
AC CVCL_U636
RX PubMed=12034742;
RX PubMed=17870066;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/8/cell-lines-detail-533.html
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID 82-6pBlox
AC CVCL_U637
SY 82-6pBloxTSH
RX PubMed=12034742;
RX PubMed=17870066;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U636 ! 82-6
CA Telomerase immortalized cell line
//
ID 821A1
AC CVCL_DQ40
DR GEO; GSM2152681
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 821B1
AC CVCL_DQ41
DR GEO; GSM2152682
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 83-12-5
AC CVCL_K120
DR CLO; CLO_0001511
DR ATCC; CRL-1971
RX PubMed=3097135;
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8305C
AC CVCL_1053
SY 8305c; 8305-C; 8305C_1
DR BTO; BTO:0000919
DR CLO; CLO_0001510
DR CLO; CLO_0050949
DR CLDB; cl132
DR CLDB; cl133
DR BioSample; SAMN01821670
DR BioSample; SAMN03470959
DR BioSample; SAMN03473414
DR CCLE; 8305C_THYROID
DR CGH-DB; 53-1
DR ChEMBL-Cells; CHEMBL3308706
DR ChEMBL-Targets; CHEMBL1075386
DR Cosmic; 906795
DR Cosmic; 922364
DR Cosmic; 2009523
DR Cosmic; 2054104
DR Cosmic-CLP; 906795
DR DSMZ; ACC-133
DR ECACC; 94090183
DR GDSC; 906795
DR GEO; GSM886846
DR GEO; GSM887910
DR GEO; GSM1669573
DR ICLC; HTL96026
DR JCRB; JCRB0824
DR NCBI_Iran; C597
DR RCB; RCB1909
DR TKG; TKG 0446
RX PubMed=9177455;
RX PubMed=9290701;
RX PubMed=16924234;
RX PubMed=21566963;
RX PubMed=22460905;
RX PubMed=23833040;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~54 hours (DSMZ); 43 hours (ECACC); ~43 hours (ICLC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9
ST D16S539: 10,11
ST D18S51: 13,24
ST D19S433: 14
ST D21S11: 30,32.2
ST D2S1338: 17,25
ST D3S1358: 15
ST D5S818: 10,13
ST D7S820: 8,10 (Cosmic-CLP; ECACC; JCRB; PubMed=25877200; RCB; TKG)
ST D7S820: 8 (DSMZ)
ST D8S1179: 11,14
ST FGA: 21,22
ST Penta D: 10
ST Penta E: 15,17
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 8328
AC CVCL_EQ47
DR GEO; GSM666040
DR GEO; GSM666041
RX PubMed=22033105;
CC Omics: Transcriptome analysis.
DI NCIt; C98994; NADH dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 833K-E
AC CVCL_2292
SY 833KE; 833-KE; 833K; HT-E
DR ChEMBL-Cells; CHEMBL3307813
DR ChEMBL-Targets; CHEMBL613103
DR Cosmic; 821812
DR Cosmic; 2077187
DR ECACC; 06072611
RX PubMed=6169654;
RX PubMed=6244232;
RX PubMed=7388807;
RX PubMed=7471097;
RX PubMed=9772905;
RX PubMed=14762065;
CC Omics: CNV analysis.
CC Derived from metastatic site: Abdomen.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 12,16
ST D21S11: 28,31
ST D8S1179: 13
ST FGA: 22
ST TH01: 6,9
ST vWA: 15,18,19
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C508 ! 833K-LC
SX Male
CA Cancer cell line
//
ID 833K-LC
AC CVCL_C508
SY 833-K-LC; 833KLC; 833K/LC
RX PubMed=6169654;
RX PubMed=7388807;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2292 ! 833K-E
SX Male
CA Transformed cell line
//
ID 836-mel
AC CVCL_8057
SY 836 mel; 836
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 84 BLCL
AC CVCL_E414
DR ECACC; 94031615
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 84BR
AC CVCL_2293
DR CLO; CLO_0001512
DR CLDB; cl134
DR ECACC; 90011805
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 13,18
ST D16S539: 11,12
ST D5S818: 11,14
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 8505C
AC CVCL_1054
SY 8505c
DR BTO; BTO:0005550
DR CLO; CLO_0001513
DR CLO; CLO_0050951
DR CLDB; cl135
DR CLDB; cl136
DR BioSample; SAMN01821611
DR BioSample; SAMN03470935
DR BioSample; SAMN03472518
DR BioSample; SAMN03473379
DR CCLE; 8505C_THYROID
DR CGH-DB; 54-1
DR ChEMBL-Cells; CHEMBL3308353
DR ChEMBL-Targets; CHEMBL1075387
DR Cosmic; 889489
DR Cosmic; 891256
DR Cosmic; 922365
DR Cosmic; 924102
DR Cosmic; 1084283
DR Cosmic; 1132598
DR Cosmic; 1152114
DR Cosmic; 1162837
DR Cosmic; 1239959
DR Cosmic; 2036694
DR Cosmic; 2054105
DR Cosmic-CLP; 924102
DR DSMZ; ACC-219
DR ECACC; 94090184
DR GDSC; 924102
DR GEO; GSM886847
DR GEO; GSM887911
DR GEO; GSM1669574
DR JCRB; JCRB0826
DR RCB; RCB2103
DR TKG; TKG 0439
RX PubMed=9290701;
RX PubMed=16924234;
RX PubMed=17725429;
RX PubMed=17804723;
RX PubMed=18713817;
RX PubMed=19087340;
RX PubMed=21566963;
RX PubMed=21868764;
RX PubMed=22460905;
RX PubMed=23162534;
RX PubMed=23833040;
RX PubMed=27397505;
WW http://www.addexbio.com/productdetail?pid=19
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30-40 hours (DSMZ); 36 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: '8509C' in Cosmic 1132598.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=18713817; PubMed=21868764; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 13
ST D16S539: 12
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 28,32.2
ST D2S1338: 17,24
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 10,13
ST FGA: 23
ST Penta D: 9,10
ST Penta E: 12,15
ST TH01: 6,9 (Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=21868764; RCB; TKG)
ST TH01: 6 (PubMed=25877200)
ST TPOX: 10,11 (Cosmic-CLP; DSMZ; RCB; TKG)
ST TPOX: 11 (ECACC; JCRB; PubMed=21868764; PubMed=25877200)
ST vWA: 17,19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 859H5
AC CVCL_C477
DR CLO; CLO_0050523
DR RCB; RCB2312
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID 86 BLCL
AC CVCL_E415
DR ECACC; 94031616
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 86-2
AC CVCL_6757
DR CLO; CLO_0050053
DR BioSample; SAMN03472011
DR CGH-DB; 9185-4
DR Cosmic; 946066
DR Cosmic; 1048223
DR Cosmic; 1066157
DR Cosmic; 1656908
DR RCB; RCB2134
DR TKG; TKG 0181
RX PubMed=7817386;
RX PubMed=15746151;
RX PubMed=22313637;
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 86-3
AC CVCL_J875
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 862L
AC CVCL_8477
SY MPC 862L
DR BTO; BTO:0004580
RX PubMed=15860353;
CC Breed/subspecies: 129S2/SvPas x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID 865-mel
AC CVCL_S564
SY 865mel
DR CGH-DB; 9306-4
DR Cosmic; 905219
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 866MT
AC CVCL_8090
SY 866 MT
DR Cosmic; 929964
DR Cosmic; 932917
DR Cosmic; 934540
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 86D
AC CVCL_G095
SY 127.5-9
DR CLO; CLO_0001514
DR ATCC; HB-286
DR ECACC; 91060557
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 86HG39
AC CVCL_7259
SY 86HG-39; 86-HG-39
RX PubMed=1460090;
RX PubMed=1708926;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 87-5
AC CVCL_6750
DR CLO; CLO_0050040
DR BioSample; SAMN03472058
DR CGH-DB; 96-1
DR CGH-DB; 9048-4
DR RCB; RCB2092
DR TKG; TKG 0503
RX PubMed=7817386;
RX PubMed=12107105;
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 13,14
ST D5S818: 13
ST D7S820: 10,11,12 (RCB)
ST D7S820: 11,12 (TKG)
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17,18 (RCB)
ST vWA: 16,18 (TKG)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 8701-BC
AC CVCL_H610
DR ChEMBL-Cells; CHEMBL3307701
DR ChEMBL-Targets; CHEMBL614777
RX PubMed=2548558;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 8709
AC CVCL_1938
DR DSMZ; ACC-588
RX PubMed=11747540;
RX PubMed=20638124;
CC From: Yoshida K.; National Institute of Radiological Sciences; Chiba-shi; Japan.
CC Doubling time: ~60-80 hours (DSMZ).
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 87HG28
AC CVCL_V026
SY 87HG-28
RX PubMed=1460090;
RX PubMed=1708926;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 87HG31
AC CVCL_V027
SY 87HG-31
RX PubMed=1460090;
RX PubMed=1708926;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 88 BLCL
AC CVCL_E416
DR ECACC; 94031617
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 88-3
AC CVCL_IU70
SY NF188-3
RX PubMed=1568246;
RX PubMed=10791998;
RX PubMed=16510576;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 8807
AC CVCL_EQ48
SY 7276
DR GEO; GSM666042
DR GEO; GSM666043
RX PubMed=22033105;
CC Omics: Transcriptome analysis.
DI NCIt; C98994; NADH dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 883-mel
AC CVCL_S565
SY 883mel
DR CGH-DB; 9307-4
DR Cosmic; 905220
RX PubMed=10048982;
RX PubMed=15467732;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 883L
AC CVCL_6A87
RX PubMed=4333982;
RX PubMed=4346033;
RX PubMed=4357683;
RX PubMed=6294325;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 884F11
AC CVCL_C476
DR CLO; CLO_0050279
DR RCB; RCB2313
RX PubMed=10616916;
CC Monoclonal antibody target: UniProtKB; P08226; Mouse Apoe.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 888-mel
AC CVCL_4632
SY 888-MEL; 888 mel; 888mel; 888; Mel888; MG-888
DR BTO; BTO:0002950
DR EFO; EFO_0006531
DR CGH-DB; 9308-4
DR Cosmic; 876679
DR Cosmic; 877281
DR Cosmic; 905221
DR Cosmic; 1042621
DR Cosmic; 1238108
DR Cosmic; 1303045
DR GEO; GSM206439
DR GEO; GSM218046
DR GEO; GSM1092556
RX PubMed=8081556;
RX PubMed=8537970;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=15467732;
RX PubMed=16470173;
RX PubMed=18172304;
RX PubMed=25485619;
WW http://www.ott.nih.gov/erma/metastatic-melanoma-cancer-cell-line-888-mel
CC Omics: Array-based CGH.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous; soft palate.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7943 ! 1290-mel
OI CVCL_DI11 ! 1858-mel a
OI CVCL_DI12 ! 1858-mel b
OI CVCL_DI13 ! 1858-mel c
OI CVCL_DI14 ! 1936-mel
OI CVCL_DI15 ! 1962-mel
SX Female
CA Cancer cell line
//
ID 888A2 mel
AC CVCL_C612
SY 888 A2 Mel
RX PubMed=11924911;
CC Transfected with: HGNC; 4931; HLA-A (allele HLA-A2).
CC Derived from metastatic site: Subcutaneous; soft palate.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4632 ! 888-mel
SX Female
CA Cancer cell line
//
ID 88B
AC CVCL_J733
DR CLO; CLO_0001515
DR ATCC; CRL-1967
RX PubMed=6189834;
CC Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
CC Monoclonal antibody target: UniProtKB; P02714; Tetronarce californica chrng.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 88TAg
AC CVCL_6768
DR CLO; CLO_0001516
DR ATCC; CRL-2820
RX PubMed=12882965;
CC Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 894-mel
AC CVCL_S566
SY 894mel
DR CGH-DB; 9309-4
DR Cosmic; 905222
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 89MS30
AC CVCL_G625
SY GLXA-Ab1
DR CLO; CLO_0001517
DR ATCC; HB-11300
RX Patent=US5656271;
RX PubMed=8837610;
CC Monoclonal antibody target: Chlamydia trachomatis exoglycolipid antigen (GLXA).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8A1
AC CVCL_0I15
DR ATCC; PTA-5115
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8A12 [Mouse hybridoma against guinea pig MBP]
AC CVCL_L532
DR ECACC; 94091319
RX PubMed=8334540;
CC Monoclonal antibody target: UniProtKB; P22032; Cavia porcellus MBP1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8A12 [Mouse hybridoma against human IL-22R]
AC CVCL_N025
DR ATCC; PTA-7318
RX Patent=US7737259;
CC Monoclonal antibody target: UniProtKB; Q8N6P7; Human IL22RA1.
CC Discontinued: ATCC; PTA-7318; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 8A2N
AC CVCL_G626
SY 8A2
DR CLO; CLO_0001518
DR ATCC; HB-8161
RX Patent=US4767710;
RX PubMed=6197636;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8A3B.6
AC CVCL_J734
DR CLO; CLO_0001519
DR ATCC; CRL-1875
RX PubMed=6186076;
CC Monoclonal antibody target: UniProtKB; P18609; Bluetongue virus 17 VP7.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 8B1B.1
AC CVCL_J735
DR CLO; CLO_0001520
DR ATCC; CRL-1877
RX PubMed=6186076;
CC Monoclonal antibody target: UniProtKB; P18609; Bluetongue virus 17 VP7.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 8B5
AC CVCL_0I16
DR ATCC; PTA-5116
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8C3
AC CVCL_0I17
DR ATCC; PTA-5246
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8C9
AC CVCL_J736
DR CLO; CLO_0050288
DR ECACC; 99072805
DR RCB; RCB0844
RX PubMed=1281958;
CC Monoclonal antibody target: UniProtKB; P16671; Human CD36.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 8CB-1
AC CVCL_9Q48
RX PubMed=186420;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
OX NCBI_TaxID=9557; ! Papio hamadryas
OI CVCL_9Q47 ! 13CB-1
OI CVCL_4087 ! 26CB-1
SX Male
CA Transformed cell line
//
ID 8D12
AC CVCL_G200
DR ECACC; 94091320
RX PubMed=8334540;
CC Monoclonal antibody target: UniProtKB; P22032; Cavia porcellus MBP1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8E11.9
AC CVCL_N026
DR ATCC; PTA-7319
RX Patent=US7737259;
CC Monoclonal antibody target: UniProtKB; Q9GZX6; Human IL22.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 8E3
AC CVCL_0I18
DR ATCC; PTA-5118
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8E5
AC CVCL_3484
SY 8E5(CEM); 8E5/LAV
DR CLO; CLO_0001521
DR ATCC; CRL-8993
DR BioSample; SAMN03471213
DR NIH-ARP; 95-75
RX Patent=US4752565;
RX PubMed=3014036;
CC Characteristics: HIV-1 producing cell line.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 12,13
ST D16S539: 10,13
ST D5S818: 12
ST D7S820: 9,13
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,20
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6244 ! A3.01
SX Female
CA Cancer cell line
//
ID 8E7
AC CVCL_6360
DR CLO; CLO_0001522
DR ATCC; CRL-8795
DR BioSample; SAMN03472814
RX Patent=US4834975;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 10,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 8G9
AC CVCL_0I19
DR ATCC; PTA-5119
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 8H11
AC CVCL_N027
DR ATCC; PTA-7317
RX Patent=US7737259;
CC Monoclonal antibody target: UniProtKB; Q8N6P7; Human IL22RA1.
CC Discontinued: ATCC; PTA-7317; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 8H7
AC CVCL_4T77
DR ATCC; CRL-9258
RX Patent=US5662905;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-9258; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 8HTEo-
AC CVCL_U404
SY 8/HTEo-
RX PubMed=2457904;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U403 ! 3HTEo-
OI CVCL_U405 ! 9HTEo-
CA Transformed cell line
//
ID 9-15c
AC CVCL_6532
SY 9-15C
DR CLO; CLO_0051036
DR JCRB; JCRB1181
DR RCB; RCB2323
RX PubMed=21155951;
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Adult stem cell
//
ID 9-1A11
AC CVCL_J737
DR CLO; CLO_0050362
DR RCB; RCB0869
CC Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 9-2-4
AC CVCL_G560
DR ATCC; CRL-2485
CC Monoclonal antibody target: Anti-idotypic against monoclonal antibody TC31.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 9-4
AC CVCL_J876
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 9-4-3
AC CVCL_4476
DR CLO; CLO_0001533
DR CLDB; cl5121
DR ATCC; HB-8935
DR IZSLER; BS Hy 39
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 9-A5
AC CVCL_J738
DR CLO; CLO_0001534
DR ATCC; CRL-1844
DR BCRC; 60144
RX PubMed=6310568;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 9-B1
AC CVCL_J047
DR CLO; CLO_0001536
DR ATCC; CRL-1845
RX PubMed=6310568;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 9.0.4.C43
AC CVCL_7242
DR CLO; CLO_0001525
DR CLDB; cl138
DR IHW; IHW8117
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID 9.3F10
AC CVCL_J739
DR CLO; CLO_0001526
DR ATCC; HB-180
RX PubMed=6190974;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 9.4
AC CVCL_C553
DR CLO; CLO_0001527
DR ATCC; HB-10508
DR CCRID; 3142C0001000000441
RX Patent=US5273738;
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 9/3L
AC CVCL_8479
SY MPC 9/3L
RX PubMed=15860353;
CC Breed/subspecies: 129S2/SvPas x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID 90 BLCL
AC CVCL_E417
DR ECACC; 94031618
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 90-8
AC CVCL_1B47
SY 90-8TL; NF90-8; NF190-8
DR EFO; EFO_0006288
RX PubMed=1568246;
RX PubMed=10791998;
RX PubMed=16239399;
RX PubMed=16510576;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 90.74
AC CVCL_6361
DR CLO; CLO_0001528
DR ATCC; CRL-11654
RX Patent=US5858740;
RX Patent=US6051427;
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 900-2K-34
AC CVCL_6E68
RX PubMed=195084;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA900].
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6E66 ! C3H2K-C4
CA Transformed cell line
//
ID 900-3Y-11
AC CVCL_6E70
RX PubMed=195084;
RX PubMed=6262522;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA900].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 9009B
AC CVCL_1K12
DR ATCC; CRL-11302
RX Patent=US5510258;
CC Group: Non-human primate cell line.
CC Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from African Green monkey instead of Rhesus macaque.
CC Discontinued: ATCC; CRL-11302; true.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_3845 ! MA-104
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 90196B
AC CVCL_6362
DR CLO; CLO_0001529
DR ATCC; CRL-9853
DR BioSample; SAMN03471078
RX Patent=US5447861;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 904.13
AC CVCL_Z933
RX PubMed=2822386;
RX PubMed=10497225;
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Breed/subspecies: RIII.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6550 ! C127
SX Female
CA Cancer cell line
//
ID 90P
AC CVCL_K050
RX PubMed=10739701;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 90P-hTERT
AC CVCL_K051
RX PubMed=17395154;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K050 ! 90P
SX Female
CA Telomerase immortalized cell line
//
ID 90PE6E7
AC CVCL_K052
RX PubMed=10739701;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K050 ! 90P
SX Female
CA Transformed cell line
//
ID 91-1
AC CVCL_2H63
SY 91-1 (Hsa21)
RX PubMed=16179473;
WW http://jaxmice.jax.org/strain/017529.html
CC Characteristics: Contains 90% of human chromosome 21.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2H62 ! MPI-VI
SX Female
CA Embryonic stem cell
//
ID 91-5
AC CVCL_9V03
DR ATCC; CRL-10038
RX Patent=US5731189;
RX PubMed=2922401;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-10038; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 91.1.F1
AC CVCL_6559
RX PubMed=22083648;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8364; ! Xenopus tropicalis
SX Sex undetermined
CA Finite cell line
//
ID 911
AC CVCL_1K15
SY HER;911
RX PubMed=8788172;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G704 ! PER.C6
CA Transformed cell line
//
ID 91MS441
AC CVCL_G627
SY GLXA-Ab2
DR CLO; CLO_0001530
DR ATCC; HB-11301
RX Patent=US5656271;
RX PubMed=8837610;
CC Monoclonal antibody target: Anti-idotypic against monoclonal antibody GLXA-Ab1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 92-1 [Human bladder carcinoma]
AC CVCL_W909
SY TCC 92-1
DR Cosmic; 1046694
DR Cosmic; 1285106
DR Cosmic; 2037941
DR Cosmic; 2050430
DR Cosmic; 2212690
DR GEO; GSM1574585
DR GEO; GSM1574588
RX PubMed=9436977;
RX PubMed=10919661;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 92-1 [Human uveal melanoma]
AC CVCL_8607
SY 92_1; 92.1
DR CLDB; cl7221
DR Cosmic; 848328
DR Cosmic; 899893
DR Cosmic; 916137
DR Cosmic; 986619
DR Cosmic; 1320371
DR Cosmic; 1628394
DR Cosmic; 1669117
DR Cosmic; 2036703
DR Cosmic; 2163829
DR ECACC; 13012458
DR ESTDAB; ESTDAB-127
DR GEO; GSM276761
DR ICLC; HTL12001
RX PubMed=7622289;
RX PubMed=15714118;
RX PubMed=16772116;
RX PubMed=17487557;
RX PubMed=22236444;
RX PubMed=24994677;
CC Doubling time: 38 hours (PubMed=24994677).
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12 (ECACC)
ST D13S317: 10,11 (ESTDAB)
ST D16S539: 12
ST D3S1358: 14,15
ST D5S818: 9,11 (ECACC)
ST D5S818: 12,13 (ESTDAB)
ST D7S820: 10,11 (ECACC)
ST D7S820: 11 (ESTDAB)
ST FGA: 21,23
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C300 ! 92-2
SX Female
CA Cancer cell line
//
ID 92-2
AC CVCL_C300
SY 92_2; 92.2
DR Cosmic; 916138
RX PubMed=7622289;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8607 ! 92-1 [Human uveal melanoma]
SX Female
CA Cancer cell line
//
ID 92BR
AC CVCL_4096
DR CLO; CLO_0001531
DR CLDB; cl140
DR ECACC; 90011874
OX NCBI_TaxID=9793; ! Equus asinus
SX Male
CA Finite cell line
//
ID 92TAg
AC CVCL_6363
DR CLO; CLO_0001532
DR ATCC; CRL-2816
RX PubMed=12882965;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 93 BLCL
AC CVCL_E418
DR ECACC; 94031619
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 938-mel
AC CVCL_8058
SY 938-MEL; 938 mel; 938
DR BTO; BTO:0002949
DR Cosmic; 876686
DR GEO; GSM218055
DR GEO; GSM1092561
RX PubMed=8027550;
RX PubMed=8081556;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 93RS2
AC CVCL_6D59
RX PubMed=9283952;
CC Characteristics: At the permissive temperature (32 Celsius) proliferates and has enhanced expression of a differentiated Sertoli cell phenotype at the restrictive temperature (40-41 Celsius).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA255].
CC Breed/subspecies: Charles River Sprague Dawley (CD(SD)).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID 93VU147T
AC CVCL_L895
SY 147T
DR Cosmic; 1122678
DR Cosmic; 2296308
RX PubMed=7585617;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 16
ST D21S11: 30,31
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 12,13.4
ST Penta E: 11,12
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 94-10
AC CVCL_8608
SY TCC 94-10
DR Cosmic; 2050431
DR Cosmic; 2057436
DR Cosmic; 2212691
DR Cosmic; 2444254
RX PubMed=9436977;
RX PubMed=10919661;
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 94-H4
AC CVCL_J818
DR BTO; BTO:0004029
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J816 ! S91 6neo
CA Hybrid cell line
//
ID 94-H48
AC CVCL_J819
DR BTO; BTO:0004027
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J816 ! S91 6neo
CA Hybrid cell line
//
ID 94A1
AC CVCL_J051
DR ECACC; 85062503
CC Group: Hybridoma fusion partner cell line.
CC Monoclonal antibody target: Sheep red blood cells (SRBC).
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 94T778
AC CVCL_U613
DR ATCC; CRL-3044
RX PubMed=18823700;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,14
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U614 ! 94T779
SX Female
CA Cancer cell line
//
ID 94T779
AC CVCL_U614
DR ATCC; CRL-3043
RX PubMed=18823700;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U613 ! 94T778
SX Female
CA Cancer cell line
//
ID 95-H1
AC CVCL_J820
DR BTO; BTO:0004028
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J816 ! S91 6neo
CA Hybrid cell line
//
ID 95-H12
AC CVCL_J821
DR BTO; BTO:0004031
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J816 ! S91 6neo
CA Hybrid cell line
//
ID 95-H3
AC CVCL_J822
DR BTO; BTO:0004030
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J816 ! S91 6neo
CA Hybrid cell line
//
ID 952-mel
AC CVCL_S567
SY 952mel
DR CGH-DB; 9311-4
DR Cosmic; 905224
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 957E/hTERT
AC CVCL_X476
RX PubMed=11507036;
RX PubMed=16413016;
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID 96-1
AC CVCL_8609
SY TCC 96-1
DR Cosmic; 1046700
DR Cosmic; 1285107
DR Cosmic; 2037942
DR Cosmic; 2050432
DR Cosmic; 2057437
DR Cosmic; 2444232
DR GEO; GSM1574576
RX PubMed=9436977;
RX PubMed=10919661;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 96-11
AC CVCL_8610
SY TCC 96-11
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 96-12
AC CVCL_8611
SY TCC 96-12
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 96-13
AC CVCL_8612
SY TCC 96-13
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 96-16
AC CVCL_8613
SY TCC 96-16
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 96-2
AC CVCL_8614
SY TCC 96-2
RX PubMed=9436977;
RX PubMed=10919661;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 96-9
AC CVCL_8615
SY TCC 96-9
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 97-1
AC CVCL_8616
SY TCC 97-1
DR Cosmic; 1046701
DR Cosmic; 1285108
DR Cosmic; 1927314
DR Cosmic; 2050433
DR Cosmic; 2057438
DR Cosmic; 2444253
DR GEO; GSM1574542
RX PubMed=9436977;
RX PubMed=10919661;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 97-10
AC CVCL_8617
SY TCC 97-10
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 97-15
AC CVCL_8618
SY TCC 97-15
RX PubMed=10919661;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 97-18-I
AC CVCL_8619
SY TCC 97-18-I; TCC 97-18; 97-18
DR Cosmic; 1046697
DR Cosmic; 2037943
DR Cosmic; 2050434
DR Cosmic; 2057440
DR Cosmic; 2444256
DR GEO; GSM1574577
RX PubMed=10919661;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8620 ! 97-21-M
SX Male
CA Cancer cell line
//
ID 97-21-M
AC CVCL_8620
SY TCC 97-21-M; TCC 97-21; 97-21
DR Cosmic; 1046698
DR Cosmic; 1285109
RX PubMed=10919661;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8619 ! 97-18-I
SX Male
CA Cancer cell line
//
ID 97-24
AC CVCL_8621
SY TCC 97-24
DR Cosmic; 1046699
DR Cosmic; 1285110
DR Cosmic; 2037944
DR Cosmic; 2050435
DR Cosmic; 2057441
DR Cosmic; 2444247
DR GEO; GSM1574582
DR GEO; GSM1574589
RX PubMed=10919661;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 97-29
AC CVCL_8622
SY TCC 97-29
DR Cosmic; 1046695
RX PubMed=10919661;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 97-5
AC CVCL_8623
SY TCC 97-5
RX PubMed=9436977;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 97-6
AC CVCL_8624
SY TCC 97-6
RX PubMed=9436977;
RX PubMed=10919661;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 97-7
AC CVCL_8625
SY TCC 97-7
DR Cosmic; 1046696
DR Cosmic; 1285111
DR Cosmic; 2050436
DR Cosmic; 2057439
DR Cosmic; 2444241
DR GEO; GSM1574551
RX PubMed=10919661;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 97A6
AC CVCL_IQ43
RX Patent=US6323321;
RX PubMed=11342463;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2297.
CC Monoclonal antibody target: UniProtKB; O14638; Human ENPP3/CD203c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 98-43
AC CVCL_9V06
RX Patent=US5731189;
RX PubMed=2922401;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 98-6
AC CVCL_9V07
RX Patent=US5731189;
RX PubMed=2922401;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 99S6
AC CVCL_J969
DR ATCC; PTA-6015
RX Patent=US7563873;
CC Registration: Chiron Master Culture Collection; CMCC 12337 (CMCC #12337).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_J972 ! 240E1-1-2
CA Hybridoma
//
ID 99S9
AC CVCL_J970
DR ATCC; PTA-6014
RX Patent=US7563873;
CC Registration: Chiron Master Culture Collection; CMCC 12336 (CMCC #12336).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_J972 ! 240E1-1-2
CA Hybridoma
//
ID 9A3M
AC CVCL_Y310
SY 9A3
DR ATCC; HB-8160
RX Patent=US4767710;
RX PubMed=6197636;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with S-20 and G-24; recognizes M blood group antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 9AE10
AC CVCL_J740
DR CLO; CLO_0001535
DR ATCC; CRL-1761
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 9BG5
AC CVCL_4498
SY 9 BG 5
DR CLO; CLO_0001524
DR CLO; CLO_0001537
DR CLDB; cl5129
DR ATCC; HB-167
DR IZSLER; BS Hy 5
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 9D10
AC CVCL_6364
DR CLO; CLO_0001538
DR ATCC; CRL-8752
DR BioSample; SAMN03471208
RX Patent=US4834975;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,13
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 9D4.9.1
AC CVCL_M908
DR ATCC; HB-11031
RX Patent=US5578704;
RX Patent=US5652110;
RX PubMed=7683273;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 9F12
AC CVCL_8944
DR CLO; CLO_0001540
DR ATCC; HB-8177
RX Patent=US4689299;
RX PubMed=6607295;
RX PubMed=7174795;
CC Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 9G2.1.3
AC CVCL_M909
DR ATCC; HB-11030
RX Patent=US5578704;
RX Patent=US5652110;
RX PubMed=7683273;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 9H10-A4
AC CVCL_J933
DR ATCC; HB-11430
RX Patent=US5763202;
RX PubMed=2449118;
CC Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC Discontinued: ATCC; HB-11430; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 9H7
AC CVCL_CW38
DR NCBI_Iran; H144
RX CelloPub=CLPUB00330;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 9HTEo-
AC CVCL_U405
SY 9/HTEo-; 9/HTEo(-); 9/HTEo; 9HTE
RX PubMed=1282304;
RX PubMed=1375758;
RX PubMed=2457904;
RX PubMed=8843701;
RX PubMed=10498856;
RX PubMed=15463957;
WW http://www.dartmouth.edu/~cysfib/cell-lines.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/9/cell-lines-detail-469.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U403 ! 3HTEo-
OI CVCL_U404 ! 8HTEo-
CA Transformed cell line
//
ID 9HTEo-/Dx
AC CVCL_HJ44
RX PubMed=7904600;
RX PubMed=8843701;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U405 ! 9HTEo-
CA Transformed cell line
//
ID 9HTEo-/S
AC CVCL_HJ45
RX PubMed=1282304;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U405 ! 9HTEo-
CA Transformed cell line
//
ID 9L
AC CVCL_1928
AS CVCL_3373
SY GS-9L; GS9L; T9
DR CLO; CLO_0003574
DR CLDB; cl1522
DR CLDB; cl1523
DR ChEMBL-Cells; CHEMBL3308019
DR ChEMBL-Targets; CHEMBL613105
DR ECACC; 94110705
DR ICLC; ATL96001
RX PubMed=5547317;
RX PubMed=7435138;
RX PubMed=7760095;
RX PubMed=9525831;
RX PubMed=19381449;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=GS-9L
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID 9L-2
AC CVCL_U696
RX PubMed=3860285;
CC Selected for resistance to: ChEBI; CHEBI:3423; Carmustine (BCNU).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1928 ! 9L
SX Male
CA Cancer cell line
//
ID 9L-7
AC CVCL_U697
RX PubMed=3860285;
CC Selected for resistance to: ChEBI; CHEBI:3423; Carmustine (BCNU).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1928 ! 9L
SX Male
CA Cancer cell line
//
ID 9L-8
AC CVCL_U698
RX PubMed=3860285;
CC Selected for resistance to: ChEBI; CHEBI:3423; Carmustine (BCNU).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1928 ! 9L
SX Male
CA Cancer cell line
//
ID 9L/ACNU
AC CVCL_4V34
RX PubMed=3479534;
CC Selected for resistance to: ChEBI; CHEBI:75270; Nimustine (ACNU).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1928 ! 9L
SX Male
CA Cancer cell line
//
ID 9L/lacZ
AC CVCL_5656
SY 9L/LacZ
DR CLO; CLO_0001541
DR ATCC; CRL-2200
DR BCRC; 60247
DR BCRJ; 0029
RX PubMed=1737331;
RX PubMed=8416743;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1928 ! 9L
SX Male
CA Cancer cell line
//
ID 9TR#1
AC CVCL_6560
DR CLO; CLO_0001542
DR ATCC; CRL-11379
RX Patent=US5684222;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1314884; Tnfrsf1a.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID A 123
AC CVCL_J176
SY A123; M-26
DR CLO; CLO_0001555
DR ATCC; HB-8451
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8451; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID A 124
AC CVCL_J177
SY A124; M-27
DR CLO; CLO_0001556
DR ATCC; HB-8452
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8452; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID a intermediate filament
AC CVCL_K121
SY alpha intermediate filament
DR CLO; CLO_0009729
DR ATCC; TIB-131
RX PubMed=6086105;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID A-10
AC CVCL_0130
SY A10
DR BTO; BTO:0002196
DR CLO; CLO_0001550
DR MCCL; MCC:0000022
DR CLDB; cl184
DR ATCC; CRL-1476
DR BCRC; 60127
DR ChEMBL-Cells; CHEMBL3307383
DR ChEMBL-Targets; CHEMBL614513
DR DSMZ; ACC-132
DR Lonza; 763
DR NCBI_Iran; C600
DR TOKU-E; 452
RX PubMed=943301;
RX PubMed=9415280;
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a10/a10cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-79.html
CC Doubling time: ~70-100 hours (DSMZ).
CC Breed/subspecies: BDIX.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID A-1207
AC CVCL_8481
SY A1207; A 1207
DR BTO; BTO:0002213
DR CCLE; A1207_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516011
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Aaronson S.A.; Mt. Sinai Medical Center; New York; USA.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: Transcriptome analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A-1235
AC CVCL_7002
SY A1235
DR BTO; BTO:0002214
DR Cosmic; 1014070
RX PubMed=7523863;
CC From: Aaronson S.A.; Mt. Sinai Medical Center; New York; USA.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A-172
AC CVCL_0131
SY A172; A 172; A-172 MG; A-172MG
DR BTO; BTO:0000016
DR CLO; CLO_0001543
DR CLO; CLO_0001559
DR CLO; CLO_0001560
DR CLO; CLO_0050637
DR EFO; EFO_0002101
DR MCCL; MCC:0000023
DR CLDB; cl142
DR CLDB; cl143
DR CLDB; cl144
DR CLDB; cl146
DR ATCC; CRL-1620
DR ATCC; CRL-7899
DR BioSample; SAMN03471115
DR BioSample; SAMN03471212
DR BioSample; SAMN03471659
DR BioSample; SAMN03471918
DR CCLE; A172_CENTRAL_NERVOUS_SYSTEM
DR CCRID; 3131C0001000700095
DR CGH-DB; 138-1
DR ChEMBL-Cells; CHEMBL3308491
DR ChEMBL-Targets; CHEMBL614512
DR CLS; 300108/p3934_A-172
DR Cosmic; 687563
DR Cosmic; 849883
DR Cosmic; 897446
DR Cosmic; 1014068
DR Cosmic; 1036334
DR Cosmic; 1066233
DR Cosmic; 1171223
DR Cosmic; 1236360
DR Cosmic; 1610751
DR Cosmic; 1746956
DR Cosmic; 1995327
DR Cosmic; 2302321
DR Cosmic; 2367506
DR Cosmic; 2516012
DR Cosmic-CLP; 687563
DR ECACC; 88062428
DR ENCODE; ENCBS225AJI
DR ENCODE; ENCBS874LTK
DR GDSC; 687563
DR GEO; GSM326244
DR GEO; GSM886850
DR GEO; GSM887914
DR GEO; GSM1374378
DR GEO; GSM1669577
DR ICLC; HTL97013
DR IZSLER; BS TCL 2
DR IGRhCellID; A172
DR JCRB; JCRB0228
DR KCB; KCB 200966YJ
DR KCLB; 21620
DR Lonza; 178
DR NCBI_Iran; C211
DR PRIDE; PXD001110
DR RCB; RCB2530
DR TKG; TKG 0183
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=833871;
RX PubMed=3759084;
RX PubMed=4357758;
RX PubMed=6260907;
RX PubMed=6652614;
RX PubMed=7523863;
RX PubMed=9220028;
RX PubMed=9290701;
RX PubMed=11351043;
RX PubMed=16232199;
RX PubMed=17254797;
RX PubMed=19365568;
RX PubMed=19435942;
RX PubMed=21406405;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-280.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC Characteristics: Has no IDH1 mutation.
CC Doubling time: 40 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7899; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=17254797; PubMed=22570425; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 9,12 (ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=22570425; PubMed=25877200; RCB; TKG)
ST CSF1PO: 9,11 (PubMed=17254797)
ST D13S317: 11
ST D16S539: 12 (ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=22570425; PubMed=25877200; RCB; TKG)
ST D16S539: 11 (PubMed=17254797)
ST D18S51: 12,13
ST D21S11: 28,32.2 (CLS; PubMed=22570425; PubMed=25877200)
ST D21S11: 27,32 (PubMed=17254797)
ST D3S1358: 14,18 (CLS; PubMed=22570425; PubMed=25877200)
ST D3S1358: 15,18 (PubMed=17254797)
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 20,22
ST Penta D: 9,13
ST Penta E: 5,10
ST TH01: 6,9.3 (ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=22570425; PubMed=25877200; RCB; TKG)
ST TH01: 6,10 (JCRB; PubMed=17254797)
ST TPOX: 8,11
ST vWA: 16,20 (ATCC)
ST vWA: 20 (CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=22570425; PubMed=25877200; TKG)
ST vWA: 17,20 (RCB)
ST vWA: 20 (PubMed=17254797)
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-1847
AC CVCL_9724
SY A1847
DR BTO; BTO:0002562
DR Cosmic; 1102822
DR Cosmic; 1175879
DR GEO; GSM184380
DR GEO; GSM184381
DR GEO; GSM184382
DR GEO; GSM184383
RX PubMed=9041185;
RX PubMed=23415752;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-2
AC CVCL_1939
SY A2
DR CLO; CLO_0001563
DR DSMZ; ACC-276
RX PubMed=528010;
CC Group: Fish cell line.
CC Doubling time: ~2-3 days (DSMZ).
CC Breed/subspecies: YF1.
OX NCBI_TaxID=8086; ! Xiphophorus xiphidium
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID A-204
AC CVCL_1058
SY A204
DR BTO; BTO:0003767
DR CLO; CLO_0001565
DR EFO; EFO_0002102
DR CLDB; cl147
DR CLDB; cl148
DR CLDB; cl149
DR CLDB; cl150
DR CLDB; cl4895
DR ATCC; CRL-7900
DR ATCC; HTB-82
DR BioSample; SAMN01821534
DR BioSample; SAMN01821612
DR BioSample; SAMN03471116
DR CCLE; A204_SOFT_TISSUE
DR CCRID; 3111C0001CCC000031
DR ChEMBL-Cells; CHEMBL3308354
DR ChEMBL-Targets; CHEMBL614514
DR CLS; 300109/p2936_A-204
DR Cosmic; 687946
DR Cosmic; 802041
DR Cosmic; 910784
DR Cosmic; 1097754
DR Cosmic; 1202066
DR Cosmic; 1995328
DR Cosmic-CLP; 910784
DR DSMZ; ACC-250
DR GDSC; 910784
DR GEO; GSM184386
DR GEO; GSM184387
DR GEO; GSM886851
DR GEO; GSM887915
DR GEO; GSM1669578
DR GEO; GSM1676295
DR GEO; GSM1676338
DR GEO; GSM1701622
DR GEO; GSM1701670
DR GEO; GSM1701697
DR ICLC; HTL99002
DR IGRhCellID; A204
DR TOKU-E; 460
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2302710;
RX PubMed=4357758;
RX PubMed=8275086;
RX PubMed=22460905;
RX PubMed=23882450;
RX PubMed=25984343;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-541.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: 28 hours (PubMed=25984343); ~36 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'HTB82' (based on the ATCC catalog number).
CC Discontinued: ATCC; CRL-7900; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 17,18
ST D21S11: 28,30
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 21
ST Penta D: 9,12
ST Penta E: 7,10
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-253
AC CVCL_1060
SY A 253; A253
DR BTO; BTO:0003206
DR CLO; CLO_0001569
DR CLO; CLO_0001570
DR ATCC; CRL-7902
DR ATCC; HTB-41
DR BCRC; 60367
DR BCRJ; 0322
DR BioSample; SAMN03471117
DR CCLE; A253_SALIVARY_GLAND
DR ChEMBL-Cells; CHEMBL3307893
DR ChEMBL-Targets; CHEMBL614255
DR Cosmic; 688036
DR Cosmic; 906794
DR Cosmic; 921831
DR Cosmic; 1017790
DR Cosmic; 1006471
DR Cosmic; 1041671
DR Cosmic; 1995330
DR Cosmic-CLP; 906794
DR GDSC; 906794
DR GEO; GSM422867
DR GEO; GSM886852
DR GEO; GSM887917
DR GEO; GSM1669580
DR IZSLER; BS TCL 199
DR KCLB; 30041
DR PRIDE; PXD002486
DR TOKU-E; 462
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=3138611;
RX PubMed=4357758;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7902; true.
CC Discontinued: KCLB; 30041; probable.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,12
ST D16S539: 12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6,8
ST TPOX: 8,12
ST vWA: 16
DI NCIt; C7991; Salivary gland squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-375
AC CVCL_0132
SY A 375; A375; A375-MEL; A375-mel; A375mel
DR BTO; BTO:0002806
DR CLO; CLO_0001544
DR CLO; CLO_0001581
DR CLO; CLO_0001582
DR EFO; EFO_0002103
DR MCCL; MCC:0000024
DR CLDB; cl198
DR CLDB; cl199
DR ATCC; CRL-1619
DR ATCC; CRL-7904
DR BCRC; 60039
DR BCRJ; 0278
DR BioSample; SAMN03472142
DR CCLE; A375_SKIN
DR CCRID; 3111C0001CCC000126
DR CCRID; 3111C0001CCC000327
DR CCRID; 3131C0001000700004
DR CCRID; 3131C0001000700155
DR CGH-DB; 9313-4
DR ChEMBL-Cells; CHEMBL3308077
DR ChEMBL-Targets; CHEMBL613859
DR ChEMBL-Targets; CHEMBL1075388
DR CLS; 300110/p852_A-375
DR Cosmic; 686480
DR Cosmic; 687431
DR Cosmic; 706114
DR Cosmic; 876698
DR Cosmic; 888861
DR Cosmic; 897482
DR Cosmic; 897735
DR Cosmic; 905226
DR Cosmic; 906793
DR Cosmic; 928688
DR Cosmic; 933003
DR Cosmic; 1006556
DR Cosmic; 1022280
DR Cosmic; 1054855
DR Cosmic; 1132587
DR Cosmic; 1155278
DR Cosmic; 1211162
DR Cosmic; 1303032
DR Cosmic; 1458961
DR Cosmic; 1459655
DR Cosmic; 1477406
DR Cosmic; 1481413
DR Cosmic; 1507620
DR Cosmic; 1537486
DR Cosmic; 1555009
DR Cosmic; 1669118
DR Cosmic; 1812178
DR Cosmic; 1888914
DR Cosmic; 1890486
DR Cosmic; 1989294
DR Cosmic; 1995332
DR Cosmic; 2036699
DR Cosmic; 2230112
DR Cosmic; 2233660
DR Cosmic; 2479252
DR Cosmic-CLP; 906793
DR ECACC; 88113005
DR ENCODE; ENCBS606AAA
DR ENCODE; ENCBS607AAA
DR GDSC; 906793
DR GEO; GSM206443
DR GEO; GSM218051
DR GEO; GSM276771
DR GEO; GSM555173
DR GEO; GSM827158
DR GEO; GSM886854
DR GEO; GSM887919
DR GEO; GSM952580
DR GEO; GSM1092559
DR GEO; GSM1138787
DR GEO; GSM1374382
DR GEO; GSM1669582
DR IGRhCellID; A375
DR IZSLER; BS TCL 88
DR KCB; KCB 99003YJ
DR LINCS; 50060
DR Lonza; 970
DR NCBI_Iran; C136
DR PRIDE; PXD001485
DR PRIDE; PXD004343
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1832891;
RX PubMed=4357758;
RX PubMed=6500159;
RX PubMed=15009714;
RX PubMed=15467732;
RX PubMed=17308088;
RX PubMed=18172304;
RX PubMed=19727395;
RX PubMed=22460905;
RX PubMed=23039341;
RX PubMed=24581590;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=A375
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7904; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D18S51: 12,17
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 11,14
ST FGA: 23
ST Penta D: 9,15
ST Penta E: 10,12
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-382
AC CVCL_S186
SY A382
DR ATCC; CRL-7903
RX PubMed=833871;
RX PubMed=4357758;
RX PubMed=6935474;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7903; true.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-388
AC CVCL_1063
SY A388
DR CLO; CLO_0001584
DR ATCC; CRL-7905
DR BioSample; SAMN03471118
DR ChEMBL-Cells; CHEMBL3308159
DR ChEMBL-Targets; CHEMBL2366355
DR Cosmic; 688037
DR Cosmic; 910697
DR Cosmic; 1995333
DR Cosmic-CLP; 910697
DR GDSC; 910697
DR GEO; GSM1669583
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=4357758;
RX PubMed=27397505;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C2929; Squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-427
AC CVCL_1055
SY A427
DR BTO; BTO:0003770
DR CLO; CLO_0001590
DR EFO; EFO_0002104
DR CLDB; cl152
DR CLDB; cl153
DR CLDB; cl5024
DR ATCC; CRL-7906
DR ATCC; HTB-53
DR BioSample; SAMN01821535
DR BioSample; SAMN01821613
DR BioSample; SAMN03471087
DR CCRID; 3111C0001CCC000213
DR ChEMBL-Cells; CHEMBL3307775
DR ChEMBL-Targets; CHEMBL614515
DR ChEMBL-Targets; CHEMBL1075389
DR CLS; 300111/p760_A-427
DR Cosmic; 724857
DR Cosmic; 735606
DR Cosmic; 801570
DR Cosmic; 844825
DR Cosmic; 876134
DR Cosmic; 910851
DR Cosmic; 917971
DR Cosmic; 929961
DR Cosmic; 932914
DR Cosmic; 933581
DR Cosmic; 961832
DR Cosmic; 1006531
DR Cosmic; 1146870
DR Cosmic; 1218868
DR Cosmic; 1239866
DR Cosmic; 2042862
DR Cosmic; 2125175
DR Cosmic-CLP; 910851
DR DSMZ; ACC-234
DR GDSC; 910851
DR GEO; GSM206444
DR GEO; GSM353235
DR GEO; GSM434323
DR GEO; GSM784204
DR GEO; GSM827284
DR GEO; GSM1374383
DR GEO; GSM1669585
DR IGRhCellID; A427
DR IZSLER; BS TCL 120
DR KCLB; 30053
DR PRIDE; PXD002556
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=3945555;
RX PubMed=4357758;
RX PubMed=6500159;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=10908148;
RX PubMed=11005564;
RX PubMed=19472407;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=21
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: ~60-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7906; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 12
ST D21S11: 31.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 18
ST Penta D: 13
ST Penta E: 15,17
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-431
AC CVCL_0037
SY A431; A431/P
DR BTO; BTO:0000017
DR CLO; CLO_0001591
DR CLO; CLO_0001592
DR CLO; CLO_0050011
DR CLO; CLO_0050012
DR EFO; EFO_0006268
DR MCCL; MCC:0000025
DR CLDB; cl155
DR CLDB; cl156
DR CLDB; cl157
DR CLDB; cl159
DR CLDB; cl160
DR CLDB; cl161
DR ATCC; CRL-1555
DR ATCC; CRL-7907
DR BCRC; 60161
DR BCRJ; 0032
DR BioSample; SAMN01821614
DR BioSample; SAMN01821671
DR BioSample; SAMN01821724
DR BioSample; SAMN03472220
DR CCRID; 3111C0001CCC000092
DR CCRID; 3131C0001000700079
DR CCRID; 3142C0001000000103
DR ChEMBL-Cells; CHEMBL3307523
DR ChEMBL-Targets; CHEMBL614069
DR ChEMBL-Targets; CHEMBL1075390
DR CLS; 300112/p753_A-431
DR Cosmic; 688038
DR Cosmic; 735609
DR Cosmic; 755305
DR Cosmic; 876559
DR Cosmic; 897743
DR Cosmic; 910564
DR Cosmic; 910925
DR Cosmic; 974317
DR Cosmic; 1071898
DR Cosmic; 1176624
DR Cosmic; 1351516
DR Cosmic; 1477434
DR Cosmic; 1945879
DR Cosmic; 1995334
DR Cosmic; 2131571
DR Cosmic; 2301592
DR Cosmic-CLP; 910925
DR DSMZ; ACC-91
DR ECACC; 85090402
DR GDSC; 910925
DR GEO; GSM183432
DR GEO; GSM183433
DR GEO; GSM827302
DR GEO; GSM1374384
DR GEO; GSM1669586
DR IFO; IFO50411
DR IZSLER; BS TCL 161
DR JCRB; JCRB0004
DR JCRB; JCRB9009
DR KCB; KCB 200651YJ
DR KCLB; 21555
DR KCLB; 80005
DR Lonza; 814
DR NCBI_Iran; C204
DR PRIDE; PXD000589
DR PRIDE; PXD000681
DR RCB; RCB0202
DR RCB; RCB1872
DR TKG; TKG 0182
DR TOKU-E; 476
DR Wikidata; Q4649310
RX PubMed=2758419;
RX PubMed=2990217;
RX PubMed=4357758;
RX PubMed=6092175;
RX PubMed=6500159;
RX PubMed=9290701;
RX PubMed=17178626;
RX PubMed=22108792;
RX PubMed=24804581;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=27397505;
WW https://en.wikipedia.org/wiki/A431_cells
WW http://www.cells-talk.com/index.php/page/copelibrary?key=A431
WW http://www.proteinatlas.org/learn/cellines
WW http://www.addexbio.com/productdetail?pid=22
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a431/a431cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-78.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: ~80-100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7907; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,13
ST D16S539: 12,14
ST D18S51: 13,17
ST D21S11: 28,30 (CLS; PubMed=11416159)
ST D21S11: 28 (PubMed=25877200)
ST D3S1358: 14
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 13
ST FGA: 20
ST Penta D: 9,11 (CLS)
ST Penta D: 11 (PubMed=25877200)
ST Penta E: 12,13
ST TH01: 9
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-498
AC CVCL_1056
SY A498
DR BTO; BTO:0003769
DR CLO; CLO_0001596
DR EFO; EFO_0002105
DR CLDB; cl163
DR CLDB; cl164
DR CLDB; cl5025
DR CLDB; cl7160
DR ATCC; CRL-7908
DR ATCC; HTB-44
DR BCRC; 60241
DR BioSample; SAMN03471119
DR BioSample; SAMN03472919
DR BioSample; SAMN03473534
DR CCLE; A498_KIDNEY
DR CCRID; 3111C0001CCC000171
DR ChEMBL-Cells; CHEMBL3308425
DR ChEMBL-Targets; CHEMBL614516
DR CLS; 300113/p784_A-498
DR Cosmic; 687937
DR Cosmic; 735612
DR Cosmic; 845930
DR Cosmic; 849378
DR Cosmic; 874610
DR Cosmic; 877453
DR Cosmic; 905948
DR Cosmic; 972874
DR Cosmic; 972928
DR Cosmic; 974301
DR Cosmic; 982277
DR Cosmic; 1092590
DR Cosmic; 1152531
DR Cosmic; 1175849
DR Cosmic; 1305373
DR Cosmic; 1312361
DR Cosmic; 1995335
DR Cosmic; 1998432
DR Cosmic; 2520636
DR Cosmic-CLP; 905948
DR DSMZ; ACC-55
DR GDSC; 905948
DR GEO; GSM50227
DR GEO; GSM50291
DR GEO; GSM750836
DR GEO; GSM799372
DR GEO; GSM799435
DR GEO; GSM846284
DR GEO; GSM843438
DR GEO; GSM886856
DR GEO; GSM887921
DR GEO; GSM1153445
DR GEO; GSM1181297
DR GEO; GSM1181323
DR GEO; GSM1669587
DR ICLC; HTL04005
DR IGRhCellID; A498
DR IZSLER; BS TCL 111
DR KCLB; 30044
DR Lonza; 1198
DR PRIDE; PXD003105
DR SKY/M-FISH/CGH; 2783
DR TOKU-E; 478
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2041050;
RX PubMed=4357758;
RX PubMed=6244232;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=7915601;
RX PubMed=10723130;
RX PubMed=11146448;
RX PubMed=15604581;
RX PubMed=17088437;
RX PubMed=17409424;
RX PubMed=19372543;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=27993170;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=37
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-361.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 66.8 hours (DTP); ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7908; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 17
ST D19S433: 12
ST D21S11: 28,32
ST D2S1338: 26
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 11,12 (CLS)
ST D7S820: 10,11 (ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543; PubMed=25877200)
ST D8S1179: 13,15
ST FGA: 18,20
ST Penta D: 9,14
ST Penta E: 10,14
ST TH01: 6,9.3
ST TPOX: 8,11 (ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543)
ST TPOX: 8 (PubMed=25877200)
ST vWA: 18 (ATCC; CLS; Cosmic-CLP; KCLB; PubMed=19372543; PubMed=25877200)
ST vWA: 16,18 (DSMZ)
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
ID A-498-Luc
AC CVCL_J241
SY A498-Luc
DR JCRB; JCRB1388
DR JCRB; NIHS0652
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0652; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1056 ! A-498
SX Female
CA Cancer cell line
//
ID A-549
AC CVCL_0023
AS CVCL_H249
SY A 549; A549; NCI-A549; A549/ATCC; A549 ATCC; hA549
DR BTO; BTO:0000018
DR CLO; CLO_0001601
DR CLO; CLO_0050025
DR EFO; EFO_0001086
DR CLDB; cl202
DR CLDB; cl203
DR CLDB; cl204
DR CLDB; cl205
DR CLDB; cl206
DR CLDB; cl207
DR CLDB; cl5100
DR CLDB; cl7131
DR ATCC; CCL-185
DR ATCC; CRM-CCL-185
DR ATCC; CRL-7909
DR BCRC; 60074
DR BCRJ; 0033
DR BioSample; SAMN01821615
DR BioSample; SAMN03472926
DR CCLE; A549_LUNG
DR CCRID; 3111C0001CCC000002
DR CCRID; 3111C0002000000008
DR CCRID; 3131C0001000700005
DR CCRID; 3131C0001000700150
DR CCRID; 3142C0001000000062
DR CCRID; 3153C0001000000062
DR CGH-DB; 202-1
DR CGH-DB; 9164-4
DR ChEMBL-Cells; CHEMBL3307651
DR ChEMBL-Targets; CHEMBL392
DR CLS; 300114/p686_A-549
DR Cosmic; 713864
DR Cosmic; 716170
DR Cosmic; 719675
DR Cosmic; 735605
DR Cosmic; 755468
DR Cosmic; 801571
DR Cosmic; 844592
DR Cosmic; 844826
DR Cosmic; 875854
DR Cosmic; 876152
DR Cosmic; 877443
DR Cosmic; 889090
DR Cosmic; 905949
DR Cosmic; 910552
DR Cosmic; 910560
DR Cosmic; 914947
DR Cosmic; 917386
DR Cosmic; 917972
DR Cosmic; 929148
DR Cosmic; 929962
DR Cosmic; 932915
DR Cosmic; 961833
DR Cosmic; 974287
DR Cosmic; 1004698
DR Cosmic; 1017830
DR Cosmic; 1028950
DR Cosmic; 1047097
DR Cosmic; 1089216
DR Cosmic; 1092591
DR Cosmic; 1146871
DR Cosmic; 1152518
DR Cosmic; 1154597
DR Cosmic; 1188587
DR Cosmic; 1219057
DR Cosmic; 1239867
DR Cosmic; 1305342
DR Cosmic; 1312328
DR Cosmic; 1352406
DR Cosmic; 1434961
DR Cosmic; 1436014
DR Cosmic; 1466799
DR Cosmic; 1571729
DR Cosmic; 1600605
DR Cosmic; 1608839
DR Cosmic; 1656896
DR Cosmic; 1802312
DR Cosmic; 1870260
DR Cosmic; 1945870
DR Cosmic; 1995337
DR Cosmic; 1998433
DR Cosmic; 2036687
DR Cosmic; 2042861
DR Cosmic; 2125176
DR Cosmic; 2301571
DR Cosmic; 2433750
DR Cosmic-CLP; 905949
DR DSMZ; ACC-107
DR ECACC; 86012804
DR ENCODE; ENCBS004IAZ
DR ENCODE; ENCBS004LAJ
DR ENCODE; ENCBS004RKE
DR ENCODE; ENCBS005TRZ
DR ENCODE; ENCBS006TYD
DR ENCODE; ENCBS007LES
DR ENCODE; ENCBS009FYJ
DR ENCODE; ENCBS009OIC
DR ENCODE; ENCBS011GKY
DR ENCODE; ENCBS015HRP
DR ENCODE; ENCBS018TOF
DR ENCODE; ENCBS021JVU
DR ENCODE; ENCBS023FRY
DR ENCODE; ENCBS025UWS
DR ENCODE; ENCBS027OSU
DR ENCODE; ENCBS029TTL
DR ENCODE; ENCBS032DUJ
DR ENCODE; ENCBS044YWQ
DR ENCODE; ENCBS059RHT
DR ENCODE; ENCBS061GHE
DR ENCODE; ENCBS066ACG
DR ENCODE; ENCBS069CLB
DR ENCODE; ENCBS070TPK
DR ENCODE; ENCBS072GEK
DR ENCODE; ENCBS076NFI
DR ENCODE; ENCBS083TEY
DR ENCODE; ENCBS086UGG
DR ENCODE; ENCBS087LLT
DR ENCODE; ENCBS090WQR
DR ENCODE; ENCBS091SYA
DR ENCODE; ENCBS092WKJ
DR ENCODE; ENCBS093FKM
DR ENCODE; ENCBS096ODB
DR ENCODE; ENCBS097ZMG
DR ENCODE; ENCBS099QUK
DR ENCODE; ENCBS100LYC
DR ENCODE; ENCBS106FRF
DR ENCODE; ENCBS106VMV
DR ENCODE; ENCBS107VVO
DR ENCODE; ENCBS108SIA
DR ENCODE; ENCBS108VDW
DR ENCODE; ENCBS109SYJ
DR ENCODE; ENCBS116MCD
DR ENCODE; ENCBS117OOH
DR ENCODE; ENCBS117POP
DR ENCODE; ENCBS121YTQ
DR ENCODE; ENCBS127GWZ
DR ENCODE; ENCBS131VWP
DR ENCODE; ENCBS133BUS
DR ENCODE; ENCBS133KFY
DR ENCODE; ENCBS139BXF
DR ENCODE; ENCBS142GEF
DR ENCODE; ENCBS144NAE
DR ENCODE; ENCBS146CRN
DR ENCODE; ENCBS148XSC
DR ENCODE; ENCBS151QJK
DR ENCODE; ENCBS153BPN
DR ENCODE; ENCBS154OIS
DR ENCODE; ENCBS157WWD
DR ENCODE; ENCBS157YZR
DR ENCODE; ENCBS159AAA
DR ENCODE; ENCBS160AAA
DR ENCODE; ENCBS161AAA
DR ENCODE; ENCBS162AAA
DR ENCODE; ENCBS163AAA
DR ENCODE; ENCBS163NSQ
DR ENCODE; ENCBS164AAA
DR ENCODE; ENCBS165AAA
DR ENCODE; ENCBS166AAA
DR ENCODE; ENCBS167AAA
DR ENCODE; ENCBS167GTR
DR ENCODE; ENCBS168AAA
DR ENCODE; ENCBS169AAA
DR ENCODE; ENCBS170AAA
DR ENCODE; ENCBS176HWE
DR ENCODE; ENCBS178CIW
DR ENCODE; ENCBS179WSX
DR ENCODE; ENCBS181LVW
DR ENCODE; ENCBS182KPQ
DR ENCODE; ENCBS183GJP
DR ENCODE; ENCBS185EJU
DR ENCODE; ENCBS189KLL
DR ENCODE; ENCBS191VYO
DR ENCODE; ENCBS194QRX
DR ENCODE; ENCBS198BBA
DR ENCODE; ENCBS198WYR
DR ENCODE; ENCBS198XRT
DR ENCODE; ENCBS204ZVO
DR ENCODE; ENCBS213WGX
DR ENCODE; ENCBS218RFX
DR ENCODE; ENCBS219THB
DR ENCODE; ENCBS229QHJ
DR ENCODE; ENCBS230KLP
DR ENCODE; ENCBS232SYQ
DR ENCODE; ENCBS235ANB
DR ENCODE; ENCBS236JDF
DR ENCODE; ENCBS239RRE
DR ENCODE; ENCBS241DOQ
DR ENCODE; ENCBS246IJP
DR ENCODE; ENCBS257YHA
DR ENCODE; ENCBS257YLQ
DR ENCODE; ENCBS260HPC
DR ENCODE; ENCBS261PDK
DR ENCODE; ENCBS262AII
DR ENCODE; ENCBS266ZMP
DR ENCODE; ENCBS270TGZ
DR ENCODE; ENCBS272CXK
DR ENCODE; ENCBS273XQH
DR ENCODE; ENCBS277AMO
DR ENCODE; ENCBS277NZL
DR ENCODE; ENCBS281AZP
DR ENCODE; ENCBS287FJW
DR ENCODE; ENCBS290TVV
DR ENCODE; ENCBS291TVJ
DR ENCODE; ENCBS293IUY
DR ENCODE; ENCBS299XUO
DR ENCODE; ENCBS302GLU
DR ENCODE; ENCBS306KID
DR ENCODE; ENCBS307KAV
DR ENCODE; ENCBS314UJS
DR ENCODE; ENCBS316RGG
DR ENCODE; ENCBS317YUF
DR ENCODE; ENCBS318NXZ
DR ENCODE; ENCBS323CFG
DR ENCODE; ENCBS327IUO
DR ENCODE; ENCBS328YSW
DR ENCODE; ENCBS330OQB
DR ENCODE; ENCBS331QMP
DR ENCODE; ENCBS336FCB
DR ENCODE; ENCBS342HZL
DR ENCODE; ENCBS343YHO
DR ENCODE; ENCBS349YRA
DR ENCODE; ENCBS369ESF
DR ENCODE; ENCBS370PMJ
DR ENCODE; ENCBS372GEL
DR ENCODE; ENCBS380JKY
DR ENCODE; ENCBS381CYW
DR ENCODE; ENCBS385PXA
DR ENCODE; ENCBS389XCA
DR ENCODE; ENCBS392TVW
DR ENCODE; ENCBS398XGZ
DR ENCODE; ENCBS399VKP
DR ENCODE; ENCBS405EQX
DR ENCODE; ENCBS405WSN
DR ENCODE; ENCBS410NHM
DR ENCODE; ENCBS417IIV
DR ENCODE; ENCBS419HCP
DR ENCODE; ENCBS419TTO
DR ENCODE; ENCBS420GJD
DR ENCODE; ENCBS420ZHM
DR ENCODE; ENCBS423AHV
DR ENCODE; ENCBS423ENC
DR ENCODE; ENCBS423SRU
DR ENCODE; ENCBS430EPP
DR ENCODE; ENCBS431FWG
DR ENCODE; ENCBS435PZT
DR ENCODE; ENCBS444ENC
DR ENCODE; ENCBS444MVA
DR ENCODE; ENCBS445ENC
DR ENCODE; ENCBS446ENC
DR ENCODE; ENCBS447ENC
DR ENCODE; ENCBS447LYH
DR ENCODE; ENCBS448ENC
DR ENCODE; ENCBS449ENC
DR ENCODE; ENCBS450ENC
DR ENCODE; ENCBS451ENC
DR ENCODE; ENCBS452TOO
DR ENCODE; ENCBS455PIS
DR ENCODE; ENCBS460QXP
DR ENCODE; ENCBS461GBL
DR ENCODE; ENCBS461XLE
DR ENCODE; ENCBS462FXS
DR ENCODE; ENCBS462SQL
DR ENCODE; ENCBS466BWX
DR ENCODE; ENCBS468TPT
DR ENCODE; ENCBS471LLC
DR ENCODE; ENCBS473OMG
DR ENCODE; ENCBS477BQZ
DR ENCODE; ENCBS478IHD
DR ENCODE; ENCBS478XMC
DR ENCODE; ENCBS479HSK
DR ENCODE; ENCBS485UNU
DR ENCODE; ENCBS487FRL
DR ENCODE; ENCBS488EBW
DR ENCODE; ENCBS488ZDO
DR ENCODE; ENCBS490YBT
DR ENCODE; ENCBS492GFZ
DR ENCODE; ENCBS497NSM
DR ENCODE; ENCBS498NRD
DR ENCODE; ENCBS503NHT
DR ENCODE; ENCBS507SWE
DR ENCODE; ENCBS508IUN
DR ENCODE; ENCBS508LJT
DR ENCODE; ENCBS514NHD
DR ENCODE; ENCBS518HSM
DR ENCODE; ENCBS518WHI
DR ENCODE; ENCBS525GZL
DR ENCODE; ENCBS528HKR
DR ENCODE; ENCBS538GZG
DR ENCODE; ENCBS540LZG
DR ENCODE; ENCBS547ACC
DR ENCODE; ENCBS547VCK
DR ENCODE; ENCBS547WFZ
DR ENCODE; ENCBS549TVN
DR ENCODE; ENCBS552KSE
DR ENCODE; ENCBS553BBK
DR ENCODE; ENCBS555HHK
DR ENCODE; ENCBS561DRV
DR ENCODE; ENCBS570ODA
DR ENCODE; ENCBS570PSF
DR ENCODE; ENCBS570WAL
DR ENCODE; ENCBS573ZZW
DR ENCODE; ENCBS574SHM
DR ENCODE; ENCBS581KGX
DR ENCODE; ENCBS582CLM
DR ENCODE; ENCBS583GBH
DR ENCODE; ENCBS593PHP
DR ENCODE; ENCBS594NFK
DR ENCODE; ENCBS597DCL
DR ENCODE; ENCBS598CCT
DR ENCODE; ENCBS598OWL
DR ENCODE; ENCBS599ALV
DR ENCODE; ENCBS600ZKV
DR ENCODE; ENCBS606CKR
DR ENCODE; ENCBS606KBB
DR ENCODE; ENCBS606UTY
DR ENCODE; ENCBS608WXT
DR ENCODE; ENCBS609BAO
DR ENCODE; ENCBS611JSC
DR ENCODE; ENCBS613VBS
DR ENCODE; ENCBS615RCL
DR ENCODE; ENCBS616EUG
DR ENCODE; ENCBS620TKD
DR ENCODE; ENCBS620YUM
DR ENCODE; ENCBS626ALW
DR ENCODE; ENCBS630KEQ
DR ENCODE; ENCBS633FJA
DR ENCODE; ENCBS640AFN
DR ENCODE; ENCBS643KEB
DR ENCODE; ENCBS646DYP
DR ENCODE; ENCBS646TBQ
DR ENCODE; ENCBS652QEI
DR ENCODE; ENCBS657XCY
DR ENCODE; ENCBS658RMM
DR ENCODE; ENCBS659JPG
DR ENCODE; ENCBS664ATC
DR ENCODE; ENCBS675TOV
DR ENCODE; ENCBS678LVM
DR ENCODE; ENCBS681JBN
DR ENCODE; ENCBS682PYF
DR ENCODE; ENCBS684TZE
DR ENCODE; ENCBS685EHX
DR ENCODE; ENCBS685QBT
DR ENCODE; ENCBS686TDM
DR ENCODE; ENCBS687HVT
DR ENCODE; ENCBS691ANI
DR ENCODE; ENCBS700HNY
DR ENCODE; ENCBS701ZPZ
DR ENCODE; ENCBS705AWL
DR ENCODE; ENCBS706OMV
DR ENCODE; ENCBS708WVC
DR ENCODE; ENCBS712HYP
DR ENCODE; ENCBS712NKI
DR ENCODE; ENCBS714CHO
DR ENCODE; ENCBS714IGN
DR ENCODE; ENCBS719BFR
DR ENCODE; ENCBS719FNK
DR ENCODE; ENCBS720VDH
DR ENCODE; ENCBS721HGM
DR ENCODE; ENCBS721JKR
DR ENCODE; ENCBS722NAW
DR ENCODE; ENCBS724JIH
DR ENCODE; ENCBS731OAC
DR ENCODE; ENCBS734NQI
DR ENCODE; ENCBS735SFW
DR ENCODE; ENCBS736RMD
DR ENCODE; ENCBS741LOB
DR ENCODE; ENCBS742QNT
DR ENCODE; ENCBS744CZP
DR ENCODE; ENCBS745XRX
DR ENCODE; ENCBS747KQQ
DR ENCODE; ENCBS749QGQ
DR ENCODE; ENCBS754LRU
DR ENCODE; ENCBS756YTM
DR ENCODE; ENCBS772RGZ
DR ENCODE; ENCBS774FRJ
DR ENCODE; ENCBS777ZVL
DR ENCODE; ENCBS779CAS
DR ENCODE; ENCBS780PIR
DR ENCODE; ENCBS780YEC
DR ENCODE; ENCBS784LUH
DR ENCODE; ENCBS787TLC
DR ENCODE; ENCBS787WXX
DR ENCODE; ENCBS788QQI
DR ENCODE; ENCBS788RGJ
DR ENCODE; ENCBS790LFN
DR ENCODE; ENCBS792THF
DR ENCODE; ENCBS795HVL
DR ENCODE; ENCBS797SEZ
DR ENCODE; ENCBS798DNC
DR ENCODE; ENCBS804CVK
DR ENCODE; ENCBS805BJW
DR ENCODE; ENCBS807RCH
DR ENCODE; ENCBS808EGR
DR ENCODE; ENCBS810BRT
DR ENCODE; ENCBS815HMT
DR ENCODE; ENCBS818CJE
DR ENCODE; ENCBS818RAI
DR ENCODE; ENCBS820MUM
DR ENCODE; ENCBS821RUT
DR ENCODE; ENCBS823HFB
DR ENCODE; ENCBS828JTD
DR ENCODE; ENCBS834ANM
DR ENCODE; ENCBS837CSI
DR ENCODE; ENCBS844DON
DR ENCODE; ENCBS844JPS
DR ENCODE; ENCBS848SUF
DR ENCODE; ENCBS851NMG
DR ENCODE; ENCBS858LUL
DR ENCODE; ENCBS859WOF
DR ENCODE; ENCBS861FXN
DR ENCODE; ENCBS868JZZ
DR ENCODE; ENCBS875AZA
DR ENCODE; ENCBS875EJK
DR ENCODE; ENCBS875EKF
DR ENCODE; ENCBS875WSM
DR ENCODE; ENCBS876BXS
DR ENCODE; ENCBS876CAE
DR ENCODE; ENCBS884PLU
DR ENCODE; ENCBS886DPW
DR ENCODE; ENCBS887WBA
DR ENCODE; ENCBS887WFS
DR ENCODE; ENCBS888YJZ
DR ENCODE; ENCBS889QXH
DR ENCODE; ENCBS890NQU
DR ENCODE; ENCBS892LLD
DR ENCODE; ENCBS894DBY
DR ENCODE; ENCBS896RCE
DR ENCODE; ENCBS897QKO
DR ENCODE; ENCBS898FLP
DR ENCODE; ENCBS901YZG
DR ENCODE; ENCBS914AZQ
DR ENCODE; ENCBS914SLE
DR ENCODE; ENCBS915DYB
DR ENCODE; ENCBS929VTV
DR ENCODE; ENCBS933OVE
DR ENCODE; ENCBS933PFW
DR ENCODE; ENCBS938EZW
DR ENCODE; ENCBS938LTP
DR ENCODE; ENCBS944KBZ
DR ENCODE; ENCBS947WTB
DR ENCODE; ENCBS950YDL
DR ENCODE; ENCBS951SRH
DR ENCODE; ENCBS952KGJ
DR ENCODE; ENCBS953AYB
DR ENCODE; ENCBS953UYS
DR ENCODE; ENCBS960LFK
DR ENCODE; ENCBS962DEK
DR ENCODE; ENCBS969VAO
DR ENCODE; ENCBS972JHA
DR ENCODE; ENCBS976TIO
DR ENCODE; ENCBS979STP
DR ENCODE; ENCBS981XNC
DR ENCODE; ENCBS993AJE
DR ENCODE; ENCBS996NTP
DR ENCODE; ENCBS996ZFV
DR ENCODE; ENCBS998UBJ
DR GDSC; 905949
DR GEO; GSM50209
DR GEO; GSM50272
DR GEO; GSM185869
DR GEO; GSM206445
DR GEO; GSM253306
DR GEO; GSM353234
DR GEO; GSM434265
DR GEO; GSM513947
DR GEO; GSM514317
DR GEO; GSM651560
DR GEO; GSM651561
DR GEO; GSM729842
DR GEO; GSM729843
DR GEO; GSM729844
DR GEO; GSM729845
DR GEO; GSM729846
DR GEO; GSM729847
DR GEO; GSM729848
DR GEO; GSM729849
DR GEO; GSM750779
DR GEO; GSM750780
DR GEO; GSM750788
DR GEO; GSM750789
DR GEO; GSM750791
DR GEO; GSM784244
DR GEO; GSM794260
DR GEO; GSM799336
DR GEO; GSM799399
DR GEO; GSM816649
DR GEO; GSM827464
DR GEO; GSM846285
DR GEO; GSM843439
DR GEO; GSM886858
DR GEO; GSM887923
DR GEO; GSM923418
DR GEO; GSM923420
DR GEO; GSM923425
DR GEO; GSM923432
DR GEO; GSM923433
DR GEO; GSM923435
DR GEO; GSM945243
DR GEO; GSM945244
DR GEO; GSM1086289
DR GEO; GSM1086290
DR GEO; GSM1153406
DR GEO; GSM1181254
DR GEO; GSM1181311
DR GEO; GSM1181344
DR GEO; GSM1181353
DR GEO; GSM1181354
DR GEO; GSM1181355
DR GEO; GSM1181356
DR GEO; GSM1181364
DR GEO; GSM1374385
DR GEO; GSM1374386
DR GEO; GSM1374387
DR GEO; GSM1557133
DR GEO; GSM1669589
DR ICLC; HTL03001
DR IFO; IFO50153
DR IGRhCellID; A549GEO
DR IZSLER; BS TCL 101
DR JCRB; JCRB0076
DR KCB; KCB 200434YJ
DR KCLB; 10185
DR LINCS; 50084
DR Lonza; 675
DR NCBI_Iran; C137
DR PRIDE; PXD000418
DR PRIDE; PXD002224
DR PRIDE; PXD002395
DR PRIDE; PXD003627
DR RCB; RCB0098
DR RCB; RCB3677
DR SKY/M-FISH/CGH; 2809
DR TKG; TKG 0184
DR TOKU-E; 3615
DR Wikidata; Q4649475
RX PubMed=175022;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=842942;
RX PubMed=2041050;
RX PubMed=3413074;
RX PubMed=3945555;
RX PubMed=4357758;
RX PubMed=6500159;
RX PubMed=6935474;
RX PubMed=7065527;
RX PubMed=7459858;
RX PubMed=7736387;
RX PubMed=8626706;
RX PubMed=9290701;
RX PubMed=9649128;
RX PubMed=11005564;
RX PubMed=11369051;
RX PubMed=12661003;
RX PubMed=14581340;
RX PubMed=15746151;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=19608861;
RX PubMed=19657000;
RX PubMed=22278370;
RX PubMed=22313637;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22576795;
RX PubMed=23325432;
RX PubMed=23404217;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24135919;
RX PubMed=24618588;
RX PubMed=25120651;
RX PubMed=25475639;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26202522;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/A549_cell
WW http://a549.com/
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=8
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/A549_protocol.pdf
WW http://www.proteinatlas.org/learn/cellines
WW http://www.cells-talk.com/index.php/page/copelibrary?key=CCL-185
WW http://www.addexbio.com/productdetail?pid=23
WW http://en.vircell.com/products/a-549-cell-line/
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a549/a549cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-58.html
WW http://141.61.102.20/mxdb/project/show/9191407937500
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 2.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 22 hours (PubMed=25984343); 22.9 hours (DTP); ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC Omics: Acetylation analysis by proteomics.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep membrane proteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
CC Misspelling: 'A594' in PubMed=18227028.
CC Misspelling: 'A59' in PubMed=16354588.
CC Discontinued: ATCC; CRL-7909; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=19372543; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 14,17
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 24
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 9
ST Penta E: 7,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-6
AC CVCL_N545
DR CLO; CLO_0050200
DR RCB; RCB1517
RX PubMed=10445502;
CC Characteristics: FGF2 or KITLG dependent.
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_N541 ! H-1
SX Male
CA Factor-dependent cell line
//
ID A-673
AC CVCL_0080
SY A673; RMS 1598; RMS1598
DR BTO; BTO:0003768
DR CLO; CLO_0001605
DR CLO; CLO_0001606
DR EFO; EFO_0002106
DR CLDB; cl166
DR ATCC; CRL-1598
DR ATCC; CRL-7910
DR BioSample; SAMN03473282
DR CCLE; A673_BONE
DR CCRID; 3131C0001000700006
DR ChEMBL-Cells; CHEMBL3307384
DR ChEMBL-Targets; CHEMBL614517
DR CLS; 300454/p491_A-673
DR Cosmic; 684052
DR Cosmic; 1091064
DR Cosmic; 1097757
DR Cosmic; 1388901
DR Cosmic; 1718108
DR Cosmic; 1995338
DR Cosmic; 2228213
DR Cosmic; 2250469
DR Cosmic; 2294580
DR Cosmic-CLP; 684052
DR ECACC; 85111504
DR ENCODE; ENCBS304EKV
DR ENCODE; ENCBS385OLC
DR ENCODE; ENCBS615MBV
DR ENCODE; ENCBS790NPQ
DR GDSC; 684052
DR GEO; GSM510002
DR GEO; GSM827304
DR GEO; GSM886859
DR GEO; GSM887924
DR GEO; GSM1669590
DR GEO; GSM1676306
DR GEO; GSM1701623
DR IGRhCellID; A673
DR KCLB; 21598
DR Lonza; 1455
RX PubMed=327080;
RX PubMed=4357758;
RX PubMed=8275086;
RX PubMed=10379870;
RX PubMed=12606131;
RX PubMed=14697648;
RX PubMed=19787792;
RX PubMed=22460905;
RX PubMed=23882450;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=25223734;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Misidentified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870, PubMed=12606131, PubMed=14697648).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: 28 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7910; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=24312454; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11
ST D18S51: 13,16
ST D19S433: 13,14
ST D21S11: 28,29 (CLS)
ST D21S11: 29,30.2 (PubMed=24312454; PubMed=25877200)
ST D2S1338: 16,21
ST D3S1358: 15,17 (CLS)
ST D3S1358: 14 (KCLB; PubMed=24312454; PubMed=25877200)
ST D5S818: 11,12 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=24312454; PubMed=25877200)
ST D5S818: 11 (CLS)
ST D7S820: 10,12
ST D8S1179: 11,15 (CLS)
ST D8S1179: 11,13 (PubMed=24312454; PubMed=25877200)
ST FGA: 20,21 (CLS)
ST FGA: 19,20 (KCLB; PubMed=24312454; PubMed=25877200)
ST Penta D: 11,13 (CLS)
ST Penta D: 12,13 (PubMed=25877200)
ST Penta E: 12 (CLS)
ST Penta E: 10,13 (PubMed=25877200)
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-704
AC CVCL_1065
SY A.704; A704
DR BTO; BTO:0004583
DR CLO; CLO_0001546
DR CLO; CLO_0001609
DR CLO; CLO_0001610
DR CLDB; cl167
DR CLDB; cl168
DR CLDB; cl170
DR CLDB; cl5026
DR ATCC; CRL-7911
DR ATCC; HTB-45
DR BioSample; SAMN03471120
DR BioSample; SAMN03472920
DR CCLE; A704_KIDNEY
DR ChEMBL-Cells; CHEMBL3307650
DR ChEMBL-Targets; CHEMBL614567
DR CLS; 300217/p486_A-704
DR Cosmic; 687938
DR Cosmic; 910920
DR Cosmic; 979707
DR Cosmic; 982279
DR Cosmic; 1995339
DR Cosmic; 2520641
DR Cosmic-CLP; 910920
DR ECACC; 93020513
DR GDSC; 910920
DR GEO; GSM374459
DR GEO; GSM886860
DR GEO; GSM887925
DR GEO; GSM1669591
DR ICLC; HTL95007
DR IZSLER; BS TCL 117
DR KCLB; 30045
RX PubMed=4357758;
RX PubMed=6244232;
RX PubMed=6500159;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7911; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 7,8
ST D13S317: 8
ST D16S539: 12,13
ST D18S51: 16,17
ST D19S433: 13
ST D21S11: 28,32
ST D2S1338: 16,21
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 13,15
ST FGA: 22,23
ST Penta D: 2.2,11
ST Penta E: 8,17
ST TH01: 7,9 (ATCC; CLS; Cosmic-CLP; ECACC; KCLB)
ST TH01: 7 (PubMed=25877200)
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A-72
AC CVCL_3453
SY A 72; A72
DR CLO; CLO_0001545
DR CLO; CLO_0001612
DR CLDB; cl171
DR CLDB; cl172
DR ATCC; CRL-1542
DR BCRC; 60480
DR BCRJ; 0368
DR CLS; 602398/p454_A-72
DR ECACC; 89050908
DR IZSLER; BS TCL 1
RX PubMed=6254399;
RX PubMed=21801068;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-558.html
CC Breed/subspecies: Golden Retriever.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID A-875
AC CVCL_4733
SY A875
DR BTO; BTO:0000525
DR CCRID; 3111C0001CCC000094
DR KCB; KCB 2012028YJ
RX PubMed=4357758;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-568.html
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-9
AC CVCL_3984
SY A9; A9 (Hamprecht); GM00346; GM346
DR BTO; BTO:0002887
DR CLO; CLO_0001618
DR CLO; CLO_0001620
DR CLO; CLO_0025566
DR CLDB; cl219
DR CLDB; cl220
DR ATCC; CCL-1.4
DR ATCC; CRL-6319
DR BCRC; 60138
DR CCRID; 3131C0001000300012
DR ChEMBL-Cells; CHEMBL3307632
DR ChEMBL-Targets; CHEMBL614518
DR Coriell; GM00346
DR ECACC; 08062526
DR ECACC; 85011426
DR IZSLER; BS CL 209
DR JCRB; JCRB0211
DR TOKU-E; 493
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Miscellaneous: ECACC has two catalogue entries for A-9 which differ in that they were deposited by different groups: A9 (ECACC 85011426) and A9 (Hamprecht) (ECACC 08062526).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID A-HER2
AC CVCL_J973
SY 4D5; NB9644P28
DR CLO; CLO_0001687
DR ATCC; CRL-10463
RX Patent=US5677171;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A-mel-3
AC CVCL_IS48
SY A-mel 3; A.Mel. 3
RX PubMed=8567124;
RX PubMed=11027436;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Cancer cell line
//
ID A-PTC
AC CVCL_W335
RX PubMed=24567186;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A-S-30D
AC CVCL_1949
AS CVCL_5684
SY AS-30D; AS30D
DR BTO; BTO:0002013
DR CLO; CLO_0001752
DR CLDB; cl179
DR CLS; 500116/p571_AS-30D
DR DSMZ; ACC-208
RX PubMed=3370139;
CC Doubling time: ~29 hours (DSMZ).
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID A-THP-1
AC CVCL_5115
DR CLO; CLO_0050998
DR RCB; RCB2128
DR TKG; TKG 0296
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,13
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID A.P.
AC CVCL_6365
SY A. P. Mongoose; APM
DR CLO; CLO_0001547
DR ATCC; CRL-6295
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/apm/apmcells.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=210642; ! Atilax paludinosus
SX Male
CA Finite cell line
//
ID A.t. GRIP-1
AC CVCL_Z265
RX PubMed=8551501;
CC Group: Insect cell line.
OX NCBI_TaxID=7162; ! Ochlerotatus triseriatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID A.t. GRIP-2
AC CVCL_Z266
RX PubMed=8551501;
CC Group: Insect cell line.
OX NCBI_TaxID=7162; ! Ochlerotatus triseriatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID A.t. GRIP-3
AC CVCL_Z267
RX PubMed=8551501;
CC Group: Insect cell line.
OX NCBI_TaxID=7162; ! Ochlerotatus triseriatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID A000013#1
AC CVCL_Y943
DR RCB; HPS0229
DR SKIP; SKIP000116
DI NCIt; C118847; Spinal muscular atrophy type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y944 ! A000013#2
OI CVCL_Y945 ! A000013#3
CA Induced pluripotent stem cell
//
ID A000013#2
AC CVCL_Y944
DR RCB; HPS0230
DR SKIP; SKIP000117
DI NCIt; C118847; Spinal muscular atrophy type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y943 ! A000013#1
OI CVCL_Y945 ! A000013#3
CA Induced pluripotent stem cell
//
ID A000013#3
AC CVCL_Y945
DR RCB; HPS0231
DR SKIP; SKIP000118
DI NCIt; C118847; Spinal muscular atrophy type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y943 ! A000013#1
OI CVCL_Y944 ! A000013#2
CA Induced pluripotent stem cell
//
ID A000014#3-6
AC CVCL_Y946
DR RCB; HPS0198
DR SKIP; SKIP000091
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y947 ! A000014#4-5
OI CVCL_Y948 ! A000014#5-4
CA Induced pluripotent stem cell
//
ID A000014#4-5
AC CVCL_Y947
DR RCB; HPS0199
DR SKIP; SKIP000092
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y946 ! A000014#3-6
OI CVCL_Y948 ! A000014#5-4
CA Induced pluripotent stem cell
//
ID A000014#5-4
AC CVCL_Y948
DR RCB; HPS0200
DR SKIP; SKIP000093
DR SKIP; SKIP000556
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y946 ! A000014#3-6
OI CVCL_Y947 ! A000014#4-5
CA Induced pluripotent stem cell
//
ID A000026#1
AC CVCL_Y940
DR RCB; HPS0235
DR SKIP; SKIP000122
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y941 ! A000026#2
OI CVCL_Y942 ! A000026#3
CA Induced pluripotent stem cell
//
ID A000026#2
AC CVCL_Y941
DR RCB; HPS0236
DR SKIP; SKIP000123
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y940 ! A000026#1
OI CVCL_Y942 ! A000026#3
CA Induced pluripotent stem cell
//
ID A000026#3
AC CVCL_Y942
DR RCB; HPS0237
DR SKIP; SKIP000124
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y940 ! A000026#1
OI CVCL_Y941 ! A000026#2
CA Induced pluripotent stem cell
//
ID A000055#3
AC CVCL_Y916
DR RCB; HPS0204
DR SKIP; SKIP000097
DI NCIt; C103968; Pyruvate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L558 ! AT-PDH1TKB
SX Male
CA Induced pluripotent stem cell
//
ID A000055#4
AC CVCL_Y917
DR RCB; HPS0205
DR SKIP; SKIP000098
DI NCIt; C103968; Pyruvate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L558 ! AT-PDH1TKB
SX Male
CA Induced pluripotent stem cell
//
ID A000055#5
AC CVCL_Y918
DR RCB; HPS0206
DR SKIP; SKIP000099
DI NCIt; C103968; Pyruvate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L558 ! AT-PDH1TKB
SX Male
CA Induced pluripotent stem cell
//
ID A000069#14-7
AC CVCL_Y926
DR RCB; HPS0238
DR SKIP; SKIP000125
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y927 ! A000069#15-1
OI CVCL_Y928 ! A000069#15-4
CA Induced pluripotent stem cell
//
ID A000069#15-1
AC CVCL_Y927
DR RCB; HPS0239
DR SKIP; SKIP000126
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y926 ! A000069#14-7
OI CVCL_Y928 ! A000069#15-4
CA Induced pluripotent stem cell
//
ID A000069#15-4
AC CVCL_Y928
DR RCB; HPS0240
DR SKIP; SKIP000127
DI NCIt; C61251; Metachromatic leukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y926 ! A000069#14-7
OI CVCL_Y927 ! A000069#15-1
CA Induced pluripotent stem cell
//
ID A000074#1
AC CVCL_Y921
DR RCB; HPS0152
DR SKIP; SKIP000058
DI NCIt; C118843; Allan-Herndon-Dudley syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y922 ! A000074#2
OI CVCL_Y923 ! A000074#3
CA Induced pluripotent stem cell
//
ID A000074#2
AC CVCL_Y922
DR RCB; HPS0153
DR SKIP; SKIP000059
DI NCIt; C118843; Allan-Herndon-Dudley syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y921 ! A000074#1
OI CVCL_Y923 ! A000074#3
CA Induced pluripotent stem cell
//
ID A000074#3
AC CVCL_Y923
DR RCB; HPS0154
DR SKIP; SKIP000060
DI NCIt; C118843; Allan-Herndon-Dudley syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y921 ! A000074#1
OI CVCL_Y922 ! A000074#2
CA Induced pluripotent stem cell
//
ID A0001
AC CVCL_T364
DR RCB; GMC0037
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T365 ! B0001
SX Female
CA Finite cell line
//
ID A0010
AC CVCL_T352
DR CLO; CLO_0050478
DR RCB; GMC0027
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T353 ! B0010
SX Female
CA Finite cell line
//
ID A0022
AC CVCL_T345
DR CLO; CLO_0050718
DR RCB; GMC0021
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T344 ! B0022
SX Male
CA Finite cell line
//
ID A0026
AC CVCL_T362
DR CLO; CLO_0050711
DR RCB; GMC0036
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T363 ! B0026
SX Female
CA Finite cell line
//
ID A0031
AC CVCL_T338
DR CLO; CLO_0050704
DR RCB; GMC0012
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T339 ! B0031
SX Male
CA Finite cell line
//
ID A0031 iPS#23
AC CVCL_IN37
SY A0031-derived iPSC clone 23
RX PubMed=25390333;
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T338 ! A0031
SX Male
CA Induced pluripotent stem cell
//
ID A0031 iPS#34
AC CVCL_IN38
SY A0031-derived iPSC clone 34; WS iPSC #34
DR GEO; GSM1519866
RX PubMed=25390333;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T338 ! A0031
SX Male
CA Induced pluripotent stem cell
//
ID A0031 iPS#64
AC CVCL_IN39
SY A0031-derived iPSC clone 64
RX PubMed=25390333;
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T338 ! A0031
SX Male
CA Induced pluripotent stem cell
//
ID A0042
AC CVCL_T343
DR CLO; CLO_0050705
DR RCB; GMC0014
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T342 ! B0042
SX Male
CA Finite cell line
//
ID A0050
AC CVCL_T354
DR CLO; CLO_0050710
DR RCB; GMC0031
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T355 ! B0050
SX Female
CA Finite cell line
//
ID A0055
AC CVCL_T346
DR CLO; CLO_0050706
DR RCB; GMC0022
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T347 ! B0055
SX Male
CA Finite cell line
//
ID A0058
AC CVCL_T357
DR CLO; CLO_0050709
DR RCB; GMC0028
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T358 ! B0058
SX Male
CA Finite cell line
//
ID A0065
AC CVCL_T337
DR CLO; CLO_0050712
DR RCB; GMC0004
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID A0072
AC CVCL_T350
DR CLO; CLO_0050708
DR RCB; GMC0024
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T351 ! B0072
SX Female
CA Finite cell line
//
ID A0082
AC CVCL_T335
DR CLO; CLO_0050701
DR RCB; GMC0002
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T334 ! B0082
SX Male
CA Finite cell line
//
ID A02
AC CVCL_W875
DR Cosmic; 888981
DR Cosmic; 1996407
DR GEO; GSM170595
DR GEO; GSM215715
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A04-GEH
AC CVCL_S856
SY A04
DR Cosmic; 928718
DR Cosmic; 1211160
DR GEO; GSM170992
DR GEO; GSM215716
RX PubMed=9354451;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A05
AC CVCL_W876
DR Cosmic; 888982
DR Cosmic; 1211161
RX PubMed=15048078;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A06-MLC
AC CVCL_S857
SY A06
DR Cosmic; 928719
DR Cosmic; 1996408
DR GEO; GSM170844
DR GEO; GSM215717
RX PubMed=9354451;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A07
AC CVCL_W879
SY A07RM; A07.RM
DR Cosmic; 888983
DR GEO; GSM78832
DR GEO; GSM78833
DR GEO; GSM78835
DR GEO; GSM228380
RX PubMed=15048078;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A1 [Human leukemia]
AC CVCL_6G43
SY A-1
RX PubMed=1531243;
RX PubMed=2595371;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A1 [Mouse astroglia]
AC CVCL_U223
DR IFO; IFO50519
CC Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID A10-2-4
AC CVCL_DD07
RX PubMed=6270122;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DD06 ! N211-1-8
SX Female
CA Spontaneously immortalized cell line
//
ID A10-85
AC CVCL_4097
DR CLO; CLO_0001552
DR CLDB; cl185
DR ECACC; 93040117
CC Breed/subspecies: BDIX.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0130 ! A-10
CA Spontaneously immortalized cell line
//
ID A10.7
AC CVCL_E301
AS CVCL_D552
SY LZ10.7; E3LZ10.7; Pa03C
DR Cosmic; 1473117
DR Cosmic; 1509850
RX PubMed=17332349;
RX PubMed=17912029;
RX PubMed=22753594;
WW http://www.addexbio.com/productdetail?pid=168
WW http://www.addexbio.com/productdetail?pid=288
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A101D
AC CVCL_1057
SY A-101D
DR CLO; CLO_0001551
DR EFO; EFO_0002100
DR ATCC; CRL-7898
DR BioSample; SAMN03471114
DR CCLE; A101D_SKIN
DR ChEMBL-Cells; CHEMBL3308182
DR ChEMBL-Targets; CHEMBL2366306
DR Cosmic; 687429
DR Cosmic; 910921
DR Cosmic; 1155279
DR Cosmic; 1995326
DR Cosmic-CLP; 910921
DR GDSC; 910921
DR GEO; GSM886849
DR GEO; GSM887913
DR GEO; GSM1669576
DR IGRhCellID; A101D
RX PubMed=833871;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0331 ! Hs 294T
SX Male
CA Cancer cell line
//
ID A11 [Human melanoma]
AC CVCL_W877
DR Cosmic; 888984
DR Cosmic; 1303028
DR GEO; GSM162928
RX PubMed=15048078;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A11 [Mouse IHW]
AC CVCL_V063
DR CLO; CLO_0001553
DR CLDB; cl186
DR IHW; IHW8006
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID A11.1 M
AC CVCL_J175
DR CLO; CLO_0001554
DR ATCC; HB-164
RX PubMed=1377666;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J171 ! Sp2/08A2
CA Hybridoma
//
ID A110L
AC CVCL_U093
DR CLO; CLO_0050065
DR RCB; RCB2816
RX PubMed=12114371;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A1165
AC CVCL_D135
DR Cosmic; 735608
RX PubMed=375235;
RX PubMed=3945555;
RX PubMed=6500159;
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A12
AC CVCL_DH60
DR GEO; GSM228381
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A121
AC CVCL_G294
DR ChEMBL-Cells; CHEMBL3308020
DR ChEMBL-Targets; CHEMBL613106
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A126-1B2
AC CVCL_0133
SY A126.1B2; A1261B2
DR MCCL; MCC:0000026
RX PubMed=1645738;
RX PubMed=3018542;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID A129L
AC CVCL_U094
DR RCB; RCB3532
RX PubMed=12114371;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A13
AC CVCL_DH61
DR GEO; GSM170833
DR GEO; GSM215718
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A14
AC CVCL_6309
RX PubMed=9054892;
DI NCIt; C4161; Thyroid gland macrofollicular adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A15 [Human melanoma]
AC CVCL_W878
DR Cosmic; 888985
DR Cosmic; 1303029
DR GEO; GSM170862
DR GEO; GSM215719
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: CNV analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A15 [Rat glioma]
AC CVCL_4098
DR CLO; CLO_0001557
DR CLDB; cl187
DR ECACC; 93040110
RX PubMed=221002;
CC Breed/subspecies: BDIX.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_Y001 ! 1A2 [Rat glioma]
SX Female
CA Cancer cell line
//
ID A1589
AC CVCL_D136
RX PubMed=375235;
DI NCIt; C2929; Squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A15A10
AC CVCL_Y002
RX PubMed=221002;
RX PubMed=638021;
CC Breed/subspecies: BDIX.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4098 ! A15 [Rat glioma]
SX Female
CA Cancer cell line
//
ID A15A5
AC CVCL_8780
RX PubMed=221002;
RX PubMed=638021;
RX PubMed=7190976;
RX PubMed=7459259;
CC Breed/subspecies: BDIX.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4098 ! A15 [Rat glioma]
SX Female
CA Cancer cell line
//
ID A1604
AC CVCL_V398
RX PubMed=7144906;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A1663
AC CVCL_D137
DR Cosmic; 735610
RX PubMed=375235;
RX PubMed=3945555;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A1698
AC CVCL_V399
SY A-1698
DR Cosmic; 760487
RX PubMed=3413074;
RX PubMed=7144906;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A1923
AC CVCL_N281
SY NR-M1-02
DR ATCC; HB-9352
RX Patent=US4879225;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A1993
AC CVCL_N282
SY NR-M1-04
DR ATCC; HB-9351
RX Patent=US4879225;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A1ATH
AC CVCL_Y379
SY A1 ATH
DR CLO; CLO_0001549
RX PubMed=6971250;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: AT.H.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID A1G3
AC CVCL_J974
DR CLO; CLO_0001561
DR ATCC; HB-177
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID A1H4
AC CVCL_L533
DR ECACC; 93062220
CC Monoclonal antibody target: UniProtKB; F1PAA9; Dog CDH1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A2
AC CVCL_4099
DR CLO; CLO_0001562
DR CLDB; cl189
DR ECACC; 89030316
RX PubMed=3924915;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_H340 ! CHO-A7
SX Female
CA Spontaneously immortalized cell line
//
ID A2.01
AC CVCL_X698
DR NIH-ARP; 2059-44
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6244 ! A3.01
SX Female
CA Cancer cell line
//
ID A2.1
AC CVCL_E303
SY GS2.1; Pa01C
DR Cosmic; 1473030
DR Cosmic; 1509848
RX PubMed=17912029;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A2.A2
AC CVCL_6243
DR Lonza; 179
OX NCBI_TaxID=10090; ! Mus musculus
CA Undefined cell line type
//
ID A20
AC CVCL_1940
SY A-20
DR BTO; BTO:0001930
DR CLO; CLO_0001564
DR CLO; CLO_0050194
DR EFO; EFO_0005285
DR ATCC; TIB-208
DR BCRC; 60556
DR BCRJ; 0030
DR ChEMBL-Cells; CHEMBL3307765
DR ChEMBL-Targets; CHEMBL613850
DR ENCODE; ENCBS119ENC
DR ENCODE; ENCBS431JNZ
DR GEO; GSM1014167
DR Lonza; 743
DR RCB; RCB2745
DR TKG; TKG 0571
DR TOKU-E; 459
RX PubMed=310843;
RX PubMed=22400032;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-448.html
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/A20_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Breed/subspecies: BALB/cAnN.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID A20/2J
AC CVCL_D138
SY A20-2J; A20.2J
RX PubMed=2415625;
CC Breed/subspecies: BALB/cAnN.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1940 ! A20
CA Cancer cell line
//
ID A20.IIA
AC CVCL_0J27
SY IIA1.6; IIA-1
RX PubMed=2415625;
RX PubMed=21949734;
RX PubMed=22400032;
CC Breed/subspecies: BALB/cAnN.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D138 ! A20/2J
CA Cancer cell line
//
ID A20.IIA-GFP
AC CVCL_0J28
RX PubMed=21949734;
RX PubMed=22400032;
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: BALB/cAnN.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0J27 ! A20.IIA
CA Cancer cell line
//
ID A204.1
AC CVCL_L305
DR EFO; EFO_0005702
DR ENCODE; ENCBS256AAA
RX PubMed=16897758;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/MRTA204.1_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1058 ! A-204
SX Female
CA Cancer cell line
//
ID A2058
AC CVCL_1059
SY A 2058; A-2058
DR BTO; BTO:0002975
DR CLO; CLO_0001566
DR EFO; EFO_0006361
DR CLDB; cl190
DR CLDB; cl7207
DR ATCC; CRL-11147
DR BCRC; 60240
DR BioSample; SAMN01821723
DR BioSample; SAMN03470825
DR CCLE; A2058_SKIN
DR CGH-DB; 9291-4
DR ChEMBL-Cells; CHEMBL3308030
DR ChEMBL-Targets; CHEMBL613503
DR Cosmic; 687430
DR Cosmic; 888986
DR Cosmic; 890885
DR Cosmic; 905205
DR Cosmic; 906792
DR Cosmic; 928750
DR Cosmic; 1022284
DR Cosmic; 1028799
DR Cosmic; 1054857
DR Cosmic; 1155286
DR Cosmic; 1303031
DR Cosmic; 1477415
DR Cosmic; 1481414
DR Cosmic; 1507608
DR Cosmic; 1669119
DR Cosmic; 1995329
DR Cosmic; 2159438
DR Cosmic; 2233659
DR Cosmic-CLP; 906792
DR ECACC; 91100402
DR GDSC; 906792
DR GEO; GSM162906
DR GEO; GSM206442
DR GEO; GSM276736
DR GEO; GSM827157
DR GEO; GSM887916
DR GEO; GSM1138786
DR GEO; GSM1374379
DR GEO; GSM1669579
DR ICLC; HTL08002
DR IFO; IFO50276
DR Lonza; 999
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=11448059;
RX PubMed=14692828;
RX PubMed=15048078;
RX PubMed=15467732;
RX PubMed=17308088;
RX PubMed=17516929;
RX PubMed=19147755;
RX PubMed=22460905;
RX PubMed=24581590;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=A2058
WW http://tcpaportal.org/mclp/
CC Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 27 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'A2658' in CGH-DB 9291-4.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 13,14
ST D16S539: 9,13
ST D18S51: 13,15
ST D21S11: 29,30.2
ST D3S1358: 14,15
ST D5S818: 9,12
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 21,24
ST Penta D: 9,12
ST Penta E: 10,13
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A208-4
AC CVCL_X983
RX PubMed=3018542;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID A208-7
AC CVCL_X984
RX PubMed=3018542;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID A2095
AC CVCL_Y038
DR Cosmic; 687564
RX PubMed=12068308;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A2106
AC CVCL_N283
SY NR-M1-05
DR ATCC; HB-9350
RX Patent=US4879225;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A2182
AC CVCL_8091
SY A-2182
DR Cosmic; 929963
DR Cosmic; 932916
RX PubMed=3413074;
RX PubMed=7144906;
RX PubMed=15848055;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A2215
AC CVCL_N284
SY NR-M1-03
DR ATCC; HB-9349
RX Patent=US4879225;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A2233
AC CVCL_V400
RX PubMed=7144906;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A224
AC CVCL_D277
SY A-224
DR BTO; BTO:0004034
RX PubMed=12080474;
CC From: De Greve J.; Oncologisch Centrum; Brussels; Belgium.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A2243
AC CVCL_F682
SY A-2243; HA2243; HA 2243
DR Cosmic; 1217473
RX PubMed=7539744;
CC From: Aaronson S.A.; Mt. Sinai Medical Center; New York; USA.
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A23-iPSC
AC CVCL_DD64
RX PubMed=27191603;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F204 ! ND27760
SX Female
CA Induced pluripotent stem cell
//
ID A238
AC CVCL_K264
SY A-238
DR CLO; CLO_0001567
DR CLDB; cl191
RX PubMed=2988162;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aa-238.htm
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_K265 ! Don/a23
SX Male
CA Spontaneously immortalized cell line
//
ID A24
AC CVCL_V064
DR CLO; CLO_0001568
DR CLDB; cl192
DR IHW; IHW8009
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID A2774
AC CVCL_U376
SY A-2774
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-63.html
CC From: Benard J.; Institute Gustave Roussy; Villejuif; France.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A2780
AC CVCL_0134
SY A-2780; 2780; A2780S
DR BTO; BTO:0002549
DR CLO; CLO_0001571
DR EFO; EFO_0006362
DR MCCL; MCC:0000027
DR CLDB; cl193
DR CLDB; cl194
DR CLDB; cl4894
DR BCRJ; 0031
DR BioSample; SAMN03472806
DR CCLE; A2780_OVARY
DR CCRID; 3111C0002000000075
DR ChEMBL-Cells; CHEMBL3308421
DR ChEMBL-Targets; CHEMBL614004
DR Cosmic; 688090
DR Cosmic; 755844
DR Cosmic; 849607
DR Cosmic; 906804
DR Cosmic; 923108
DR Cosmic; 948284
DR Cosmic; 987394
DR Cosmic; 1102819
DR Cosmic; 1139223
DR Cosmic; 1198265
DR Cosmic; 1305309
DR Cosmic; 1609529
DR Cosmic; 1707564
DR Cosmic; 1708387
DR Cosmic; 1709251
DR Cosmic; 1945872
DR Cosmic; 1995331
DR Cosmic; 2582805
DR Cosmic-CLP; 906804
DR ECACC; 93112519
DR GDSC; 906804
DR GEO; GSM184388
DR GEO; GSM184389
DR GEO; GSM503257
DR GEO; GSM659370
DR GEO; GSM827312
DR GEO; GSM851909
DR GEO; GSM886853
DR GEO; GSM887918
DR GEO; GSM1001419
DR GEO; GSM1001420
DR GEO; GSM1001488
DR GEO; GSM1374380
DR GEO; GSM1374381
DR GEO; GSM1669581
DR ICLC; HTL98008
DR Lonza; 207
DR PRIDE; PXD001176
DR PRIDE; PXD003105
DR Ximbio; 152706
RX PubMed=9041185;
RX PubMed=12080474;
RX PubMed=15677628;
RX PubMed=19714814;
RX PubMed=22328975;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=A2780
WW http://www.addexbio.com/productdetail?pid=20
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-64.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 16 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (PubMed=15677628; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; ICLC; PubMed=11416159; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11,13 (Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200)
ST D16S539: 11,12,13 (ICLC)
ST D18S51: 16,18
ST D19S433: 12
ST D21S11: 28
ST D2S1338: 21,22
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 15,17
ST FGA: 19,24
ST Penta D: 8,9
ST Penta E: 10,13
ST TH01: 6
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A2780-cisR
AC CVCL_H745
SY A2780-CISR; A2780/cisR; A2780cisR; A2780(cisR)
DR ChEMBL-Cells; CHEMBL3307508
DR ChEMBL-Targets; CHEMBL614023
DR Cosmic; 688091
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780-DR
AC CVCL_EG64
DR PRIDE; PXD001176
RX PubMed=25096996;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Proteome analysis.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780-DX1
AC CVCL_4T95
RX PubMed=2243668;
RX PubMed=2598402;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780-DX2
AC CVCL_4T96
RX PubMed=2598402;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T95 ! A2780-DX1
SX Female
CA Cancer cell line
//
ID A2780-DX3
AC CVCL_7225
SY A2780/DX3; A2780 DX3; DX3
DR BTO; BTO:0002642
RX PubMed=2598402;
RX PubMed=2751261;
RX PubMed=7713987;
RX PubMed=8012063;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T96 ! A2780-DX2
SX Female
CA Cancer cell line
//
ID A2780-DX4
AC CVCL_4T97
RX PubMed=2598402;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7225 ! A2780-DX3
SX Female
CA Cancer cell line
//
ID A2780-DX5
AC CVCL_4T98
SY A2780 DX5; A2780/Dx5
RX PubMed=2598402;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T97 ! A2780-DX4
SX Female
CA Cancer cell line
//
ID A2780-DX6
AC CVCL_4T99
RX PubMed=2598402;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T98 ! A2780-DX5
SX Female
CA Cancer cell line
//
ID A2780-E(80)
AC CVCL_S476
SY A2780 E(80)
RX PubMed=10772682;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H619 ! 1A9
SX Female
CA Cancer cell line
//
ID A2780-SCA
AC CVCL_DI16
DR GEO; GSM459649
DR GEO; GSM459730
RX PubMed=12509269;
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780-TC1
AC CVCL_1F93
SY A2780 TC1; A2780TC1; TC1
RX PubMed=12815160;
RX PubMed=19714814;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/100
AC CVCL_7224
SY A2780(100)
DR BTO; BTO:0003207
RX PubMed=10413308;
RX PubMed=10644989;
CC Selected for resistance to: ChEBI; CHEBI:28830; Chlorambucil (CBL; Leukeran).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/ACR6
AC CVCL_D156
SY ACR6
RX PubMed=12726863;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/ACRP
AC CVCL_D157
SY ACRP
DR BCRJ; 0036
RX PubMed=12726863;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
ST Source(s): BCRJ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11,13
ST D18S51: 16,18
ST D19S433: 12
ST D21S11: 28
ST D2S1338: 21,22
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 15,17
ST FGA: 19,23
ST TH01: 6
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/AD10
AC CVCL_B037
SY A2780-AD10; AD10; AD-10
DR BTO; BTO:0004037
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/ADDP
AC CVCL_D537
SY A2780 ADDP; ADDP
DR ChEMBL-Cells; CHEMBL3307898
DR ChEMBL-Targets; CHEMBL614264
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/C200
AC CVCL_F638
SY C200
DR GEO; GSM184394
DR GEO; GSM184395
RX PubMed=7954422;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/C30
AC CVCL_F639
SY C30
DR GEO; GSM184396
DR GEO; GSM184397
RX PubMed=7954422;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/CBP
AC CVCL_D620
SY A-car
RX PubMed=15254775;
RX PubMed=17269733;
CC Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/cDDP
AC CVCL_Y180
DR CGH-DB; 9110-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/CDDP
AC CVCL_D619
DR BTO; BTO:0005152
RX PubMed=15254775;
RX PubMed=17269733;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/CP70
AC CVCL_0135
SY A2780/CP; A2780-CP; A 2780 CP; A2780CP; 2780CP; A2780CP70; CP70; CP-70
DR BTO; BTO:0003845
DR BTO; BTO:0005766
DR MCCL; MCC:0000028
DR GEO; GSM184400
DR GEO; GSM184401
DR GEO; GSM851908
DR NCBI_Iran; C454
RX PubMed=7954422;
RX PubMed=12080474;
RX PubMed=17254797;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Deep proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11,13
ST D18S51: 16,18
ST D21S11: 27,28
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 15,17
ST FGA: 19,24
ST TH01: 6
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/R
AC CVCL_4862
DR BTO; BTO:0005130
CC Selected for resistance to: ChEBI; CHEBI:48120; Anthracycline.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/S
AC CVCL_4863
SY A 2780 S
DR BTO; BTO:0005129
DR NCBI_Iran; C461
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/Taxol
AC CVCL_IJ13
RX PubMed=24175763;
CC Doubling time: 24.22 +- 0.22 hours (PubMed=24175763).
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780/TPT
AC CVCL_4V45
RX DOI=10.3969/j.issn.1004-7379.2004.03.003;
RX PubMed=14693055;
RX PubMed=15196431;
CC Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780ADR
AC CVCL_1941
SY A2780-ADR; A2780 ADR
DR CLO; CLO_0001572
DR Cosmic; 1139224
DR ECACC; 93112520
DR GEO; GSM827329
DR Ximbio; 152707
RX PubMed=25230021;
CC Part of: OCCP ovarian cancer cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
ST Source(s): ECACC; PubMed=11416159; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 11,14
ST D18S51: 15
ST D19S433: 12
ST D21S11: 28
ST D2S1338: 21,22
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 15,16,17 (PubMed=11416159)
ST D8S1179: 14,15,16,17 (PubMed=25230021)
ST FGA: 19,25
ST Penta D: 8,9
ST Penta E: 10,13
ST TH01: 6 (ECACC; PubMed=25230021)
ST TH01: 6,9.3 (PubMed=11416159)
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2780cis
AC CVCL_1942
SY A2780CIS; A2780_CIS; A2780 CIS
DR CLO; CLO_0001573
DR CLDB; cl195
DR ECACC; 93112517
DR GEO; GSM827456
DR Ximbio; 152708
RX PubMed=25230021;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=A2780_CIS
CC Part of: OCCP ovarian cancer cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
ST Source(s): ECACC; PubMed=11416159; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 11,13
ST D18S51: 16,17
ST D19S433: 12
ST D21S11: 28
ST D2S1338: 21,23
ST D3S1358: 13,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 15,18
ST FGA: 19,24
ST Penta D: 8,9
ST Penta E: 10,13
ST TH01: 6
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID A2B5 clone 105
AC CVCL_7946
DR CLO; CLO_0001574
DR ATCC; CRL-1520
DR ATCC; HB-29
DR ECACC; 90070501
DR IFO; IFO50284
CC Discontinued: ATCC; HB-29; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID A2C7
AC CVCL_J024
DR ATCC; HB-8397
RX Patent=US4806465;
RX PubMed=6365778;
CC Monoclonal antibody target: UniProtKB; P30575; Candida albicans enolase 1 (ENO1).
CC Discontinued: ATCC; HB-8397; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID A2E11
AC CVCL_D151
DR CLO; CLO_0001575
DR ATCC; CRL-1846
RX PubMed=3453564;
CC Monoclonal antibody target: ChEBI; CHEBI:27584; Aldosterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID A2EN
AC CVCL_0P36
RX PubMed=18201283;
RX PubMed=21943934;
WW https://www.abmgood.com/Immortalized-Endocervical-Epithelial-Cells-HPV-E6/E7-(A2EN)-T0595.html
WW https://www.kerafast.com/product/2032/human-endocervical-epithelial-cell-line
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID A2L
AC CVCL_X201
RX PubMed=6088881;
RX PubMed=6324641;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID A2L/AH
AC CVCL_X202
RX PubMed=3008992;
RX PubMed=6088881;
RX PubMed=6324641;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X201 ! A2L
HI CVCL_X200 ! Ad-AH
CA Hybrid cell line
//
ID A2H
AC CVCL_4100
DR CLO; CLO_0001576
DR CLDB; cl196
DR ECACC; 85011441
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID A3
AC CVCL_1061
SY Jurkat clone A3
DR BTO; BTO:0001342
DR CLO; CLO_0001577
DR ATCC; CRL-2570
DR BCRC; 60485
DR BioSample; SAMN03471678
DR CCRID; 3131C0001000700096
DR KCB; KCB 201084YJ
RX PubMed=8972182;
RX PubMed=10616904;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID A3.01
AC CVCL_6244
DR Lonza; 362
DR NIH-ARP; 166-382
RX PubMed=2989831;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID A3.4H2
AC CVCL_G628
DR CLO; CLO_0001579
DR ATCC; HB-12319
RX Patent=US6207156;
CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID A3.6B10
AC CVCL_G629
DR CLO; CLO_0001580
DR ATCC; HB-12318
RX Patent=US6207156;
CC Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID A3-1
AC CVCL_GS33
RX DOI=10.1262/jrd1977.37.37;
RX PubMed=8648758;
RX PubMed=9353641;
RX PubMed=9373942;
CC Breed/subspecies: 129X1/SvJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID A3/MHV
AC CVCL_GS34
RX PubMed=8648758;
CC Characteristics: Persistently infected by MHV-2.
CC Breed/subspecies: 129X1/SvJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_GS33 ! A3-1
SX Male
CA Embryonic stem cell
//
ID A3/Kawakami
AC CVCL_1062
SY A3/KAW; A3-KAW
DR EFO; EFO_0006532
DR BioSample; SAMN03470896
DR CCLE; A3KAW_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308225
DR ChEMBL-Targets; CHEMBL2366273
DR Cosmic; 910935
DR Cosmic; 919153
DR Cosmic-CLP; 910935
DR GDSC; 910935
DR GEO; GSM886855
DR GEO; GSM887920
DR GEO; GSM1669584
DR JCRB; JCRB0101
RX PubMed=6601597;
RX PubMed=9290701;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 20 hours (JCRB).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 10
ST D18S51: 17
ST D19S433: 12,14
ST D21S11: 32.2,33.2
ST D2S1338: 19
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 11,12
ST D8S1179: 11,15
ST FGA: 20,23
ST Penta D: 10,14
ST Penta E: 15,18
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A3026
AC CVCL_N285
SY NR-M1-06
DR ATCC; HB-9348
RX Patent=US4879225;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A303
AC CVCL_9V39
RX PubMed=11956167;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID A304
AC CVCL_9V40
RX PubMed=11956167;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID A31-714 C4
AC CVCL_L989
DR IFO; IFO50021
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Spontaneously immortalized cell line
//
ID A31N-ts20
AC CVCL_B385
SY A31N ts20; A31Nts20
DR BTO; BTO:0004582
RX PubMed=8114731;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Spontaneously immortalized cell line
//
ID A32-1
AC CVCL_E275
SY Pa07c
DR Cosmic; 1473089
DR Cosmic; 1509853
RX PubMed=18772397;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Peritoneum.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A364
AC CVCL_6561
SY A-364
DR BTO; BTO:0004246
RX PubMed=12080474;
CC From: De Greve J.; Oncologisch Centrum; Brussels; Belgium.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A375-12R5-1
AC CVCL_R746
SY 12R5-1
DR Cosmic; 1890494
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-12R5-3
AC CVCL_R747
SY 12R5-3
DR Cosmic; 1890487
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-12R5-5
AC CVCL_R748
SY 12R5-5
DR Cosmic; 1890495
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-12R8-1
AC CVCL_R749
SY 12R8-1
DR Cosmic; 1890488
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-12R8-3
AC CVCL_R750
SY 12R8-3
DR Cosmic; 1890489
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-16R5-2
AC CVCL_R751
SY 16R5-2
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-16R5-5
AC CVCL_R752
SY 16R5-5
DR Cosmic; 1890491
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-16R6-2
AC CVCL_R753
SY 16R6-2
DR Cosmic; 1890492
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-16R6-3
AC CVCL_R754
SY 16R6-3
DR Cosmic; 1890490
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-16R6-4
AC CVCL_R755
SY 16R6-4
DR Cosmic; 1890493
RX Patent=US8835450;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R745 ! A375PF11
SX Female
CA Cancer cell line
//
ID A375-C5
AC CVCL_2294
SY A375Cl-5
DR Cosmic; 932715
DR ECACC; 97011320
RX PubMed=2584706;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=A375-C5
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-C6
AC CVCL_2295
DR ECACC; 97011321
DR GEO; GSM827328
RX PubMed=2584706;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=A375-C6
CC Misspelling: 'A373-C6' in Sigma catalog.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-M
AC CVCL_B222
SY A375M; A375m
RX PubMed=1671030;
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-MA1
AC CVCL_X494
SY MA-1
DR ATCC; CRL-3222
RX PubMed=18505921;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-MA2
AC CVCL_X495
SY MA-2
DR ATCC; CRL-3223
RX PubMed=18505921;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X494 ! A375-MA1
SX Female
CA Cancer cell line
//
ID A375-P
AC CVCL_6233
SY A-375P; A375P; A375p
DR BTO; BTO:0003984
DR ATCC; CRL-3224
DR Cosmic; 932714
DR Cosmic; 1045406
DR Cosmic; 1067223
DR Cosmic; 1238110
DR KCLB; 80003
RX PubMed=1671030;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-R
AC CVCL_6234
RX PubMed=3260254;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=A375-R
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-SM
AC CVCL_5649
SY A-375SM; A375SM
DR BTO; BTO:0003985
DR Cosmic; 932716
DR Cosmic; 1238111
DR Cosmic; 1303033
DR KCLB; 80004
RX PubMed=1826230;
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 9
ST FGA: 20,23
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-VR [2014]
AC CVCL_AP96
RX PubMed=24398428;
CC Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375-VR [2015]
AC CVCL_AQ00
RX PubMed=26497853;
CC Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375/R
AC CVCL_IW10
RX PubMed=26365896;
CC Selected for resistance to: ChEBI; CHEBI:90295; PLX-4720.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375.S2
AC CVCL_0136
SY A-375.S2; A375-S2; A375S2; A375s2
DR BTO; BTO:0005815
DR CLO; CLO_0001583
DR MCCL; MCC:0000029
DR ATCC; CRL-1872
DR BCRC; 60263
DR GEO; GSM827493
DR LINCS; 50003
CC Miscellaneous: Not sure what is the relationship between A375.S2 and A375S1.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375P-beta6/puro
AC CVCL_5F66
SY A375Pbeta6puro
DR Ximbio; 151626
RX PubMed=17244604;
CC Transfected with: HGNC; 6161; ITGB6.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6233 ! A375-P
SX Female
CA Cancer cell line
//
ID A375PF11
AC CVCL_R745
SY A375 PF11
RX Patent=US8835450;
RX PubMed=22389471;
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A375S1
AC CVCL_Y439
RX PubMed=3261584;
CC Miscellaneous: Not sure what is the relationship between A375.S2 and A375S1.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID A3R5.7
AC CVCL_S540
SY A3.01/R5.7
DR NIH-ARP; 12386-390
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6244 ! A3.01
SX Female
CA Cancer cell line
//
ID A38-5
AC CVCL_E276
SY Pa08c
DR Cosmic; 1473125
DR Cosmic; 1509854
RX PubMed=18772397;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A4 [Mouse]
AC CVCL_F962
DR TKG; TKG 0298
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID A4 [Pig PBM]
AC CVCL_6G31
RX PubMed=3261912;
RX PubMed=7951345;
CC Breed/subspecies: Duroc.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID A4.1025
AC CVCL_1943
AS CVCL_0E77
SY A4-1025
DR CLO; CLO_0001588
DR ATCC; CRL-2044
DR DSMZ; ACC-296
RX PubMed=7531198;
CC Doubling time: ~40-50 hours (DSMZ).
CC Monoclonal antibody target: Human myosin heavy chains (also reacts with other species).
CC Discontinued: ATCC; CRL-2044; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A4.1077
AC CVCL_1944
SY A4-1077; 4A.1077
DR CLO; CLO_0001589
DR DSMZ; ACC-297
RX PubMed=7531198;
CC Doubling time: ~20-40 hours (DSMZ).
CC Monoclonal antibody target: Human myosin heavy chains (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A4.1519
AC CVCL_0E78
SY 4A.1519
DR ATCC; CRL-2045
RX PubMed=7531198;
CC Monoclonal antibody target: Human myosin heavy chains (also reacts with other species).
CC Discontinued: ATCC; CRL-2045; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A4.74
AC CVCL_J940
SY 4A.74
DR CLO; CLO_0001585
DR ATCC; CRL-2041
RX PubMed=7531198;
RX PubMed=7687223;
CC Monoclonal antibody target: Human myosin heavy chains (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A4.840
AC CVCL_1945
AS CVCL_0E79
SY A4-840; 4A.840
DR CLO; CLO_0001586
DR CLO; CLO_0001594
DR CLDB; cl49
DR ATCC; CRL-2043
DR DSMZ; ACC-213
RX PubMed=7531198;
RX PubMed=7687223;
CC Doubling time: ~25 hours (DSMZ).
CC Monoclonal antibody target: Human myosin heavy chains (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A4.951
AC CVCL_1946
AS CVCL_0E80
SY A4-951; 4A.951
DR CLO; CLO_0001587
DR CLO; CLO_0001595
DR ATCC; CRL-2046
DR DSMZ; ACC-214
RX PubMed=7687223;
CC Doubling time: ~24 hours (DSMZ).
CC Monoclonal antibody target: Human myosin heavy chains (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID A4/Fukuda
AC CVCL_1064
SY A4/Fuk; A4/FUK; A4-Fuk; A4-FUK
DR EFO; EFO_0006533
DR BioSample; SAMN03470900
DR CCLE; A4FUK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308226
DR ChEMBL-Targets; CHEMBL2366356
DR Cosmic; 910934
DR Cosmic; 998704
DR Cosmic; 1037706
DR Cosmic; 1995336
DR Cosmic-CLP; 910934
DR GDSC; 910934
DR GEO; GSM886857
DR GEO; GSM887922
DR GEO; GSM1669588
DR JCRB; JCRB0097
RX PubMed=6601597;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,12
ST D16S539: 9,12
ST D18S51: 14,17
ST D19S433: 14,15.2
ST D21S11: 28,29
ST D2S1338: 19,20
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 14,16
ST FGA: 19
ST Penta D: 13
ST Penta E: 5
ST TH01: 7,9
ST TPOX: 11
ST vWA: 18,19,20
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A431-PR
AC CVCL_EQ67
SY A431 PR
DR GEO; GSM183434
DR GEO; GSM183435
RX PubMed=17560336;
CC Knockout cell: Method=shRNA knockdown; HGNC; 9588; PTEN.
CC Omics: Transcriptome analysis.
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0037 ! A-431
SX Female
CA Cancer cell line
//
ID A431/CDDP1
AC CVCL_GY97
RX PubMed=9755302;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0037 ! A-431
SX Female
CA Cancer cell line
//
ID A431/CDDP2
AC CVCL_GY98
RX PubMed=9755302;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0037 ! A-431
SX Female
CA Cancer cell line
//
ID A431/TPT
AC CVCL_4V41
RX PubMed=19765546;
CC Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0037 ! A-431
SX Female
CA Cancer cell line
//
ID A431NS
AC CVCL_3485
SY A431-NS
DR CLO; CLO_0001593
DR ATCC; CRL-2592
DR TOKU-E; 477
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,13
ST D16S539: 12,14
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 9
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0037 ! A-431
SX Female
CA Cancer cell line
//
ID A4573
AC CVCL_6245
SY A-4573; ES-A4573
DR Cosmic; 1718428
DR Cosmic; 2060798
DR GEO; GSM510001
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2620246;
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=6750238;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A4xC
AC CVCL_9258
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aa4xc.htm
OX NCBI_TaxID=9823; ! Sus scrofa
CA Hybrid cell line
//
ID A4xL
AC CVCL_9257
DR CLO; CLO_0001597
DR CLDB; cl200
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aa4xl.htm
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=9823; ! Sus scrofa
CA Hybrid cell line
//
ID A5-BAG
AC CVCL_9Y71
RX PubMed=8845386;
RX PubMed=9548567;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_9Y70 ! RSMT-A5
CA Transformed cell line
//
ID A5-DAP
AC CVCL_9Y72
RX PubMed=9358855;
RX PubMed=9548567;
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_9Y70 ! RSMT-A5
CA Transformed cell line
//
ID A5.12.14
AC CVCL_J004
SY 5.12.14
DR CLO; CLO_0001598
DR ATCC; HB-11553
RX Patent=US5677426;
CC Monoclonal antibody target: UniProtKB; P10145; Human IL8.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID A5.4
AC CVCL_G630
SY 1506 A5.4
DR CLO; CLO_0001599
DR ATCC; CRL-2275
CC Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID A529L
AC CVCL_8655
DR CLO; CLO_0050056
DR BioSample; SAMN03471928
DR RCB; RCB2817
RX PubMed=11267941;
RX PubMed=11518743;
RX PubMed=12114371;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A547
AC CVCL_6562
SY A-547
DR BTO; BTO:0004247
RX PubMed=12080474;
CC From: De Greve J.; Oncologisch Centrum; Brussels; Belgium.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A549 NucLight Green
AC CVCL_DF39
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/a549-nuclight-green-cells/
CC Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549 NucLight Red
AC CVCL_DF40
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/a549-nuclight-red/
CC Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549-CR
AC CVCL_IP03
DR BTO; BTO:0005816
RX PubMed=26692948;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549-Dual
AC CVCL_5I73
WW http://www.invivogen.com/a549-dual
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549-Luc
AC CVCL_J242
DR JCRB; JCRB1414
DR JCRB; NIHS0659
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0659; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549-luc-C8
AC CVCL_5J13
RX PubMed=14713107;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119266.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549-Red-FLuc
AC CVCL_5I86
SY A549 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW119266
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549-Taxol
AC CVCL_W218
SY A549/Taxol
RX PubMed=20499251;
RX PubMed=22460125;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549/CPT
AC CVCL_H268
DR CGH-DB; 9107-4
RX PubMed=2170010;
RX PubMed=2174738;
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549/TXL10
AC CVCL_W190
RX CelloPub=CLPUB00006;
CC Doubling time: 75.5 hours (CelloPub=CLPUB00006).
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549/TXL20
AC CVCL_W191
RX CelloPub=CLPUB00006;
CC Doubling time: 77.3 hours (CelloPub=CLPUB00006).
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549/TXL5
AC CVCL_W192
RX CelloPub=CLPUB00006;
CC Doubling time: 74.7 hours (CelloPub=CLPUB00006).
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549.EpoB40
AC CVCL_4Z15
SY EpoB40
RX PubMed=12467233;
RX PubMed=15956256;
CC Selected for resistance to: ChEBI; CHEBI:31550; Epothilone B (EpoB).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549(VM)28
AC CVCL_4V06
RX PubMed=1717144;
CC Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A549(VP)28
AC CVCL_4V07
RX PubMed=1717144;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID A590
AC CVCL_6A73
SY A 590
DR Cosmic; 933523
RX PubMed=1906154;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A5GR1
AC CVCL_5V00
RX PubMed=8695360;
RX PubMed=9347924;
CC Transfected with: RGD; 2741; Nr3c1.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U93 ! NAL1A clone C1SA5
CA Transformed cell line
//
ID A6 [Human/mouse hybridoma]
AC CVCL_9088
SY A-6
DR CLO; CLO_0001602
DR ATCC; CRL-8192
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
HI CVCL_0566 ! U266B1
CA Hybridoma
//
ID A6 [Xenopus]
AC CVCL_4101
SY A-6
DR BTO; BTO:0004248
DR CLO; CLO_0001603
DR CLO; CLO_0050248
DR CLDB; cl209
DR ATCC; CCL-102
DR ECACC; 89072613
DR RCB; RCB0772
RX PubMed=1556737;
RX PubMed=20732225;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-366.html
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Male
CA Spontaneously immortalized cell line
//
ID A6-2F3
AC CVCL_F714
SY A6 2F3; 2F3
RX PubMed=1556737;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
HI CVCL_4101 ! A6 [Xenopus]
SX Male
CA Spontaneously immortalized cell line
//
ID A6-iPSC
AC CVCL_DD59
RX PubMed=27191603;
ST Source(s): PubMed=27191603
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 11,12
ST D21S11: 30,31.2
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F204 ! ND27760
SX Female
CA Induced pluripotent stem cell
//
ID A61-5
AC CVCL_E281
SY Pa101C
DR Cosmic; 1477307
DR Cosmic; 1509878
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Not specified.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A64-CLS
AC CVCL_5968
SY A-64CLS
DR CLS; 300199/p726_A64-CLS
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 12,14
ST D21S11: 30,31
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 11
ST FGA: 21.2
ST Penta D: 9,10
ST Penta E: 10,11
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A640-3Y1-1
AC CVCL_H731
SY A640-3Y1
DR RCB; RCB0344
RX PubMed=3533570;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA640].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID A640-IS
AC CVCL_H640
DR BTO; BTO:0003530
RX PubMed=9252141;
RX PubMed=17760834;
CC Characteristics: Grows actively at the permissive temperature (33 Celsius). At the repressive temperature (39 Celsius) the cells do not grow and differentiate into Ito cells.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA640].
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID A68177
AC CVCL_6366
SY A68-177
DR CLO; CLO_0001607
DR ATCC; CRL-7714
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7714; true.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID A6ATL
AC CVCL_Y380
SY A6 ATL; A6.ATL
DR CLO; CLO_0001604
RX PubMed=6971250;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: AT.L.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID A6L
AC CVCL_E302
AS CVCL_D553
SY A6; GM6L; Pa02C
DR Cosmic; 1473116
DR Cosmic; 1509849
RX PubMed=17912029;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A7 [Mouse stellate]
AC CVCL_M113
DR BTO; BTO:0003532
RX PubMed=17760834;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID A7 [Rat astrocyte]
AC CVCL_E150
RX PubMed=22358592;
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID A7 [Rat astrocyte transformed]
AC CVCL_E148
RX PubMed=3053737;
RX PubMed=7583324;
RX PubMed=8076662;
RX PubMed=10516297;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID A716
AC CVCL_D595
SY A-716
DR BTO; BTO:0005308
CC From: Lerman M.; Center for Cancer Research; National Cancer Institute; Frederick; USA.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A717
AC CVCL_G631
DR CLO; CLO_0001611
DR ATCC; HB-9596
RX Patent=US5518720;
CC Monoclonal antibody target: UniProtKB; P02768; Human ALB (glycated).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID A735
AC CVCL_X371
RX PubMed=10475274;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [p375.6].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID A7573
AC CVCL_9501
SY A 7573
DR CLO; CLO_0001613
DR CLDB; cl213
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_3363 ! CF2.Th
SX Female
CA Spontaneously immortalized cell line
//
ID A7573/HL-23V
AC CVCL_L209
SY A7573-HL23V; A7573(HL-23V)
RX PubMed=52117;
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_9501 ! A7573
SX Female
CA Spontaneously immortalized cell line
//
ID A79V-hiPSC
AC CVCL_DQ85
RX PubMed=27345973;
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID A7d
AC CVCL_6870
DR CCRID; 3111C0001CCC000093
CC Characteristics: IL3 dependent.
CC Transfected with: HGNC; 6342; KIT.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2039 ! FDC-P1
CA Factor-dependent cell line
//
ID A7r5
AC CVCL_0137
SY A7R5
DR BTO; BTO:0000019
DR CLO; CLO_0001614
DR MCCL; MCC:0000030
DR CLDB; cl214
DR CLDB; cl215
DR ATCC; CRL-1444
DR BCRC; 60082
DR BCRJ; 0034
DR CCRID; 3131C0001000500007
DR ECACC; 86050803
DR IZSLER; BS CL 162
DR KCB; KCB 2010186YJ
DR Lonza; 997
DR NCBI_Iran; C607
RX PubMed=943301;
CC Breed/subspecies: BDIX.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID A8
AC CVCL_4564
SY A-8
DR CLO; CLO_0050154
DR RCB; RCB0773
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Female
CA Spontaneously immortalized cell line
//
ID A8/D1
AC CVCL_3272
SY A8/DI
DR CLO; CLO_0001615
DR CLDB; cl218
DR CLDB; cl4896
DR ECACC; 94031011
DR ICLC; ATL98012
CC Discontinued: ECACC; 94031011; probable.
CC Breed/subspecies: AKR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID A818
AC CVCL_3890
RX PubMed=10415853;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A818-1
AC CVCL_3891
AS CVCL_8604
SY A-818-1; A818.1; A818 1; 818-1; 818_1
DR Cosmic; 736266
DR Cosmic; 808169
DR Cosmic; 933524
RX PubMed=1906154;
RX PubMed=8430098;
RX PubMed=10415853;
RX PubMed=11169959;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/A818.html
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3890 ! A818
SX Female
CA Cancer cell line
//
ID A818-4
AC CVCL_3892
AS CVCL_0128
SY A-818-4; A818.4; A818 4; A8184; 818-4; 818_4; 8184
DR MCCL; MCC:0000020
DR Cosmic; 710850
DR Cosmic; 736267
DR Cosmic; 808168
DR Cosmic; 933525
DR Cosmic; 1108342
DR Cosmic; 1320466
RX PubMed=1906154;
RX PubMed=8430098;
RX PubMed=9472115;
RX PubMed=10415853;
RX PubMed=11787853;
RX PubMed=12692724;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3890 ! A818
SX Female
CA Cancer cell line
//
ID A818-6
AC CVCL_3893
SY A818.6; A818 6
RX PubMed=11238448;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3890 ! A818
SX Female
CA Cancer cell line
//
ID A818-7
AC CVCL_8777
AS CVCL_8605
SY A-818-7; 818-7
DR Cosmic; 736268
DR Cosmic; 933526
RX PubMed=1906154;
RX PubMed=8105469;
RX PubMed=8430098;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3890 ! A818
SX Female
CA Cancer cell line
//
ID A9 [Mouse hybridoma]
AC CVCL_9094
DR CLO; CLO_0001619
DR ATCC; CRL-1811
RX PubMed=6688077;
CC Monoclonal antibody target: UniProtKB; P00347; Cricetulus griseus Hmgcr.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID A9 [Mouse Lewis lung carcinoma]
AC CVCL_S007
RX PubMed=6490207;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5653 ! 3LL
CA Cancer cell line
//
ID A9 L hD2 S.C. 18
AC CVCL_9095
SY A9 L cell line hD2 subclone #18; A9 D2 Subclone 18
DR CLO; CLO_0001621
DR ATCC; CRL-10225
RX Patent=US5554500;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Transfected with: HGNC; 3023; DRD2.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
SX Male
CA Transformed cell line
//
ID A9+12
AC CVCL_1P15
SY GM13259
DR CLO; CLO_0013121
DR Coriell; GM13259
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9+15
AC CVCL_1P16
SY GM11715
DR CLO; CLO_0021263
DR Coriell; GM11715
RX PubMed=1582264;
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9+2
AC CVCL_1P17
SY GM11712
DR CLO; CLO_0021273
DR Coriell; GM11712
RX PubMed=1582264;
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9+20
AC CVCL_1P18
SY GM13260
DR CLO; CLO_0013119
DR Coriell; GM13260
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9+22
AC CVCL_1P19
SY GM13258
DR CLO; CLO_0013066
DR Coriell; GM13258
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9+3
AC CVCL_1P20
SY GM11713
DR CLO; CLO_0021275
DR Coriell; GM11713
RX PubMed=1582264;
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9+5
AC CVCL_1P21
SY GM11714
DR CLO; CLO_0021262
DR Coriell; GM11714
RX PubMed=1582264;
RX PubMed=8325652;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(An4)-2
AC CVCL_2830
DR JCRB; JCRB0727
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Bsr10)
AC CVCL_2831
DR JCRB; JCRB2210
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(BsrX)
AC CVCL_2832
DR JCRB; JCRB2223
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(GM0097)-1
AC CVCL_1P02
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V747 ! GM00097
HI CVCL_3575 ! RAG
CA Hybrid cell line
//
ID A9(GM0194)-3
AC CVCL_1P03
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_H961 ! GM00194
CA Hybrid cell line
//
ID A9(GM0439)-1
AC CVCL_2825
SY A9(0439)-1
DR JCRB; JCRB0732
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_V771 ! GM00439
CA Hybrid cell line
//
ID A9(GM1533)-1
AC CVCL_1P04
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_V806 ! GM01533
CA Hybrid cell line
//
ID A9(GM1695)-3
AC CVCL_1P05
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_V811 ! GM01695
CA Hybrid cell line
//
ID A9(GM1695)-4
AC CVCL_1P06
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_V811 ! GM01695
CA Hybrid cell line
//
ID A9(GM1695)-5
AC CVCL_1P07
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_V811 ! GM01695
CA Hybrid cell line
//
ID A9(GM2621)-4
AC CVCL_2826
SY A9(2621)-4
DR JCRB; JCRB0730
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_1P01 ! GM02621
CA Hybrid cell line
//
ID A9(GM2859)-3
AC CVCL_1P08
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_M932 ! GM02859
CA Hybrid cell line
//
ID A9(GM2859)-4
AC CVCL_1P09
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_M932 ! GM02859
CA Hybrid cell line
//
ID A9(GM3322)-1
AC CVCL_1P10
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_Y091 ! GM03322
CA Hybrid cell line
//
ID A9(GM3322)-2
AC CVCL_1P11
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_Y091 ! GM03322
CA Hybrid cell line
//
ID A9(GM3552)-2
AC CVCL_2827
SY A9(3552)-2
DR JCRB; JCRB0731
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_N009 ! GM03552
CA Hybrid cell line
//
ID A9(GM3884)-1
AC CVCL_2828
SY A9(3884)-1
DR JCRB; JCRB0729
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_1N62 ! GM03884
CA Hybrid cell line
//
ID A9(GM3884)-2
AC CVCL_1P12
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_1N62 ! GM03884
CA Hybrid cell line
//
ID A9(GM4618)-10
AC CVCL_1P13
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_N128 ! GM04618
CA Hybrid cell line
//
ID A9(GM4618)-2
AC CVCL_1P14
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_N128 ! GM04618
CA Hybrid cell line
//
ID A9(GM7151)-3
AC CVCL_2829
SY A9(7151)-3
DR JCRB; JCRB0728
RX PubMed=2498246;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_X048 ! GM07151
CA Hybrid cell line
//
ID A9(Hygro13)
AC CVCL_2833
DR JCRB; JCRB2213
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Hygro14)
AC CVCL_2834
DR JCRB; JCRB2214
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Hygro21)
AC CVCL_2835
DR JCRB; JCRB2221
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Hygro22)
AC CVCL_2836
DR JCRB; JCRB2222
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo1)
AC CVCL_2837
SY A9(neo-1); A9(Neo-1)-4; A9-1neo; GM13139
DR CLO; CLO_0013668
DR Coriell; GM13139
DR JCRB; JCRB2201
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_0440 ! MRC-5
CA Hybrid cell line
//
ID A9(Neo11)
AC CVCL_2838
SY A9(neo11); A9(Neo-11)-1
DR JCRB; JCRB2211
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_0440 ! MRC-5
CA Hybrid cell line
//
ID A9(Neo12)
AC CVCL_2839
SY A9(neo-12); A9(Neo-12)-4
DR JCRB; JCRB2212
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_3080 ! NTI-4
CA Hybrid cell line
//
ID A9(Neo15)
AC CVCL_2840
SY A9(Neo-15)-2
DR JCRB; JCRB2215
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo16)
AC CVCL_2841
DR JCRB; JCRB2216
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo17)
AC CVCL_2842
DR JCRB; JCRB2217
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo18)
AC CVCL_2843
SY A9(Neo-18)-5
DR JCRB; JCRB2218
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo19)
AC CVCL_2844
SY A9(Neo-19)-1
DR JCRB; JCRB2219
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_0440 ! MRC-5
CA Hybrid cell line
//
ID A9(Neo2)
AC CVCL_2845
SY A9(Neo-2)-1
DR JCRB; JCRB2202
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo20)
AC CVCL_2846
SY A9(Neo-20)-3; A9-20neo; GM13140
DR CLO; CLO_0013667
DR Coriell; GM13140
DR JCRB; JCRB2220
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_0440 ! MRC-5
CA Hybrid cell line
//
ID A9(Neo3)
AC CVCL_2847
DR JCRB; JCRB2203
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_3080 ! NTI-4
CA Hybrid cell line
//
ID A9(Neo4)
AC CVCL_2848
DR JCRB; JCRB2204
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_0440 ! MRC-5
CA Hybrid cell line
//
ID A9(Neo5)
AC CVCL_2849
SY A9(Neo-5)-4
DR JCRB; JCRB2205
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo6)
AC CVCL_2850
SY A9(Neo-6)-3
DR JCRB; JCRB2206
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(Neo7)
AC CVCL_2851
SY A9(Neo-7)-2
DR JCRB; JCRB2207
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_3080 ! NTI-4
CA Hybrid cell line
//
ID A9(Neo8)
AC CVCL_2852
SY A9(Neo-8)-1
DR JCRB; JCRB2208
RX PubMed=2502516;
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A9(NTI8)-2
AC CVCL_2853
DR JCRB; JCRB0726
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID A924
AC CVCL_N715
RX PubMed=16820947;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A9423
AC CVCL_W143
SY 9423
RX PubMed=3004699;
RX PubMed=6750238;
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A964
AC CVCL_N716
RX PubMed=16820947;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A99
AC CVCL_D699
DR Cosmic; 1767220
RX PubMed=21768923;
DI NCIt; C95583; Pancreatic small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID A904L
AC CVCL_U095
DR RCB; RCB3531
DR TOKU-E; 3583
RX PubMed=11267941;
RX PubMed=12114371;
RX PubMed=17131342;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID A925L
AC CVCL_U096
RX PubMed=12114371;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID A9HT
AC CVCL_4387
SY A9 high take
DR CLO; CLO_0001626
DR CLDB; cl225
DR ECACC; 88042804
RX PubMed=4506195;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
SX Male
CA Transformed cell line
//
ID AA 4.1
AC CVCL_D664
DR BCRJ; 0035
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID AA-2
AC CVCL_8168
SY AA2
DR NIH-ARP; 135-12
RX PubMed=3261775;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID AA224
AC CVCL_J178
DR CLO; CLO_0001628
DR ATCC; HB-10183
RX Patent=US5238824;
CC Monoclonal antibody target: Edwardsiella ictaluri antigens of about 14, 39, 48, 60, 66, 83 and 93 Kda.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Aa23
AC CVCL_Z817
RX PubMed=9013253;
RX PubMed=18401667;
CC Group: Insect cell line.
CC Characteristics: Infected by the intracellular symbiont Wolbachia pipientis.
OX NCBI_TaxID=7160; ! Aedes albopictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AA5
AC CVCL_J053
DR CLO; CLO_0001629
DR ATCC; CRL-2637
RX PubMed=9922460;
CC Monoclonal antibody target: UniProtKB; P30944; Xenopus laevis cad1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AA859
AC CVCL_F546
SY TER47; TER156; TER264
DR IMGT/HLA; 10216
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AA9
AC CVCL_0P26
RX DOI=10.1016/j.vetimm.2008.10.066;
RX Patent=US8563313;
WW https://www.kerafast.com/product/1780/mouse-macrophage-cell-line-aa9-for-prrsv-propagation
CC Transfected with: UniProtKB; A7LCJ3; Pig sialoadhesin.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0358 ! J774A1
SX Female
CA Cancer cell line
//
ID AAE12
AC CVCL_Z188
RX PubMed=17662657;
RX PubMed=19242658;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=6943; ! Amblyomma americanum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AAE2
AC CVCL_Z189
DR TCB; 3121
RX PubMed=17662657;
RX PubMed=16922866;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=6943; ! Amblyomma americanum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Aag-2
AC CVCL_Z617
SY Aag2; Peleg's line 59
RX PubMed=2267971;
RX PubMed=4869110;
RX PubMed=22827926;
WW http://hawaii.eagle-i.net/i/0000012b-5661-c263-2f73-b43980000000
WW https://www.vectorbase.org/data/aedes-aegypti-aag-2-cell-line-avcl
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7159; ! Aedes aegypti
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Aalb-105
AC CVCL_Z535
SY Aalb105
RX DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC Group: Insect cell line.
OX NCBI_TaxID=7160; ! Aedes albopictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AAV-293
AC CVCL_6871
DR CCRID; 3131C0001000200013
DR NCBI_Iran; C548
WW http://www.chem.agilent.com/Library/usermanuals/Public/240073.pdf
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID Ab 21.1
AC CVCL_J054
SY Ab21.1
DR CLO; CLO_0001634
DR ATCC; HB-11601
RX Patent=US5587458;
CC Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Ab 23.1
AC CVCL_J055
SY Ab23.1
DR CLO; CLO_0001635
DR ATCC; HB-11602
RX Patent=US5587458;
CC Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID AB.11
AC CVCL_X985
SY AB-11
RX PubMed=1651325;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID AB.9
AC CVCL_6311
SY AB-9; AB9
DR CLO; CLO_0001636
DR ATCC; CRL-2298
DR BCRC; 60478
DR CCRID; 3131C0001001100002
DR Wikidata; Q4650009
RX PubMed=9891354;
WW https://en.wikipedia.org/wiki/AB9
CC Group: Fish cell line.
CC Breed/subspecies: AB.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AB0001
AC CVCL_8B35
DR ECACC; 89092221
CC Part of: ECACC chromosomal abnormality collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID AB1 [Mouse ESC]
AC CVCL_N791
SY AB-1
DR ATCC; SCRC-1022
RX PubMed=2205396;
RX PubMed=9353641;
RX PubMed=9853825;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-83.html
CC Discontinued: ATCC; SCRC-1022; true.
CC Breed/subspecies: 129S7/SvEvBrd-Hprt<+>.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AB1 [Mouse hybridoma]
AC CVCL_U858
DR CLO; CLO_0050384
DR RCB; RCB2316
RX PubMed=9106500;
CC Monoclonal antibody target: ChEBI; CHEBI:28175; Ganglioside GD1b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AB1 [Mouse mesothelioma]
AC CVCL_4403
SY AB-1
DR CBA; CBA-0144
DR ECACC; 10092305
RX PubMed=1459729;
RX PubMed=22581112;
CC Breed/subspecies: BALB/c.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID AB1 HA
AC CVCL_G361
SY AB-1 HA
DR CBA; CBA-1374
DR ECACC; 12070506
RX PubMed=10070965;
CC Transfected with: UniProtKB; P03452; Influenza A/Puerto Rico/8/1934 HA.
CC Breed/subspecies: BALB/c.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4403 ! AB1 [Mouse mesothelioma]
SX Female
CA Cancer cell line
//
ID AB1-2
AC CVCL_4404
DR CLO; CLO_0001637
DR ATCC; HB-33
RX PubMed=7035186;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID AB12
AC CVCL_4405
DR CBA; CBA-0146
DR ECACC; 10092306
RX PubMed=1459729;
RX PubMed=22581112;
CC Breed/subspecies: BALB/c.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID AB2.1
AC CVCL_Y609
RX PubMed=1997203;
RX PubMed=9853825;
CC Breed/subspecies: 129S7/SvEvBrd-Hprt
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AB2.2
AC CVCL_C261
DR EFO; EFO_0002812
DR ATCC; SCRC-1023
DR TOKU-E; 4119
RX PubMed=9853825;
CC Breed/subspecies: 129S7/SvEvBrd-Hprt
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AB22
AC CVCL_4406
DR CBA; CBA-0148
DR ECACC; 10092307
RX PubMed=1459729;
CC Breed/subspecies: BALB/c.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID ABAD-CuVa-1087-1
AC CVCL_Z968
SY CuVa-1
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-2
AC CVCL_Z969
SY CuVa-2
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-3
AC CVCL_Z970
SY CuVa-3
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-4
AC CVCL_Z971
SY CuVa-4
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-5
AC CVCL_Z972
SY CuVa-5
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-6
AC CVCL_Z973
SY CuVa-6
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-7
AC CVCL_Z974
SY CuVa-7
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ABAD-CuVa-1087-8
AC CVCL_Z975
SY CuVa-8
RX PubMed=2553822;
CC Group: Insect cell line.
OX NCBI_TaxID=46212; ! Culicoides variipennis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Abana
AC CVCL_N701
RX PubMed=6243721;
RX PubMed=6243722;
RX PubMed=6265077;
RX PubMed=8344493;
RX PubMed=8515068;
CC Characteristics: EBV-negative.
CC Characteristics: Heterozygous for the TP53 p.Arg273Cys mutation.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ABC-1
AC CVCL_1066
SY ABC1
DR CLO; CLO_0001641
DR EFO; EFO_0002813
DR BioSample; SAMN03471587
DR CCLE; ABC1_LUNG
DR CGH-DB; 203-1
DR CGH-DB; 9165-4
DR ChEMBL-Cells; CHEMBL3308707
DR ChEMBL-Targets; CHEMBL1075391
DR Cosmic; 801582
DR Cosmic; 876153
DR Cosmic; 906791
DR Cosmic; 917991
DR Cosmic; 946050
DR Cosmic; 1066158
DR Cosmic; 1154598
DR Cosmic; 1239868
DR Cosmic; 1571728
DR Cosmic; 2125217
DR Cosmic-CLP; 906791
DR GDSC; 906791
DR GEO; GSM784267
DR GEO; GSM827573
DR GEO; GSM886861
DR GEO; GSM887926
DR GEO; GSM1669592
DR JCRB; JCRB0815
RX CelloPub=CLPUB00014;
RX CelloPub=CLPUB00257;
RX DOI=10.2482/haigan.22.53;
RX PubMed=9290701;
RX PubMed=11005564;
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 72 hours (CelloPub=CLPUB00014).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,12
ST D18S51: 18
ST D21S11: 30,32.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 8,11
ST Penta E: 5,16
ST TH01: 10
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ABC-1#IL-6
AC CVCL_Y023
RX PubMed=15185009;
CC Transfected with: HGNC; 6018; IL6.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1066 ! ABC-1
SX Male
CA Cancer cell line
//
ID ABC-11
AC CVCL_Y477
RX PubMed=25170107;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ABE-8.1/2
AC CVCL_3487
SY Abelson 8.1
DR CLO; CLO_0001642
DR ATCC; TIB-205
DR ChEMBL-Cells; CHEMBL3307803
DR ChEMBL-Targets; CHEMBL612562
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID ABFTL-1
AC CVCL_S485
RX PubMed=2988783;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: NFS/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ABFTL-2
AC CVCL_S486
RX PubMed=2988783;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: NFS/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ABFTL-3
AC CVCL_S487
RX PubMed=2988783;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: NFS/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ABFTL-6
AC CVCL_8830
DR BTO; BTO:0002172
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID aBJ-2
AC CVCL_0J13
DR RCB; AES0147
RX PubMed=19241381;
CC Breed/subspecies: C57BL/6Cr x JF1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID aBJ-3
AC CVCL_0J14
DR RCB; AES0148
RX PubMed=19241381;
CC Breed/subspecies: C57BL/6Cr x JF1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID aBJ-4
AC CVCL_0J15
DR RCB; AES0149
RX PubMed=19241381;
CC Breed/subspecies: C57BL/6Cr x JF1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID ABL-2
AC CVCL_D321
DR CGH-DB; 9188-4
RX PubMed=3934897;
CC Characteristics: EBV-negative.
CC Doubling time: 32 hours (PubMed=3934897).
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID aBL5C2.870005
AC CVCL_8945
SY alpha BL5C2.870005; 870005
DR ATCC; HB-9907
RX Patent=US5087693;
CC Monoclonal antibody target: Bovine herpesvirus 1 (BHV-1).
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID aBL5C2.870009
AC CVCL_8946
SY alpha BL5C2.870009; 870009
DR ATCC; HB-9908
RX Patent=US5087693;
CC Monoclonal antibody target: Bovine herpesvirus 1 (BHV-1).
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID aBL5C2.870016
AC CVCL_8947
SY alpha BL5C2.870016; 870016
DR ATCC; HB-9909
RX Patent=US5087693;
CC Monoclonal antibody target: Bovine herpesvirus 1 (BHV-1).
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Abrams
AC CVCL_L309
DR BTO; BTO:0005353
DR GEO; GSM1974775
RX PubMed=21552385;
RX PubMed=21908323;
RX PubMed=22916246;
RX PubMed=26842912;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Doubling time: 27.2 hours (PubMed=22916246).
CC Omics: Transcriptome analysis.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID ABS-9
AC CVCL_E133
DR RCB; RCB1427
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
CC Discontinued: RCB; RCB1427; true.
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ABSa15
AC CVCL_6E03
SY Arches Branchial Sparus aurata 15
DR ECACC; 13112201
RX DOI=10.1111/j.1439-0426.2010.01411.x;
RX PubMed=15820747;
RX PubMed=19002990;
RX PubMed=24361749;
CC Group: Fish cell line.
OX NCBI_TaxID=8175; ! Sparus aurata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AC
AC CVCL_HA69
DR CLDB; cl7228
DR ICLC; HTL14005
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC-1M32
AC CVCL_1799
SY AC1M-32
DR CLO; CLO_0001644
DR BioSample; SAMN03473546
DR DSMZ; ACC-442
CC Doubling time: ~20-30 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 9,11
ST D16S539: 12,13
ST D5S818: 10,11
ST D7S820: 10,12,13
ST TH01: 9,9.3
ST TPOX: 8,11,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1804 ! ACH1P
CA Hybrid cell line
//
ID AC-1M46
AC CVCL_1800
DR CLO; CLO_0001645
DR CLDB; cl7074
DR DSMZ; ACC-454
CC Doubling time: ~40-50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 9,11
ST D16S539: 12,13,14
ST D5S818: 10,11
ST D7S820: 10,12,13
ST TH01: 9,9.3
ST TPOX: 8,11,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1804 ! ACH1P
CA Hybrid cell line
//
ID AC-1M59
AC CVCL_1801
DR CLO; CLO_0001646
DR CLDB; cl7075
DR BioSample; SAMN03473552
DR DSMZ; ACC-455
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 9,11
ST D16S539: 12,13,14
ST D5S818: 10,11
ST D7S820: 10,12,13
ST TH01: 9,10
ST TPOX: 8,11,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1804 ! ACH1P
CA Hybrid cell line
//
ID AC-1M81
AC CVCL_1802
DR CLO; CLO_0001647
DR CLDB; cl7076
DR BioSample; SAMN03473553
DR DSMZ; ACC-456
CC Doubling time: ~24 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11,12
ST D13S317: 9,11
ST D16S539: 12,13,14
ST D5S818: 11
ST D7S820: 10,12,13
ST TH01: 9,10
ST TPOX: 8,11,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1804 ! ACH1P
CA Hybrid cell line
//
ID AC-1M88
AC CVCL_1803
SY AC1M-88
DR CLO; CLO_0001648
DR CLDB; cl7077
DR BioSample; SAMN03473554
DR DSMZ; ACC-457
CC Doubling time: ~30-50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11,12
ST D13S317: 9,11
ST D16S539: 12,13,14
ST D5S818: 10,11
ST D7S820: 10,12,13
ST TH01: 9,10
ST TPOX: 8,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1804 ! ACH1P
CA Hybrid cell line
//
ID AC-33
AC CVCL_Z046
DR IFO; IFO50155
RX Patent=US5126259;
CC Group: Hybridoma fusion partner cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2143.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: IFO; IFO50155; true.
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID AC-6.21
AC CVCL_5980
SY AC 6.21; AC6.21
RX PubMed=3493849;
RX PubMed=21374134;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AC6.21
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID AC0001
AC CVCL_8B36
DR ECACC; 89092229
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0002
AC CVCL_8B37
DR ECACC; 90092405
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0004
AC CVCL_8B38
DR ECACC; 89121302
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AC0006
AC CVCL_8B39
DR ECACC; 90041201
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0094
AC CVCL_8B40
DR ECACC; 91042507
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2993; Down syndrome
DI NCIt; C84505; Tetralogy of Fallot
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0291
AC CVCL_8B41
DR ECACC; 92110606
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AC0302
AC CVCL_8B42
DR ECACC; 92120901
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0350
AC CVCL_8B43
DR ECACC; 93032603
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0360
AC CVCL_8B44
DR ECACC; 93051436
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0451
AC CVCL_8B45
DR ECACC; 94092014
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC0452
AC CVCL_8B46
DR ECACC; 94092015
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AC1 [Human cardiomyocyte]
AC CVCL_4U15
RX PubMed=15913645;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4U14 ! DWFb1-rho0
CA Hybrid cell line
//
ID AC1 [Human gestational choriocarcinoma]
AC CVCL_9559
RX DOI=10.1016/S0143-4004(97)80089-6;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0363 ! JEG-3
SX Male
CA Cancer cell line
//
ID AC1 [Mouse hybridoma]
AC CVCL_U859
DR CLO; CLO_0050355
DR RCB; RCB2317
RX PubMed=9106500;
RX PubMed=9644263;
CC Monoclonal antibody target: ChEBI; CHEBI:87990; Ganglioside GD1c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AC1-1
AC CVCL_9560
RX DOI=10.1016/S0143-4004(97)80089-6;
RX PubMed=10616526;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9559 ! AC1 [Human gestational choriocarcinoma]
SX Male
CA Cancer cell line
//
ID AC1-5
AC CVCL_9561
RX DOI=10.1016/S0143-4004(97)80089-6;
RX PubMed=10616526;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9559 ! AC1 [Human gestational choriocarcinoma]
SX Male
CA Cancer cell line
//
ID AC1-9
AC CVCL_9562
RX DOI=10.1016/S0143-4004(97)80089-6;
RX PubMed=10616526;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9559 ! AC1 [Human gestational choriocarcinoma]
SX Male
CA Cancer cell line
//
ID AC10
AC CVCL_4U16
DR ATCC; PTA-1501
RX Patent=US7223599;
RX PubMed=15913645;
CC Discontinued: ATCC; PTA-1501; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4U14 ! DWFb1-rho0
CA Hybrid cell line
//
ID AC12
AC CVCL_4U17
RX PubMed=15913645;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4U14 ! DWFb1-rho0
CA Hybrid cell line
//
ID AC133.1
AC CVCL_G632
DR CLO; CLO_0001643
DR ATCC; HB-12346
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AC16
AC CVCL_4U18
DR ATCC; PTA-1500
RX Patent=US7223599;
RX PubMed=15913645;
CC Discontinued: ATCC; PTA-1500; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4U14 ! DWFb1-rho0
CA Hybrid cell line
//
ID AC173
AC CVCL_2H64
SY AC173/GrsrJ; DBA/2J AC173/GrsrJ
RX PubMed=23209647;
WW http://jaxmice.jax.org/strain/021138.html
CC Breed/subspecies: DBA/2J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC175
AC CVCL_2H93
RX PubMed=23209647;
CC Breed/subspecies: DBA/2J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC2
AC CVCL_4102
DR CLO; CLO_0001649
DR CLDB; cl233
DR ECACC; 86061902
RX PubMed=3089920;
RX PubMed=3491256;
CC Characteristics: IL3 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID AC20
AC CVCL_Z577
SY AC-20
RX PubMed=4633071;
RX PubMed=6053431;
RX PubMed=8799737;
CC Group: Insect cell line.
OX NCBI_TaxID=1585285; ! Agallia constricta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AC203
AC CVCL_2H65
SY AC203/GrsrJ; DBA/2J AC203/GrsrJ
RX PubMed=23209647;
WW http://jaxmice.jax.org/strain/021137.html
CC Breed/subspecies: DBA/2J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC216
AC CVCL_2H94
RX PubMed=23209647;
CC Breed/subspecies: DBA/2J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC29
AC CVCL_4407
DR CBA; CBA-0152
DR ECACC; 10092308
RX PubMed=1459729;
RX PubMed=22581112;
CC Breed/subspecies: CBA.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID Ac2F
AC CVCL_D262
SY AC2F; JTC-37; Japanese Tissue Culture-37
DR JCRB; JCRB0408
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID Ac2F-CR10
AC CVCL_9W03
RX PubMed=10353263;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D262 ! Ac2F
CA Spontaneously immortalized cell line
//
ID Ac2F-CR4
AC CVCL_9W04
RX PubMed=10353263;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D262 ! Ac2F
CA Spontaneously immortalized cell line
//
ID Ac2F(DT)
AC CVCL_G286
DR JCRB; JCRB0416
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D262 ! Ac2F
CA Transformed cell line
//
ID Ac2F(ST)
AC CVCL_G287
DR JCRB; JCRB0417
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D262 ! Ac2F
CA Spontaneously immortalized cell line
//
ID AC2M2
AC CVCL_AZ67
DR BTO; BTO:0005748
RX PubMed=15987432;
CC Caution: Could be identical to SP1-3M (CVCL_AZ66).
CC Breed/subspecies: CBA/J.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AZ65 ! SP1
SX Female
CA Cancer cell line
//
ID AC34
AC CVCL_Y610
RX PubMed=1459729;
RX PubMed=22581112;
CC Breed/subspecies: CBA.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID AC383
AC CVCL_2H66
SY AC383/GrsrJ; BALB/cByJ AC383/GrsrJ
WW http://jaxmice.jax.org/strain/019035.html
CC Breed/subspecies: BALB/cByJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC386
AC CVCL_2H67
SY AC386/GrsrJ; C3H/HeJ AC386/GrsrJ
WW http://jaxmice.jax.org/strain/019036.html
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC401
AC CVCL_2H68
SY AC401/GrsrJ; PWD/PhJ AC401/GrsrJ
WW http://jaxmice.jax.org/strain/019037.html
CC Breed/subspecies: PWD/PhJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC429
AC CVCL_2H69
SY AC429/GrsrJ; C57BL/6J-Chr 9A/J/NaJ AC429/GrsrJ
WW http://jaxmice.jax.org/strain/025645.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC446
AC CVCL_2H70
SY AC446/GrsrJ; C57BL/6J-Chr 10A/J/NaJ AC446/GrsrJ
WW http://jaxmice.jax.org/strain/025646.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC453
AC CVCL_2H71
SY AC453/GrsrJ; AC453/GrsJ; C57BL/6J-Chr 11A/J/NaJ AC453/GrsJ; C57BL/6J-Chr 11A/J/NaJ AC453/GrsrJ
WW http://jaxmice.jax.org/strain/025647.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AC576
AC CVCL_2H72
SY AC576/GrsJ; NOD/ShiLtJ AC576/GrsJ
WW http://jaxmice.jax.org/strain/026874.html
CC Breed/subspecies: NOD/ShiLtJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID AcA101
AC CVCL_5F75
SY AcA 101
RX PubMed=11784300;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID AcA201
AC CVCL_5F76
SY AcA 201
RX PubMed=11784300;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID ACB-1085
AC CVCL_M488
RX PubMed=3472643;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M487 ! ACB-885
SX Male
CA Cancer cell line
//
ID ACB-885
AC CVCL_M487
RX PubMed=3472643;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M488 ! ACB-1085
SX Male
CA Cancer cell line
//
ID ACC-2
AC CVCL_6872
SY ACC2
DR BioSample; SAMN03151659
DR CCRID; 3111C0001CCC000272
DR CCRID; 3131C0001000700062
DR CCRID; 3142C0001000000048
DR Cosmic; 932295
RX PubMed=19557180;
RX PubMed=20143388;
RX PubMed=21868764;
RX PubMed=26116706;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=19557180, PubMed=20143388, PubMed=21868764, PubMed=26116706). Was originally thought to originate from a female patient with salivary gland adenoid cystic carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): PubMed=21868764; PubMed=26116706
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27,28
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 21
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID ACC-3
AC CVCL_6873
SY Acc-3; ACC3
DR BioSample; SAMN03151660
DR CCRID; 3131C0001000700063
RX PubMed=19557180;
RX PubMed=20143388;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=19557180, PubMed=20143388, PubMed=21868764). Was originally thought to originate from a male patient with salivary gland adenoid cystic carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID ACC-LC-170
AC CVCL_7003
SY SA; SCLC-SA
DR CGH-DB; 84-1
DR CGH-DB; 9054-4
DR Cosmic; 934437
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=12107105;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-171
AC CVCL_7004
SY SM; SCLC-SM
DR Cosmic; 934438
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-172
AC CVCL_7005
AS CVCL_Y201
SY ACC-LC172; SK3; SCLC-SK3
DR CGH-DB; 85-1
DR CGH-DB; 9055-4
DR Cosmic; 934472
DR Cosmic; 1089237
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=2547517;
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=12107105;
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7020 ! ACC-LC-5
OI CVCL_7016 ! ACC-LC-35
SX Male
CA Cancer cell line
//
ID ACC-LC-172/CDDP
AC CVCL_Y202
SY SK3/CDDP
RX PubMed=2547517;
RX PubMed=8384671;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7005 ! ACC-LC-172
SX Male
CA Cancer cell line
//
ID ACC-LC-173
AC CVCL_7006
SY NT2; SCLC-NT2
DR CGH-DB; 86-1
DR CGH-DB; 9056-4
DR Cosmic; 934433
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=12107105;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7029 ! ACC-LC-87
CA Cancer cell line
//
ID ACC-LC-174
AC CVCL_7007
SY TS2
DR Cosmic; 934454
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7032 ! ACC-LC-94
CA Cancer cell line
//
ID ACC-LC-175
AC CVCL_Z026
SY TG; SCLC-TG
RX PubMed=1710138;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-176
AC CVCL_7008
SY KS
DR Cosmic; 934456
DR Cosmic; 1089226
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-177
AC CVCL_7009
SY SL1; SCLC-SL1
DR Cosmic; 934440
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7010 ! ACC-LC-178
CA Cancer cell line
//
ID ACC-LC-178
AC CVCL_7010
SY SL2; SCLC-SL2
DR Cosmic; 934441
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7009 ! ACC-LC-177
CA Cancer cell line
//
ID ACC-LC-314
AC CVCL_7011
DR Cosmic; 934458
RX PubMed=7834619;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7012 ! ACC-LC-319
CA Cancer cell line
//
ID ACC-LC-319
AC CVCL_7012
SY ACC-LC319
DR BTO; BTO:0004887
DR Cosmic; 934459
DR Cosmic; 1089222
RX PubMed=7834619;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7011 ! ACC-LC-314
CA Cancer cell line
//
ID ACC-LC-321
AC CVCL_7013
DR Cosmic; 934443
RX PubMed=7834619;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-323
AC CVCL_7014
DR Cosmic; 934461
RX PubMed=7834619;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-33
AC CVCL_7015
SY YI
DR CGH-DB; 196-1
DR CGH-DB; 9182-4
DR Cosmic; 934444
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=15746151;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-35
AC CVCL_7016
AS CVCL_Y200
SY SK2; SCLC-SK2
DR Cosmic; 934413
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=2547517;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7020 ! ACC-LC-5
OI CVCL_7005 ! ACC-LC-172
SX Male
CA Cancer cell line
//
ID ACC-LC-35D
AC CVCL_Z024
SY SK2D
RX PubMed=2547517;
RX PubMed=8384671;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7016 ! ACC-LC-35
SX Male
CA Cancer cell line
//
ID ACC-LC-36
AC CVCL_7017
AS CVCL_Y207
SY TM1; SCLC-TM1
DR Cosmic; 934415
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=2547517;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y208 ! ACC-LC-51
SX Male
CA Cancer cell line
//
ID ACC-LC-48
AC CVCL_7018
SY OT1; SCLC-OT1
DR Cosmic; 934417
DR Cosmic; 1089234
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7021 ! ACC-LC-52
CA Cancer cell line
//
ID ACC-LC-49
AC CVCL_7019
SY MO; SCLC-MO
DR Cosmic; 934420
DR Cosmic; 1089235
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACC-LC-5
AC CVCL_7020
AS CVCL_Y199
SY SK1; SCLC-SK1
DR CGH-DB; 87-1
DR CGH-DB; 9052-4
DR Cosmic; 934412
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=2547517;
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=12107105;
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7016 ! ACC-LC-35
OI CVCL_7005 ! ACC-LC-172
SX Male
CA Cancer cell line
//
ID ACC-LC-51
AC CVCL_Y208
SY TM2; SCLC-TM2
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=2547517;
RX PubMed=8384671;
CC Derived from metastatic site: Mesenterium.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7017 ! ACC-LC-36
SX Male
CA Cancer cell line
//
ID ACC-LC-52
AC CVCL_7021
SY OT2; SCLC-OT2
DR Cosmic; 934418
RX PubMed=1710138;
RX PubMed=2540905;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7018 ! ACC-LC-48
CA Cancer cell line
//
ID ACC-LC-60
AC CVCL_7022
SY ZM; SCLC-ZM
DR Cosmic; 934422
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-61
AC CVCL_7023
SY KA; SCLC-KA
DR Cosmic; 934424
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-66
AC CVCL_Z028
SY MY; SCLC-MY
RX PubMed=1710138;
RX PubMed=8384671;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-67
AC CVCL_7024
SY YN; SCLC-YN
DR Cosmic; 934426
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-71
AC CVCL_7025
SY ST
DR Cosmic; 934446
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-73
AC CVCL_7026
SY TH
DR Cosmic; 934447
DR CGH-DB; 9179-4
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=14581340;
RX PubMed=15746151;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-76
AC CVCL_7027
SY SS; SCLC-SS
DR Cosmic; 934428
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-78
AC CVCL_Z027
SY MA; SCLC-MA
RX PubMed=1710138;
RX PubMed=8384671;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-80
AC CVCL_7028
SY ACC-LC80; SY; SCLC-SY
DR CGH-DB; 104-1
DR CGH-DB; 9053-4
DR Cosmic; 934430
DR Cosmic; 1089236
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
RX PubMed=12107105;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-87
AC CVCL_7029
SY NT1; SCLC-NT1
DR Cosmic; 934432
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7006 ! ACC-LC-173
CA Cancer cell line
//
ID ACC-LC-91
AC CVCL_7030
SY YS
DR Cosmic; 934449
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-93
AC CVCL_7031
SY YO
DR Cosmic; 934451
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-94
AC CVCL_7032
SY ACC-LC94; TS1
DR Cosmic; 934453
DR Cosmic; 1089221
RX PubMed=7834619;
RX PubMed=8384671;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7007 ! ACC-LC-174
CA Cancer cell line
//
ID ACC-LC-96
AC CVCL_7033
SY HS; SCLC-HS
DR Cosmic; 934435
RX PubMed=1710138;
RX PubMed=7834619;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-LC-97
AC CVCL_Z025
SY TU; SCLC-TU
RX PubMed=1710138;
RX PubMed=8384671;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACC-M
AC CVCL_6874
SY Acc-M; ACCM
DR BioSample; SAMN03151661
DR CCRID; 3142C0001000000065
RX PubMed=19557180;
RX PubMed=20143388;
RX PubMed=21868764;
RX PubMed=26116706;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=19557180, PubMed=20143388, PubMed=21868764, PubMed=26116706). Was originally thought to originate from a female patient salivary gland adenoid cystic carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): PubMed=21868764; PubMed=26116706
ST Amelogenin: X
ST CSF1PO: 9,10
ST D12S391: 20,25
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 11,12
ST D6S1043: 18,19
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 21
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 17,18 (PubMed=21868764)
ST vWA: 16,18 (PubMed=26116706)
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID ACC-MESO-1
AC CVCL_5113
DR CLO; CLO_0050082
DR BioSample; SAMN03471958
DR CCLE; ACCMESO1_PLEURA
DR Cosmic; 877273
DR Cosmic; 1481540
DR GEO; GSM551967
DR GEO; GSM886862
DR GEO; GSM887927
DR RCB; RCB2292
RX PubMed=16630136;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 11
ST vWA: 17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-MESO-4
AC CVCL_5114
DR CLO; CLO_0050083
DR BioSample; SAMN03471959
DR Cosmic; 877274
DR Cosmic; 1481541
DR GEO; GSM551968
DR RCB; RCB2293
RX PubMed=16630136;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 9,11
ST D7S820: 12,14
ST TH01: 7,8
ST TPOX: 11
ST vWA: 17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACC-OV43
AC CVCL_DG87
RX PubMed=16759149;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-OV551
AC CVCL_DG88
SY OV55-1
DR GEO; GSM185121
DR GEO; GSM185122
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG89 ! ACC-OV552
SX Female
CA Cancer cell line
//
ID ACC-OV552
AC CVCL_DG89
SY OV55-2
DR GEO; GSM185123
DR GEO; GSM185124
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG88 ! ACC-OV551
SX Female
CA Cancer cell line
//
ID ACC-OV60
AC CVCL_DG90
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-OV614
AC CVCL_DG91
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG92 ! ACC-OV616
SX Female
CA Cancer cell line
//
ID ACC-OV616
AC CVCL_DG92
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG91 ! ACC-OV614
SX Female
CA Cancer cell line
//
ID ACC-OV62
AC CVCL_DG93
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-OV682
AC CVCL_DG94
RX PubMed=16759149;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG95 ! ACC-OV684
OI CVCL_DG96 ! ACC-OV68A
SX Female
CA Cancer cell line
//
ID ACC-OV684
AC CVCL_DG95
SY OV684
DR GEO; GSM185127
DR GEO; GSM185128
RX PubMed=16759149;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG94 ! ACC-OV682
OI CVCL_DG96 ! ACC-OV68A
SX Female
CA Cancer cell line
//
ID ACC-OV68A
AC CVCL_DG96
SY OV68 ASC; OV68ASC
DR GEO; GSM185125
DR GEO; GSM185126
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DG94 ! ACC-OV682
OI CVCL_DG95 ! ACC-OV684
SX Female
CA Cancer cell line
//
ID ACC-OV7
AC CVCL_DG86
SY OV7
DR GEO; GSM185129
DR GEO; GSM185130
RX PubMed=16759149;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-OV77
AC CVCL_DG97
RX PubMed=16759149;
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-OV79
AC CVCL_DG98
RX PubMed=16759149;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC-OV84
AC CVCL_DG99
RX PubMed=16759149;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACC212102
AC CVCL_D074
RX PubMed=21971914;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACCNS
AC CVCL_6875
DR BioSample; SAMN03152000
RX PubMed=17203170;
RX PubMed=19557180;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=19557180, PubMed=20143388). Was originally thought to originate from a male patient salivary gland adenoid cystic carcinoma.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Undefined cell line type
//
ID ACCS
AC CVCL_6876
DR BioSample; SAMN03151936
DR CCLE; ACCS_URINARY_TRACT
RX PubMed=2162254;
RX PubMed=19557180;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=19557180, PubMed=20143388). Was originally thought to originate from salivary gland adenoid cystic carcinoma.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID ACCY
AC CVCL_6877
RX PubMed=2162254;
DI NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ace-1
AC CVCL_L310
SY ACE-1
RX PubMed=16683269;
RX PubMed=21801068;
RX PubMed=23335024;
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C128122; Canine prostate carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID Ace-1(CMV)
AC CVCL_DA11
SY Ace-1CMV
RX PubMed=26940014;
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C128122; Canine prostate carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L310 ! Ace-1
SX Male
CA Cancer cell line
//
ID Ace-1(huGRPr)
AC CVCL_DA12
SY Ace-1huGRPr
RX PubMed=26940014;
CC Transfected with: HGNC; 4609; GRPR.
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C128122; Canine prostate carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L310 ! Ace-1
SX Male
CA Cancer cell line
//
ID AcE60
AC CVCL_5F77
SY Ace 60
RX PubMed=11784300;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID ACH-2
AC CVCL_0138
SY ACH2
DR BTO; BTO:0002551
DR MCCL; MCC:0000031
DR ChEMBL-Cells; CHEMBL3307897
DR ChEMBL-Targets; CHEMBL614263
DR NIH-ARP; 349-443
RX PubMed=2463307;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6244 ! A3.01
SX Female
CA Cancer cell line
//
ID ACH-3P
AC CVCL_4829
SY ACH 3P
DR BTO; BTO:0003421
DR EFO; EFO_0006269
RX PubMed=18093301;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9560 ! AC1-1
CA Hybrid cell line
//
ID ACH1P
AC CVCL_1804
SY ACH-1P
DR CLO; CLO_0001653
DR CLDB; cl7078
DR BioSample; SAMN03473561
DR DSMZ; ACC-481
RX PubMed=10616526;
CC Doubling time: ~40-50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 9,11
ST D16S539: 12,13,14
ST D5S818: 10,11
ST D7S820: 10,12,13
ST TH01: 9,9.3
ST TPOX: 8,11,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9560 ! AC1-1
CA Hybrid cell line
//
ID ACHN
AC CVCL_1067
DR BTO; BTO:0003846
DR CLO; CLO_0001654
DR EFO; EFO_0002108
DR CLDB; cl236
DR CLDB; cl237
DR CLDB; cl4951
DR ATCC; CRL-1611
DR BioSample; SAMN01821536
DR BioSample; SAMN03473205
DR CCLE; ACHN_KIDNEY
DR CCRID; 3111C0001CCC000334
DR CCRID; 3142C0001000000086
DR ChEMBL-Cells; CHEMBL3307633
DR ChEMBL-Targets; CHEMBL614519
DR CLS; 300117/p472_ACHN
DR Cosmic; 687939
DR Cosmic; 849382
DR Cosmic; 875873
DR Cosmic; 877456
DR Cosmic; 897462
DR Cosmic; 905950
DR Cosmic; 974302
DR Cosmic; 979708
DR Cosmic; 982275
DR Cosmic; 1044260
DR Cosmic; 1092592
DR Cosmic; 1152534
DR Cosmic; 1175850
DR Cosmic; 1305374
DR Cosmic; 1312362
DR Cosmic; 1436045
DR Cosmic; 1998434
DR Cosmic; 2520631
DR Cosmic-CLP; 905950
DR ECACC; 88100508
DR ENCODE; ENCBS569UYK
DR ENCODE; ENCBS897ZFQ
DR GDSC; 905950
DR GEO; GSM50228
DR GEO; GSM50292
DR GEO; GSM750837
DR GEO; GSM799373
DR GEO; GSM799436
DR GEO; GSM846286
DR GEO; GSM886863
DR GEO; GSM887928
DR GEO; GSM1153446
DR GEO; GSM1181298
DR GEO; GSM1181324
DR GEO; GSM1669593
DR ICLC; HTL99007
DR IGRhCellID; ACHN
DR IZSLER; BS TCL 68
DR KCB; KCB 200611YJ
DR KCLB; 21611
DR NCBI_Iran; C206
DR PRIDE; PXD001962
DR PRIDE; PXD003105
DR RCB; RCB1962
DR SKY/M-FISH/CGH; 2789
RX PubMed=2041050;
RX PubMed=11146448;
RX PubMed=11414198;
RX PubMed=17088437;
RX PubMed=17409424;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=27993170;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=41
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-614.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 32 hours (PubMed=25984343); 27.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB1962; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=19372543; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 16
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 17
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 12
ST FGA: 22
ST Penta D: 12
ST Penta E: 16
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACHN-IL2
AC CVCL_W666
DR IZSLER; BS TCL 116
CC Transfected with: HGNC; 6001; IL2.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1067 ! ACHN
SX Male
CA Cancer cell line
//
ID ACHN-luc2
AC CVCL_5J27
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 125056.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1067 ! ACHN
SX Male
CA Cancer cell line
//
ID ACI-1
AC CVCL_IU11
RX PubMed=19888321;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-126
AC CVCL_N827
DR Cosmic; 1622889
RX PubMed=21882256;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-158
AC CVCL_D716
DR Cosmic; 1622905
RX PubMed=21882256;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-17
AC CVCL_IU12
RX PubMed=19888321;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-181
AC CVCL_N828
DR Cosmic; 1622891
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-23
AC CVCL_N830
RX PubMed=19888321;
RX PubMed=27235858;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-27
AC CVCL_N831
RX PubMed=19888321;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-35
AC CVCL_IU13
RX PubMed=19888321;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-45
AC CVCL_N833
DR Cosmic; 1622882
RX PubMed=21882256;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-52
AC CVCL_N834
DR Cosmic; 1622883
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-54
AC CVCL_N832
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-61
AC CVCL_N835
DR Cosmic; 1622884
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-68
AC CVCL_N836
DR Cosmic; 1622885
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-70
AC CVCL_N837
DR Cosmic; 1622886
RX PubMed=21882256;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-8
AC CVCL_N829
RX PubMed=19888321;
RX PubMed=27235858;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-80
AC CVCL_N838
DR Cosmic; 1622887
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-89
AC CVCL_D717
SY ACI-89-2
DR Cosmic; 1622907
RX PubMed=19888321;
RX PubMed=21882256;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-98
AC CVCL_N839
DR Cosmic; 1622888
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ACI-RCC
AC CVCL_4W27
DR JCRB; JCRB1585
RX PubMed=20303523;
CC Transformant: ChEBI; CHEBI:132238; Iron(III) nitrilotriacetate.
CC Breed/subspecies: ACI.
DI NCIt; C64111; Carcinoma of the rat kidney
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID ACL
AC CVCL_DE03
SY Atlantic Cod Larvae
RX PubMed=23108254;
CC Group: Fish cell line.
OX NCBI_TaxID=8049; ! Gadus morhua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ACL-15
AC CVCL_5491
DR CLO; CLO_0051586
DR RCB; RCB0510
RX CelloPub=CLPUB00016;
CC Doubling time: 24 hours (CelloPub=CLPUB00016).
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: Fischer 344.
DI NCIt; C63866; Adenocarcinoma of the rat colon
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID ACN
AC CVCL_1068
DR CLO; CLO_0001655
DR CLDB; cl239
DR ChEMBL-Cells; CHEMBL3308148
DR ChEMBL-Targets; CHEMBL2366195
DR Cosmic; 906803
DR Cosmic-CLP; 906803
DR GDSC; 906803
DR GEO; GSM1669594
DR ICLC; HTL96020
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=2467885;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): Cosmic-CLP; ICLC
ST Amelogenin: X
ST CSF1PO: 11 (Cosmic-CLP)
ST CSF1PO: 10,11 (ICLC)
ST D13S317: 11,13
ST D16S539: 11 (Cosmic-CLP)
ST D16S539: 10,11 (ICLC)
ST D21S11: 28
ST D5S818: 12 (Cosmic-CLP)
ST D5S818: 11,12 (ICLC)
ST D7S820: 10,13
ST TH01: 9 (Cosmic-CLP)
ST TH01: 8,9 (ICLC)
ST TPOX: 9,12
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACP01
AC CVCL_9490
RX PubMed=15558189;
CC Doubling time: ~40 hours (PubMed=15558189).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACP02
AC CVCL_IK51
RX DOI=10.3748/wjg.v22.i43.9506;
RX PubMed=19837275;
CC Omics: Array-based CGH.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACP03
AC CVCL_IK52
RX DOI=10.3748/wjg.v22.i43.9506;
RX PubMed=19837275;
CC Omics: Array-based CGH.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACr41
AC CVCL_U185
RX PubMed=3163531;
CC Selected for resistance to: ChEBI; CHEBI:75270; Nimustine (ACNU).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U181 ! MR10-1
SX Female
CA Cancer cell line
//
ID ACr42
AC CVCL_U186
RX PubMed=3163531;
CC Selected for resistance to: ChEBI; CHEBI:75270; Nimustine (ACNU).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U181 ! MR10-1
SX Female
CA Cancer cell line
//
ID ACT I
AC CVCL_4499
SY ACT 1
DR CLO; CLO_0001656
DR CLO; CLO_0001657
DR CLDB; cl5131
DR ATCC; HB-80
DR IZSLER; BS Hy 1
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID ACT IV
AC CVCL_C410
DR CLO; CLO_0001658
DR ATCC; HB-81
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID ACT-1 [Human adrenocortical carcinoma]
AC CVCL_6290
RX PubMed=11168692;
RX PubMed=21924324;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ACT-1 [Human thyroid carcinoma]
AC CVCL_6291
SY ACT1
DR BTO; BTO:0004858
DR Cosmic; 1152115
DR Cosmic; 1239968
DR Cosmic; 2054109
RX PubMed=12495476;
RX PubMed=18713817;
RX PubMed=23833040;
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 10,12
ST D18S51: 15,16
ST D21S11: 30,31
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 23,24
ST vWA: 17,18
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ACT-14
AC CVCL_B523
AS CVCL_C336
SY MA14; MA 14; ACTe003-A
DR hPSCreg; ACTe003-A
DR ISCR; 139
RX PubMed=15885296;
WW http://umassmed.edu/uploadedFiles/umscr/Human%20Embryonic%20Stem%20Cell%20lines%20established%20at%20ACT.pdf
CC From: Advanced Cell Technology, Inc.
CC Anecdotal: First human embryonic stem cell line derived in feeder-free conditions.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID ACTK1
AC CVCL_BS99
SY African Clawed Toad Kidney 1
DR KCB; KCB 82004YJ
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Undefined cell line type
//
ID AD
AC CVCL_M606
RX PubMed=16039953;
CC Doubling time: 24 hours (PubMed=16039953).
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ad Hot
AC CVCL_3639
DR CLO; CLO_0001659
DR ATCC; CRL-1227
DI NCIt; C125697; Ehlers-Danlos syndrome, type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Ad-211/SV40
AC CVCL_V288
RX PubMed=1384660;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Ad-248/SV40
AC CVCL_V289
RX PubMed=1384660;
RX PubMed=7850744;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Ad-263/SV40
AC CVCL_V290
RX PubMed=1384660;
RX PubMed=7850744;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AD-293
AC CVCL_9804
SY AD293; 293AD; HEK-AD293; HEK (AD293); HEK AD293; HEK-AD 293
DR BTO; BTO:0003263
DR NCBI_Iran; C559
WW http://www.chem-agilent.com/pdf/strata/240085.pdf
WW http://www.cellbiolabs.com/sites/default/files/AD-100-adenoviral-293-cell-line.pdf
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID Ad-295/SV40
AC CVCL_V291
RX PubMed=1384660;
RX PubMed=7850744;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Ad-302/SV40
AC CVCL_V292
RX PubMed=1384660;
RX PubMed=7850744;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Ad-312/SV40
AC CVCL_V293
RX PubMed=1384660;
RX PubMed=7850744;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Ad-366/SV40
AC CVCL_V294
RX PubMed=7850744;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AD-A
AC CVCL_0C05
DR Cosmic; 2239082
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=10100721;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ad-AH
AC CVCL_X200
SY AdAH
RX PubMed=6088881;
RX PubMed=6324641;
RX PubMed=24991015;
CC Omics: Deep RNAseq analysis.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AD-iPS26B
AC CVCL_0U10
RX PubMed=25765079;
CC Omics: Transcriptome analysis.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U09 ! AD-iPS5
SX Female
CA Induced pluripotent stem cell
//
ID AD-iPS5
AC CVCL_0U09
RX PubMed=25765079;
CC Omics: Transcriptome analysis.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U10 ! AD-iPS26B
SX Female
CA Induced pluripotent stem cell
//
ID AD-S
AC CVCL_DE06
RX PubMed=2543775;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3820; Cyclic neutropenia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AD1-CR10 iPSC
AC CVCL_IK93
RX PubMed=27789410;
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID AD1-CR14 iPSC
AC CVCL_IK94
RX PubMed=27789410;
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID Ad12-3Y1-W5
AC CVCL_H233
DR RCB; RCB0331
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID Ad12-3Y1-Z11
AC CVCL_H234
DR RCB; RCB0328
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID Ad12-3Y1-Z13
AC CVCL_H235
DR RCB; RCB0329
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID Ad12-3Y1-Z19
AC CVCL_F283
DR JCRB; JCRB0737
DR RCB; RCB0330
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID Ad2-3Y1-1
AC CVCL_K107
DR RCB; RCB0338
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 10515; Adenovirus 2.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID Ad2-3Y1-2
AC CVCL_K108
DR RCB; RCB0339
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 10515; Adenovirus 2.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID Ad2-3Y1-3
AC CVCL_K109
DR RCB; RCB0340
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 10515; Adenovirus 2.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID AD2-4 iPSC
AC CVCL_IK95
RX PubMed=27789408;
CC Characteristics: Heterozygous for the TREM2 p.Arg47His mutation.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID AD3
AC CVCL_M504
RX PubMed=1697013;
CC Derived from metastatic site: Ascites.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M505 ! FR4
SX Male
CA Cancer cell line
//
ID AD387
AC CVCL_M811
SY AD 387
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AD94IL2
AC CVCL_IM43
DR CLO; CLO_0001660
DR CLDB; cl240
CC From: Galliera Genetic Bank; E.O. Ospedali Galliera; Genova; Italy.
CC Characteristics: IL2 dependent.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M078 ! AD94LEBV
SX Female
CA Finite cell line
//
ID AD94LEBV
AC CVCL_M078
DR CLO; CLO_0001661
DR CLDB; cl241
CC From: Galliera Genetic Bank; E.O. Ospedali Galliera; Genova; Italy.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IM43 ! AD94IL2
SX Female
CA Transformed cell line
//
ID ADA-iPS2
AC CVCL_C104
SY ADA-IPS2
DR ISCR; 11
RX Patent=US20110151447;
RX PubMed=18691744;
WW http://harvard.eagle-i.net/i/0000012c-6042-8346-c437-ff0b80000000
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8517 ! GM01390
SX Male
CA Induced pluripotent stem cell
//
ID ADA-iPS3
AC CVCL_C105
SY ADA-IPS3
DR ISCR; 12
RX Patent=US20110151447;
RX PubMed=18691744;
WW http://harvard.eagle-i.net/i/00000144-0852-5730-0803-96bd80000000
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8517 ! GM01390
SX Male
CA Induced pluripotent stem cell
//
ID Ade-A
AC CVCL_1N32
SY Ade A; AdeA; CHO Ade-A; ade A
RX PubMed=1235902;
RX PubMed=4525316;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-B
AC CVCL_1N33
SY AdeB; ade B
RX PubMed=1235902;
RX PubMed=4525316;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-C
AC CVCL_1N34
SY Ade C; AdeC; CHO Ade-C; CHO-K1 ade-C; ade C
RX PubMed=1235902;
RX PubMed=4525316;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-D
AC CVCL_1N35
SY Ade D; AdeD; CHO Ade-D; ade D
RX PubMed=1235902;
RX PubMed=2004782;
RX PubMed=4525316;
RX PubMed=23394948;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-E
AC CVCL_1N36
SY Ade E; AdeE; CHO Ade-E; CHO Ade E; ade E
RX PubMed=1235902;
RX PubMed=1887335;
RX PubMed=4525316;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-F
AC CVCL_1N37
SY AdeF; ade F
RX PubMed=1235902;
RX PubMed=4525316;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-G
AC CVCL_1N38
SY AdeG; CHO-K1 ade-G
RX PubMed=483121;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-H
AC CVCL_1N39
SY AdeH; ade-H
RX PubMed=849250;
RX PubMed=2004783;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-I
AC CVCL_1N40
SY Ade I; ade-I; AdeI; Ade-1; CHO-Ade I
RX PubMed=849250;
RX PubMed=20884265;
RX PubMed=23394948;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Ade-PAB
AC CVCL_1N41
RX PubMed=7418008;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID ADF
AC CVCL_4689
DR BTO; BTO:0004326
DR CLO; CLO_0001662
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ADHD-10 iPSC
AC CVCL_GP68
RX PubMed=27558611;
DI NCIt; C97160; Attention deficit hyperactivity disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ADHD-4 iPSC
AC CVCL_GP69
RX PubMed=27558611;
DI NCIt; C97160; Attention deficit hyperactivity disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ADHD-5 iPSC
AC CVCL_GP70
RX PubMed=27558611;
DI NCIt; C97160; Attention deficit hyperactivity disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ADJ/PC6
AC CVCL_1E22
SY ADJ/PC 6
DR ChEMBL-Cells; CHEMBL3307899
DR ChEMBL-Targets; CHEMBL614265
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID ADL,HG
AC CVCL_E452
SY ADL, HG
DR dbMHC; 48470
DR ECACC; 94082244
DR IHW; IHW9144
DR IMGT/HLA; 11687
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl144.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ADLC-5M2
AC CVCL_8169
DR BioSample; SAMN03151662
RX PubMed=2840315;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a non-small-cell lung carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID ADRI Cf2Th-69/EIAV
AC CVCL_0E87
SY ADRI/Cf2Th-EIAV
DR ATCC; CRL-2251
RX Patent=US5112756;
CC Characteristics: In vitro infected by Equine infectious anemia virus.
CC Discontinued: ATCC; CRL-2251; true.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_3363 ! CF2.Th
SX Female
CA Spontaneously immortalized cell line
//
ID ADRI Cf2Th/BMVLV
AC CVCL_W644
SY ADRI/Cf2Th/BMVLV; Cf2Th/BMVLV
DR ATCC; CRL-10816
RX Patent=US5112756;
CC Characteristics: In vitro infected by Bovine immunodeficiency virus.
CC Discontinued: ATCC; CRL-10816; probable.
CC Breed/subspecies: Mixed breed.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_3363 ! CF2.Th
SX Female
CA Spontaneously immortalized cell line
//
ID ADRI-PFT-19
AC CVCL_0F46
SY 19-PFT; 19PFT; PFT; Pig Fallopian Tube
DR ATCC; CRL-2250
RX PubMed=3274;
RX PubMed=1335761;
RX PubMed=4586534;
CC Doubling time: 20-25 hours (PubMed=3274).
CC Discontinued: ATCC; CRL-2250; true.
CC Breed/subspecies: Large white.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Spontaneously immortalized cell line
//
ID Adult/T315I
AC CVCL_5K96
RX PubMed=21474579;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ae
AC CVCL_Z109
SY Grace's Antheraea cells; Grace's Antheraea eucalypti cells; Antheraea cells
DR CLO; CLO_0051456
DR CLDB; cl278
DR ATCC; CCL-80
DR ECACC; 90111908
DR RCB; RCB0985
RX DOI=10.11416/kontyushigen1930.35.349;
RX PubMed=4402510;
RX PubMed=6020481;
RX PubMed=13900940;
CC Group: Insect cell line.
CC Anecdotal: First arthropod cell line to be established.
CC Discontinued: ECACC; 90111908; probable.
OX NCBI_TaxID=180277; ! Opodiphthera eucalypti
SX Female
CA Spontaneously immortalized cell line
//
ID AE-1
AC CVCL_4500
SY AE1
DR CLO; CLO_0001666
DR CLDB; cl5132
DR ATCC; HB-72
DR CCRID; 3131C0001000600054
DR IZSLER; BS Hy 2
RX PubMed=6175961;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-582.html
CC Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AE-2
AC CVCL_4501
SY AE2
DR CLO; CLO_0001667
DR CLDB; cl5133
DR ATCC; HB-73
DR CCRID; 3131C0001000600055
DR IZSLER; BS Hy 3
RX PubMed=6175961;
CC Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AE-3
AC CVCL_1Y16
SY AE3
RX PubMed=6175961;
WW https://www.citeab.com/antibodies/149706-ae-3-acetylcholinesterase
CC Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Ae-Aedae
AC CVCL_1R48
SY Aedes aegypti, Suitor's clone
DR BioSample; SAMN03151994
RX PubMed=4402510;
RX PubMed=5337207;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Insect cell line.
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of Aedes aegypti origin but found to be a Opodiphthera eucalypti Ae derivative (PubMed=4402510, PubMed=20143388).
OX NCBI_TaxID=180277; ! Opodiphthera eucalypti
HI CVCL_Z109 ! Ae
SX Female
CA Spontaneously immortalized cell line
//
ID Ae-Aedve
AC CVCL_1R46
SY Aedes vexans culture
DR BioSample; SAMN03151995
RX PubMed=4393461;
RX PubMed=4402510;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Insect cell line.
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of Aedes vexans origin but found to be a Opodiphthera eucalypti Ae derivative (PubMed=4402510, PubMed=20143388).
OX NCBI_TaxID=180277; ! Opodiphthera eucalypti
HI CVCL_Z109 ! Ae
SX Female
CA Spontaneously immortalized cell line
//
ID Ae-Culin
AC CVCL_1R47
SY Culiseta inornata culture
DR BioSample; SAMN03151997
RX PubMed=4393461;
RX PubMed=4402510;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Insect cell line.
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of Culiseta inornata origin but found to be a Opodiphthera eucalypti Ae derivative (PubMed=4402510, PubMed=20143388).
OX NCBI_TaxID=180277; ! Opodiphthera eucalypti
HI CVCL_Z109 ! Ae
SX Female
CA Spontaneously immortalized cell line
//
ID AE1
AC CVCL_L849
SY AE 1
DR CLO; CLO_0001663
DR CLDB; cl244
RX PubMed=22358579;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L850 ! AE2
OI CVCL_L851 ! AE3
SX Male
CA Cancer cell line
//
ID AE1-2a
AC CVCL_U656
SY AE1-2A
RX PubMed=8648763;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID AE1201
AC CVCL_8470
SY AE 1201
DR CCRID; 3142C0001000000543
RX Patent=CN1061093C;
CC Group: Adeno-associated virus packaging cell line.
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C97001.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID AE17
AC CVCL_4408
DR CBA; CBA-0156
DR ECACC; 10092310
RX PubMed=22581112;
CC Breed/subspecies: C57BL/6J.
DI NCIt; C21619; Mouse mesothelioma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID AE2
AC CVCL_L850
SY AE 2
DR CLO; CLO_0001664
DR CLDB; cl245
RX PubMed=22358579;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L849 ! AE1
OI CVCL_L851 ! AE3
SX Male
CA Cancer cell line
//
ID AE3
AC CVCL_L851
SY AE 3
DR CLO; CLO_0001665
DR CLDB; cl246
RX PubMed=22358579;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L849 ! AE1
OI CVCL_L850 ! AE2
SX Male
CA Cancer cell line
//
ID AE9D6
AC CVCL_G633
DR CLO; CLO_0001669
DR ATCC; HB-125
RX PubMed=6193965;
CC Monoclonal antibody target: UniProtKB; P01308; Human INS (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AF-2 clone 9B5
AC CVCL_2573
SY AF-2 cl.9B5
DR CLO; CLO_0001674
DR CLDB; cl252
DR CLDB; cl253
DR ICLC; HYL95001
RX PubMed=2004654;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID AF-6
AC CVCL_U801
SY AF6
DR Cosmic; 928732
DR GEO; GSM162930
DR GEO; GSM215720
RX PubMed=9354451;
RX PubMed=17363583;
RX PubMed=17516929;
WW http://biogps.org/dataset/1409/63-melanoma-cell-lines/
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AF10
AC CVCL_C833
SY AF-10
DR Cosmic; 1070696
DR Cosmic; 1071879
DR Cosmic; 1176601
RX PubMed=9762409;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0566 ! U266B1
SX Male
CA Cancer cell line
//
ID AF3-12.1.3
AC CVCL_J742
DR CLO; CLO_0001675
DR ATCC; HB-160
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AF4-73.3.1
AC CVCL_J743
DR CLO; CLO_0001676
DR ATCC; HB-201
RX PubMed=6690619;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AF5
AC CVCL_8831
SY AF-5
DR BTO; BTO:0003422
RX PubMed=9426306;
RX PubMed=12061863;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID AF6-120.1.2
AC CVCL_J744
DR CLO; CLO_0001677
DR ATCC; HB-163
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AF6-122.2.5
AC CVCL_J745
DR CLO; CLO_0001678
DR ATCC; HB-199
RX PubMed=6690619;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AF6-78.25.4
AC CVCL_J746
SY AF6-78.25
DR CLO; CLO_0001679
DR ATCC; HB-162
RX PubMed=6690619;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AF6-88.5.3
AC CVCL_J747
DR CLO; CLO_0001680
DR ATCC; HB-158
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AFB-1
AC CVCL_HA76
RX PubMed=1327557;
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344/JCI.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AFC003
AC CVCL_9U83
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID AFF
AC CVCL_IW60
SY AngelFish Fin
RX PubMed=27458084;
CC Group: Fish cell line.
OX NCBI_TaxID=74131; ! Pterophyllum scalare
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AFiPSC10
AC CVCL_9T26
SY AFiPSC line 10
RX PubMed=26987930;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T27 ! AFiPSC4
OI CVCL_9T29 ! AFiPSC5
OI CVCL_9T30 ! AFiPSC6
OI CVCL_9T28 ! AFiPSC41
SX Female
CA Induced pluripotent stem cell
//
ID AFiPSC4
AC CVCL_9T27
SY AFiPSC line 4
RX PubMed=26987930;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T29 ! AFiPSC5
OI CVCL_9T30 ! AFiPSC6
OI CVCL_9T26 ! AFiPSC10
OI CVCL_9T28 ! AFiPSC41
SX Female
CA Induced pluripotent stem cell
//
ID AFiPSC41
AC CVCL_9T28
SY AFiPSC line 41
RX PubMed=26987930;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T27 ! AFiPSC4
OI CVCL_9T29 ! AFiPSC5
OI CVCL_9T30 ! AFiPSC6
OI CVCL_9T26 ! AFiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID AFiPSC5
AC CVCL_9T29
SY AFiPSC line 5
RX PubMed=26987930;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T27 ! AFiPSC4
OI CVCL_9T30 ! AFiPSC6
OI CVCL_9T26 ! AFiPSC10
OI CVCL_9T28 ! AFiPSC41
SX Female
CA Induced pluripotent stem cell
//
ID AFiPSC6
AC CVCL_9T30
SY AFiPSC line 6
RX PubMed=26987930;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T27 ! AFiPSC4
OI CVCL_9T29 ! AFiPSC5
OI CVCL_9T26 ! AFiPSC10
OI CVCL_9T28 ! AFiPSC41
SX Female
CA Induced pluripotent stem cell
//
ID AFKM-On-H
AC CVCL_9T82
RX PubMed=17846857;
CC Group: Insect cell line.
OX NCBI_TaxID=29057; ! Ostrinia nubilalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AFLB8
AC CVCL_C125
RX PubMed=7514612;
RX PubMed=10223185;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID AFRC 17D1
AC CVCL_L815
SY EQ17
DR ECACC; 94120825
RX PubMed=1632074;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybrid cell line
//
ID AFRC 56D2
AC CVCL_L816
DR ECACC; 94120826
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 58D6
AC CVCL_L817
DR ECACC; 94120827
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 78A3
AC CVCL_L818
DR ECACC; 94120828
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 84B4
AC CVCL_L819
DR ECACC; 94120829
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 84C6
AC CVCL_L820
DR ECACC; 94120830
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 85A2
AC CVCL_L821
DR ECACC; 94120831
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 85B5
AC CVCL_L822
DR ECACC; 94120832
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC 85D6
AC CVCL_L823
DR ECACC; 94120833
CC Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus isolate A/Equine/New Market/1979 H3N8 hemagglutinin (HA).
OX NCBI_TaxID=9796; ! Equus caballus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L815 ! AFRC 17D1
CA Hybridoma
//
ID AFRC MAC 1
AC CVCL_K178
SY ARC MAC 1
DR ECACC; 85102263
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 10
AC CVCL_K179
SY ARC MAC 10
DR ECACC; 85102274
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 11
AC CVCL_K180
SY ARC MAC 11
DR ECACC; 85102273
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 12
AC CVCL_K181
SY ARC MAC 12
DR ECACC; 86030301
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 127
AC CVCL_K182
SY MAC127
DR ECACC; 92102334
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 128
AC CVCL_K183
SY MAC128
DR ECACC; 92102335
RX PubMed=2458711;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 129
AC CVCL_K184
SY MAC129
DR ECACC; 92102340
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 13
AC CVCL_K185
SY ARC MAC 13
DR ECACC; 86030302
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 130
AC CVCL_K186
SY MAC130
DR ECACC; 92102342
RX PubMed=2458711;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 131
AC CVCL_K187
SY MAC131
DR ECACC; 92102343
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 132
AC CVCL_K188
SY MAC132
DR ECACC; 92102341
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 133
AC CVCL_K189
SY MAC133
DR ECACC; 92102344
RX PubMed=2458711;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 14
AC CVCL_K190
SY ARC MAC 14
DR ECACC; 86030303
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 15
AC CVCL_J005
SY ARC MAC 15
DR ECACC; 86030304
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 156
AC CVCL_K191
DR ECACC; 93090996
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID AFRC MAC 157
AC CVCL_K192
DR ECACC; 93090997
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID AFRC MAC 158
AC CVCL_K193
DR ECACC; 93090998
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID AFRC MAC 159
AC CVCL_K194
DR ECACC; 93090999
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID AFRC MAC 16
AC CVCL_CZ00
SY ARC MAC 16
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 160
AC CVCL_K195
DR ECACC; 93091001
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID AFRC MAC 17
AC CVCL_K196
SY ARC MAC 17
DR ECACC; 86030306
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 18
AC CVCL_J006
SY ARC MAC 18
DR ECACC; 86030307
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 188
AC CVCL_K197
SY MAC188
DR ECACC; 92102372
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 19
AC CVCL_J007
SY ARC MAC 19
DR ECACC; 86030308
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 2
AC CVCL_J008
SY ARC MAC 2
DR ECACC; 85102264
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 20
AC CVCL_J009
SY ARC MAC 20
DR ECACC; 86030309
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 22
AC CVCL_K198
SY MAC22
DR ECACC; 92102336
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 23
AC CVCL_K199
SY MAC23
DR ECACC; 92102338
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 24
AC CVCL_K200
SY MAC24
DR ECACC; 92102337
RX PubMed=2458711;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 25
AC CVCL_K201
SY MAC25
DR ECACC; 92102330
RX PubMed=2458711;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 252
AC CVCL_G702
DR ECACC; 01071008
DR ECACC; 92012453
CC Monoclonal antibody target: ChEBI; CHEBI:2365; (+)-abscisic acid.
CC Discontinued: ECACC; 92012453; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G701 ! AFRC MAC 60
CA Hybridoma
//
ID AFRC MAC 256
AC CVCL_J010
DR ECACC; 89120557
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7675 ! IR983F
CA Hybridoma
//
ID AFRC MAC 257
AC CVCL_K202
DR ECACC; 89120558
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID AFRC MAC 258
AC CVCL_L824
DR ECACC; 89120559
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7675 ! IR983F
CA Hybridoma
//
ID AFRC MAC 259
AC CVCL_L825
DR ECACC; 89120560
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7675 ! IR983F
CA Hybridoma
//
ID AFRC MAC 26
AC CVCL_L826
SY MAC26
DR ECACC; 92102345
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2783 ! Y0
CA Hybridoma
//
ID AFRC MAC 260
AC CVCL_L827
DR ECACC; 89120561
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID AFRC MAC 27
AC CVCL_H164
SY MAC27
DR ECACC; 92102339
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2783 ! Y0
CA Hybridoma
//
ID AFRC MAC 28
AC CVCL_H165
SY MAC28
DR ECACC; 92102331
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2783 ! Y0
CA Hybridoma
//
ID AFRC MAC 29
AC CVCL_H166
SY MAC29
DR ECACC; 92102332
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2783 ! Y0
CA Hybridoma
//
ID AFRC MAC 3
AC CVCL_H167
SY ARC MAC 3
DR ECACC; 85102265
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 31
AC CVCL_L828
SY MAC31
DR ECACC; 92102333
RX PubMed=2458711;
CC Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2783 ! Y0
CA Hybridoma
//
ID AFRC MAC 4
AC CVCL_L829
SY ARC MAC 4
DR ECACC; 85102266
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 48
AC CVCL_L830
SY AFR MAC 48
DR ECACC; 85060403
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 49
AC CVCL_L831
SY AFR MAC 49
DR ECACC; 85060404
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 5
AC CVCL_H168
SY ARC MAC 5
DR ECACC; 85102267
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 50
AC CVCL_K145
SY AFR MAC 50
DR ECACC; 85102259
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 51
AC CVCL_K146
SY AFR MAC 51
DR ECACC; 85060405
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 52
AC CVCL_K147
SY AFR MAC 52
DR ECACC; 85060406
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 54
AC CVCL_K148
SY AFR MAC 54
DR ECACC; 85060407
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 55
AC CVCL_CZ01
SY AFR MAC 55
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 56
AC CVCL_CZ02
SY AFR MAC 56
RX PubMed=24258587;
CC Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (probably also other PHYA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 57
AC CVCL_K149
DR ECACC; 86030310
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 6
AC CVCL_H169
SY ARC MAC 6
DR ECACC; 85102268
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 60
AC CVCL_G701
DR ECACC; 86052303
CC Monoclonal antibody target: ChEBI; CHEBI:2365; (+)-abscisic acid.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 61
AC CVCL_H170
DR ECACC; 86052301
CC Monoclonal antibody target: ChEBI; CHEBI:2365; (+)-abscisic acid.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 61.6
AC CVCL_U067
DR ECACC; 01010804
CC Monoclonal antibody target: ChEBI; CHEBI:2365; (+)-abscisic acid.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_H170 ! AFRC MAC 61
CA Hybridoma
//
ID AFRC MAC 63
AC CVCL_K150
DR ECACC; 86030311
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 65
AC CVCL_K151
DR ECACC; 86030313
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 7
AC CVCL_K152
SY ARC MAC 7
DR ECACC; 85102269
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
CC Discontinued: ECACC; 85102269; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 74
AC CVCL_K153
DR ECACC; 86112690
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 75
AC CVCL_K154
DR ECACC; 85102260
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 76
AC CVCL_K155
DR ECACC; 85102261
CC Discontinued: ECACC; 85102261; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 77
AC CVCL_K156
DR ECACC; 85102262
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID AFRC MAC 78
AC CVCL_K157
DR ECACC; 85102272
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 79
AC CVCL_H171
DR ECACC; 86112691
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 8
AC CVCL_K158
SY ARC MAC 8
DR ECACC; 85102270
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFRC MAC 9
AC CVCL_K159
SY ARC MAC 9
DR ECACC; 85102271
RX PubMed=24253722;
CC Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybridoma
//
ID AFT011
AC CVCL_9U84
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID AFT024
AC CVCL_5431
DR CLO; CLO_0001682
DR ATCC; SCRC-1007
DR BCRJ; 0038
RX PubMed=9108096;
RX PubMed=9192756;
RX PubMed=12244569;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AFT024
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID AG-F
AC CVCL_D101
SY AGF
DR ATCC; CRL-2530
DR ATCC; CRL-11391
DR BioSample; SAMN03151617
DR BioSample; SAMN03471608
RX Patent=US5480825;
RX PubMed=8255104;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AG-F
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342, PubMed=20143388).
CC Doubling time: ~8-9 hours (Patent=US5480825).
CC Discontinued: ATCC; CRL-2530; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11,12
ST D13S317: 11,12
ST D16S539: 10,13,14
ST D5S818: 11,13,14,15
ST D7S820: 8,14.1
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 16,17,18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID AG00364
AC CVCL_X759
SY AG00364C; AG00364E
DR CLO; CLO_0036915
DR Coriell; AG00364
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG00780
AC CVCL_U282
SY AG780; AG 780
DR CLO; CLO_0036916
DR Coriell; AG00780
DR GEO; GSM1184264
DR GEO; GSM1184265
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG00781
AC CVCL_W842
SY AG0781B
DR Coriell; AG00781
CC Discontinued: Coriell; AG00781; probable.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID AG00989
AC CVCL_W837
SY AG0989B
DR CLO; CLO_0036917
DR Coriell; AG00989
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG00990
AC CVCL_W843
SY KH2
DR CLO; CLO_0036899
DR Coriell; AG00990
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG00991
AC CVCL_V551
SY AG991
DR Coriell; AG00991
RX PubMed=7471105;
CC Discontinued: Coriell; AG00991; probable.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01123
AC CVCL_V556
SY AG1123; AG 1123
DR Coriell; AG01123
RX PubMed=7471105;
CC Discontinued: Coriell; AG01123; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG01131
AC CVCL_V555
SY AG1131; AG 1131
DR Coriell; AG01131
RX PubMed=7471105;
CC Discontinued: Coriell; AG01131; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG01142
AC CVCL_V542
SY AG-1142; AG 1142; AG1142
DR Coriell; AG01142
RX PubMed=2973075;
RX PubMed=7329430;
RX PubMed=7338842;
RX PubMed=7471105;
CC Discontinued: Coriell; AG01142; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG01178
AC CVCL_X761
DR CLO; CLO_0036894
DR Coriell; AG01178
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0124
AC CVCL_8B47
DR ECACC; 90052207
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG0138
AC CVCL_8B48
DR ECACC; 90070301
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG0143
AC CVCL_8B49
DR ECACC; 90072402
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG01437
AC CVCL_U701
SY AG1437; AG01437B; HG3004
DR CLO; CLO_0036897
DR BioSamples; SAME56937
DR Coriell; AG01437
CC Discontinued: Coriell; AG01437; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01439
AC CVCL_X760
DR CLO; CLO_0036890
DR Coriell; AG01439
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01440
AC CVCL_2Q69
DR CLO; CLO_0036893
DR Coriell; AG01440
CC Discontinued: Coriell; AG01440; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0150
AC CVCL_8B50
DR ECACC; 90081516
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35139; Alagille syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG0151
AC CVCL_8B51
DR ECACC; 90081517
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35139; Alagille syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG01518
AC CVCL_F696
SY AG 1518; AG1518
DR CLO; CLO_0036887
DR Coriell; AG01518
DR GEO; GSM158559
DR GEO; GSM158560
DR GEO; GSM158561
RX PubMed=2973075;
RX PubMed=6810166;
RX PubMed=7329430;
RX PubMed=7471105;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01519
AC CVCL_H764
SY AG1519; AG 1519
DR CLO; CLO_0036888
DR Coriell; AG01519
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0152
AC CVCL_8B52
DR ECACC; 90082301
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG01520
AC CVCL_H750
SY AG1520; AG 1520
DR CLO; CLO_0036903
DR Coriell; AG01520
RX PubMed=3745952;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01521
AC CVCL_H751
SY AG1521; AG 1521
DR CLO; CLO_0036904
DR Coriell; AG01521
RX PubMed=6810166;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01522
AC CVCL_H759
SY AG-1522; AG 1522; AG1522; AGO 1522; AGO1522
DR CLO; CLO_0036902
DR Coriell; AG01522
DR GEO; GSM520723
DR GEO; GSM520724
DR GEO; GSM520725
DR GEO; GSM520726
DR GEO; GSM520727
DR GEO; GSM520728
DR GEO; GSM520729
DR GEO; GSM520730
DR GEO; GSM520731
DR GEO; GSM520732
DR NCBI_Iran; C449
RX PubMed=2973075;
RX PubMed=6810166;
RX PubMed=6843573;
RX PubMed=7329430;
RX PubMed=7471105;
WW http://faculty.washington.edu/trawets/archive/Human/fibroblast/ag1522/index.html
ST Source(s): NCBI_Iran
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,10
ST D16S539: 10
ST D18S51: 12
ST D21S11: 29,30
ST D5S818: 10
ST D7S820: 15
ST D8S1179: 12,14
ST FGA: 20,25
ST TH01: 9
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01523
AC CVCL_F697
SY AG 1523; AG1523; Ag1523
DR CLO; CLO_0036879
DR ChEMBL-Cells; CHEMBL3307578
DR ChEMBL-Targets; CHEMBL614268
DR Coriell; AG01523
RX PubMed=2848260;
RX PubMed=3020539;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0158
AC CVCL_8B53
DR ECACC; 90091901
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG01615
AC CVCL_V541
SY AG1615
DR Coriell; AG01615
RX PubMed=7471105;
CC Discontinued: Coriell; AG01615; probable.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0179
AC CVCL_8B54
DR ECACC; 90101202
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG01879
AC CVCL_V557
SY AG1879; AG 1879
DR Coriell; AG01879
RX PubMed=7471105;
CC Discontinued: Coriell; AG01879; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG01880
AC CVCL_V543
SY AG1880; AG 1880
DR Coriell; AG01880
RX PubMed=2973075;
RX PubMed=6843573;
RX PubMed=7471105;
CC Discontinued: Coriell; AG01880; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG01946
AC CVCL_V552
SY AG1946; AG 1946
DR Coriell; AG01946
RX PubMed=7471105;
CC Discontinued: Coriell; AG01946; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01947
AC CVCL_V553
SY AG1947; AG 1947
DR Coriell; AG01947
RX PubMed=7471105;
CC Discontinued: Coriell; AG01947; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01951
AC CVCL_X762
SY LHC638
DR CLO; CLO_0036880
DR Coriell; AG01951
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01952
AC CVCL_X763
SY LHC484
DR CLO; CLO_0036881
DR Coriell; AG01952
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01972
AC CVCL_F262
SY AG01972A; AG01972B; AG 1972
DR CLO; CLO_0036882
DR Coriell; AG01972
DR GEO; GSM603044
DR GEO; GSM603045
RX PubMed=7471105;
RX PubMed=12714972;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F261 ! GM01972
SX Female
CA Finite cell line
//
ID AG01978
AC CVCL_V544
SY AG1978; AG 1978
DR Coriell; AG01978
RX PubMed=2973075;
RX PubMed=6843573;
CC Discontinued: Coriell; AG01978; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG01979
AC CVCL_V554
SY AG1979; AG 1979
DR Coriell; AG01979
RX PubMed=7471105;
CC Discontinued: Coriell; AG01979; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0206
AC CVCL_8B55
DR ECACC; 91010404
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG02101
AC CVCL_W439
DR CLO; CLO_0036875
DR Coriell; AG02101
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02102
AC CVCL_W440
DR CLO; CLO_0036876
DR Coriell; AG02102
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02122
AC CVCL_X808
DR CLO; CLO_0036877
DR Coriell; AG02122
DI NCIt; C84906; Mulibrey nanism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02222
AC CVCL_0D97
DR CLO; CLO_0036878
DR Coriell; AG02222
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG02258
AC CVCL_0N52
DR CLO; CLO_0036883
DR Coriell; AG02258
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02261
AC CVCL_0D98
SY AG02261B
DR CLO; CLO_0036884
DR Coriell; AG02261
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0D99 ! AG02262
SX Male
CA Finite cell line
//
ID AG02262
AC CVCL_0D99
SY AG02262A
DR CLO; CLO_0036993
DR Coriell; AG02262
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0D98 ! AG02261
SX Male
CA Finite cell line
//
ID AG02496
AC CVCL_X771
DR CLO; CLO_0037004
DR Coriell; AG02496
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG02505
AC CVCL_X809
DR CLO; CLO_0037003
DR Coriell; AG02505
DI NCIt; C84906; Mulibrey nanism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02506
AC CVCL_X810
DR CLO; CLO_0037006
DR Coriell; AG02506
DI NCIt; C84906; Mulibrey nanism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02602
AC CVCL_0D95
SY AG02602A
DR CLO; CLO_0037005
DR Coriell; AG02602
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0D96 ! AG02603
SX Female
CA Finite cell line
//
ID AG02603
AC CVCL_0D96
DR CLO; CLO_0037008
DR Coriell; AG02603
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0D95 ! AG02602
SX Female
CA Finite cell line
//
ID AG02718
AC CVCL_V550
SY AG2718; AG 2718
DR Coriell; AG02718
RX PubMed=7329430;
RX PubMed=7471105;
CC Discontinued: Coriell; AG02718; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02719
AC CVCL_X049
SY AG2719; AG 2719
DR Coriell; AG02719
RX PubMed=7329430;
CC Discontinued: Coriell; AG02719; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG02804
AC CVCL_M222
SY 90VA-VI; AG02804A; AG02804C; AG02804D; AG2804B; AG2804
DR CLO; CLO_0037007
DR Coriell; AG02804
RX PubMed=2995426;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [Rh911].
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16,17
ST D21S11: 30.2,31
ST D8S1179: 13,14
ST FGA: 25,26
ST TH01: 8,9.3
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M230 ! AG03204
SX Female
CA Transformed cell line
//
ID AG02871
AC CVCL_X780
DR CLO; CLO_0037010
DR BioSamples; SAME58121
DR Coriell; AG02871
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG02872
AC CVCL_X781
SY XP1SA
DR CLO; CLO_0037009
DR BioSamples; SAME58122
DR Coriell; AG02872
CC Caution: Seems to originate from a different patient than the XP1SA from Japan.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03057
AC CVCL_X764
DR CLO; CLO_0037002
DR Coriell; AG03057
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03058
AC CVCL_X765
DR CLO; CLO_0036981
DR Coriell; AG03058
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03059
AC CVCL_X766
DR CLO; CLO_0036982
DR Coriell; AG03059
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG03139
AC CVCL_HF28
SY AG3139
DR Coriell; AG03139
RX PubMed=2973075;
RX PubMed=3762576;
CC Discontinued: Coriell; AG03139; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG03141
AC CVCL_X767
SY AG3141; AG 3141
DR CLO; CLO_0036986
DR Coriell; AG03141
DR GEO; GSM1184266
DR GEO; GSM1184267
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03198
AC CVCL_L614
SY AG03198A; AG3198
DR CLO; CLO_0036985
DR Coriell; AG03198
RX PubMed=8246632;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L616 ! AG03199
OI CVCL_L617 ! AG03259
SX Female
CA Finite cell line
//
ID AG03199
AC CVCL_L616
SY AG3199
DR CLO; CLO_0036984
DR Coriell; AG03199
RX PubMed=8246632;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L614 ! AG03198
OI CVCL_L617 ! AG03259
SX Female
CA Finite cell line
//
ID AG03204
AC CVCL_M230
SY AG03204A; AG3204
DR CLO; CLO_0036983
DR Coriell; AG03204
RX PubMed=2995426;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [Rh911].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Transformed cell line
//
ID AG03257
AC CVCL_L621
SY AG3257
DR CLO; CLO_0036990
DR Coriell; AG03257
RX PubMed=8246632;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L618 ! AG03260
SX Female
CA Finite cell line
//
ID AG03258
AC CVCL_L622
SY AG3258
DR CLO; CLO_0036989
DR Coriell; AG03258
RX PubMed=8246632;
RX PubMed=12714972;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG03259
AC CVCL_L617
SY AG03259A
DR CLO; CLO_0036988
DR Coriell; AG03259
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L614 ! AG03198
OI CVCL_L616 ! AG03199
SX Female
CA Transformed cell line
//
ID AG03260
AC CVCL_L618
SY AG03260A
DR CLO; CLO_0036987
DR Coriell; AG03260
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L621 ! AG03257
SX Female
CA Transformed cell line
//
ID AG03262
AC CVCL_L619
DR CLO; CLO_0036961
DR Coriell; AG03262
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG03263
AC CVCL_L620
DR CLO; CLO_0036962
DR Coriell; AG03263
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03326
AC CVCL_HF29
SY AG3326
DR Coriell; AG03326
RX PubMed=2973075;
RX PubMed=3762576;
CC Discontinued: Coriell; AG03326; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03342
AC CVCL_2A30
DR CLO; CLO_0036963
DR Coriell; AG03342
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; AG03342; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03343
AC CVCL_W838
DR CLO; CLO_0036978
DR Coriell; AG03343
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG03344
AC CVCL_W839
SY AG3344
DR CLO; CLO_0036977
DR Coriell; AG03344
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03345
AC CVCL_W840
DR CLO; CLO_0036980
DR Coriell; AG03345
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG03346
AC CVCL_W841
DR CLO; CLO_0036979
DR Coriell; AG03346
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03364
AC CVCL_U309
DR CLO; CLO_0036975
DR Coriell; AG03364
DR GEO; GSM1052417
RX PubMed=23257959;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: DNA methylation analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03504
AC CVCL_L603
DR CLO; CLO_0036974
DR Coriell; AG03504
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L604 ! AG03512
SX Female
CA Transformed cell line
//
ID AG03505
AC CVCL_L608
DR CLO; CLO_0036976
DR Coriell; AG03505
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CV35 ! AG03511
SX Male
CA Transformed cell line
//
ID AG03506
AC CVCL_L609
DR CLO; CLO_0036943
DR Coriell; AG03506
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L610 ! AG03513
SX Male
CA Transformed cell line
//
ID AG03507
AC CVCL_L611
DR CLO; CLO_0036944
DR Coriell; AG03507
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG03508
AC CVCL_L612
DR CLO; CLO_0036941
DR Coriell; AG03508
RX PubMed=12714972;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03511
AC CVCL_CV35
SY AG3511; AG 3511
DR Coriell; AG03511
RX PubMed=8246632;
CC Discontinued: Coriell; AG03511; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L608 ! AG03505
SX Male
CA Finite cell line
//
ID AG03512
AC CVCL_L604
SY AG3512
DR CLO; CLO_0036942
DR Coriell; AG03512
RX PubMed=8246632;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L603 ! AG03504
SX Female
CA Finite cell line
//
ID AG03513
AC CVCL_L610
SY AG03513D; AG03513d; AG3513
DR CLO; CLO_0036960
DR Coriell; AG03513
RX PubMed=8246632;
RX PubMed=16126733;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L609 ! AG03506
SX Male
CA Finite cell line
//
ID AG03587
AC CVCL_X811
DR CLO; CLO_0036959
DR Coriell; AG03587
DI NCIt; C3335; Rothmund-Thomson syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG03738
AC CVCL_X785
DR CLO; CLO_0036958
DR Coriell; AG03738
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG03739
AC CVCL_2A31
DR CLO; CLO_0036957
DR Coriell; AG03739
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; AG03739; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03829
AC CVCL_W043
SY AG3829
DR CLO; CLO_0036956
DR Coriell; AG03829
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG03961
AC CVCL_0J77
SY XP10CA
DR CLO; CLO_0036955
DR Coriell; AG03961
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03962
AC CVCL_X782
SY XP11CA
DR CLO; CLO_0034759
DR Coriell; AG03962
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG03963
AC CVCL_X783
SY XP12CA
DR CLO; CLO_0034760
DR Coriell; AG03963
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG03964
AC CVCL_V266
SY XP13CA
DR CLO; CLO_0034763
DR Coriell; AG03964
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG03965
AC CVCL_X784
SY XP14CA
DR CLO; CLO_0034764
DR Coriell; AG03965
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG04054
AC CVCL_2A41
SY AG04054A; AG04054B; AG 4054
DR CLO; CLO_0034761
DR Coriell; AG04054
DR GEO; GSM244109
DR GEO; GSM244110
RX PubMed=3745952;
RX PubMed=18631391;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E07 ! AG11557
OI CVCL_2G15 ! AG13442
SX Male
CA Finite cell line
//
ID AG04055
AC CVCL_2A42
DR CLO; CLO_0034762
DR Coriell; AG04055
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04056
AC CVCL_2A43
DR CLO; CLO_0034767
DR Coriell; AG04056
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04057
AC CVCL_2A44
DR CLO; CLO_0034768
DR Coriell; AG04057
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E33 ! AG11730
SX Male
CA Finite cell line
//
ID AG04058
AC CVCL_0J78
DR CLO; CLO_0034765
DR Coriell; AG04058
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04059
AC CVCL_L623
SY AG04059B; AG-4059; AG 4059
DR CLO; CLO_0034766
DR Coriell; AG04059
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0406
AC CVCL_8B56
DR ECACC; 91072504
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG04060
AC CVCL_2A45
DR CLO; CLO_0034769
DR Coriell; AG04060
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04061
AC CVCL_2A46
DR CLO; CLO_0034770
DR Coriell; AG04061
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04062
AC CVCL_2A47
DR CLO; CLO_0034771
DR Coriell; AG04062
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 34-44 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E76 ! AG12660
SX Male
CA Finite cell line
//
ID AG04063
AC CVCL_2A48
DR CLO; CLO_0034772
DR Coriell; AG04063
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04064
AC CVCL_L624
SY AG04064A
DR CLO; CLO_0034773
DR Coriell; AG04064
DR GEO; GSM244111
DR GEO; GSM244112
RX PubMed=9724752;
RX PubMed=18631391;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 32 PDL (PubMed=9724752).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L625 ! AG08433
SX Male
CA Finite cell line
//
ID AG04065
AC CVCL_2A49
SY AG04065D
DR CLO; CLO_0034774
DR Coriell; AG04065
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04103
AC CVCL_U310
DR CLO; CLO_0034775
DR Coriell; AG04103
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG04110
AC CVCL_U311
DR CLO; CLO_0034776
DR Coriell; AG04110
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG04142
AC CVCL_2A50
DR CLO; CLO_0034777
DR Coriell; AG04142
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04143
AC CVCL_2A51
DR CLO; CLO_0034778
DR Coriell; AG04143
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04144
AC CVCL_0J79
DR CLO; CLO_0034781
DR Coriell; AG04144
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J80 ! AG09558
SX Male
CA Finite cell line
//
ID AG04145
AC CVCL_2A52
DR CLO; CLO_0034782
DR Coriell; AG04145
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E10 ! AG11643
SX Male
CA Finite cell line
//
ID AG04146
AC CVCL_2A53
DR CLO; CLO_0034779
DR Coriell; AG04146
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C18 ! AG07123
SX Male
CA Finite cell line
//
ID AG04147
AC CVCL_2A54
DR CLO; CLO_0034780
DR Coriell; AG04147
DR GEO; GSM426260
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04148
AC CVCL_2A55
DR CLO; CLO_0034787
DR Coriell; AG04148
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04149
AC CVCL_2A56
DR CLO; CLO_0034788
DR Coriell; AG04149
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F05 ! AG12965
SX Male
CA Finite cell line
//
ID AG04150
AC CVCL_2A57
DR CLO; CLO_0034785
DR Coriell; AG04150
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G31 ! AG14099
SX Male
CA Finite cell line
//
ID AG04151
AC CVCL_2A58
SY AG-4151
DR CLO; CLO_0034786
DR Coriell; AG04151
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G01 ! AG13334
SX Male
CA Finite cell line
//
ID AG04152
AC CVCL_2A59
DR CLO; CLO_0034783
DR Coriell; AG04152
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04153
AC CVCL_2A60
SY AG04153A
DR CLO; CLO_0034784
DR Coriell; AG04153
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04159
AC CVCL_V150
SY AG04159A
DR CLO; CLO_0034793
DR Coriell; AG04159
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V151 ! AG04160
SX Female
CA Finite cell line
//
ID AG04160
AC CVCL_V151
SY AG04160C
DR CLO; CLO_0034789
DR Coriell; AG04160
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V150 ! AG04159
SX Female
CA Transformed cell line
//
ID AG0422
AC CVCL_8B57
DR ECACC; 91081203
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG0423
AC CVCL_8B58
DR ECACC; 91081204
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG0425
AC CVCL_8B59
DR ECACC; 91082128
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG04250
AC CVCL_4Y27
SY AG4250; RB9T
DR Coriell; AG04250
DR JCRB; KURB2685
CC Discontinued: Coriell; AG04250; probable.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG04260
AC CVCL_H785
SY AG4260
DR Coriell; AG04260
CC Discontinued: Coriell; AG04260; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID AG04316
AC CVCL_0J82
SY XP17CA
DR CLO; CLO_0034790
DR Coriell; AG04316
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG04348
AC CVCL_2A61
DR CLO; CLO_0034791
DR Coriell; AG04348
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04349
AC CVCL_2A62
DR CLO; CLO_0034792
DR Coriell; AG04349
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04350
AC CVCL_2A63
DR CLO; CLO_0034795
DR Coriell; AG04350
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E06 ! AG11555
SX Male
CA Finite cell line
//
ID AG04351
AC CVCL_2A64
DR CLO; CLO_0034796
DR Coriell; AG04351
DR GEO; GSM426261
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04352
AC CVCL_2A65
DR CLO; CLO_0034797
DR Coriell; AG04352
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G10 ! AG13367
SX Male
CA Finite cell line
//
ID AG04353
AC CVCL_2A66
SY AG-4353; AG 4353
DR CLO; CLO_0034798
DR Coriell; AG04353
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B52 ! AG05804
SX Male
CA Finite cell line
//
ID AG04354
AC CVCL_2A67
DR CLO; CLO_0034794
DR Coriell; AG04354
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E77 ! AG12733
SX Male
CA Finite cell line
//
ID AG04355
AC CVCL_2A68
DR CLO; CLO_0034804
DR Coriell; AG04355
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04356
AC CVCL_2A69
DR CLO; CLO_0034803
DR Coriell; AG04356
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04357
AC CVCL_2A70
DR CLO; CLO_0034808
DR Coriell; AG04357
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04378
AC CVCL_2A71
DR CLO; CLO_0034807
DR Coriell; AG04378
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04379
AC CVCL_2A72
DR CLO; CLO_0034806
DR Coriell; AG04379
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0438
AC CVCL_8B60
DR ECACC; 91091602
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG04380
AC CVCL_2A73
SY AG04380A
DR CLO; CLO_0034805
DR Coriell; AG04380
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G04 ! AG13348
SX Male
CA Finite cell line
//
ID AG04381
AC CVCL_2A74
DR CLO; CLO_0034802
DR Coriell; AG04381
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04382
AC CVCL_2A75
DR CLO; CLO_0034801
DR Coriell; AG04382
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C70 ! AG08791
SX Male
CA Finite cell line
//
ID AG04383
AC CVCL_2A76
DR CLO; CLO_0034800
DR Coriell; AG04383
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04384
AC CVCL_2A77
DR CLO; CLO_0034799
DR Coriell; AG04384
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04385
AC CVCL_2A78
DR CLO; CLO_0034812
DR Coriell; AG04385
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04386
AC CVCL_2A79
DR CLO; CLO_0034814
DR Coriell; AG04386
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04387
AC CVCL_2A80
DR CLO; CLO_0034813
DR Coriell; AG04387
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04388
AC CVCL_2I14
DR CLO; CLO_0034816
DR Coriell; AG04388
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Finite cell line
//
ID AG0439
AC CVCL_8B61
DR ECACC; 91092529
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG04392
AC CVCL_0J95
DR CLO; CLO_0034815
DR Coriell; AG04392
RX PubMed=9724752;
CC Characteristics: Senesces at 55 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J96 ! AG04393
SX Female
CA Finite cell line
//
ID AG04393
AC CVCL_0J96
DR CLO; CLO_0034818
DR Coriell; AG04393
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J95 ! AG04392
SX Female
CA Finite cell line
//
ID AG0440
AC CVCL_8B62
DR ECACC; 91092530
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG04400
AC CVCL_H786
SY AG4400; AG04400A
DR CLO; CLO_0034817
DR Coriell; AG04400
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG04401
AC CVCL_H787
SY AG4401; AG04401D
DR CLO; CLO_0034810
DR Coriell; AG04401
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG04402
AC CVCL_H788
SY AG4402; AG04402A
DR CLO; CLO_0034809
DR Coriell; AG04402
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04405
AC CVCL_X772
SY AG 04405
DR CLO; CLO_0034811
DR Coriell; AG04405
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04407
AC CVCL_X773
DR Coriell; AG04407
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG0441
AC CVCL_8B63
DR ECACC; 91092607
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG0442
AC CVCL_8B64
DR ECACC; 91092608
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG04431
AC CVCL_0J97
SY AG04431B
DR CLO; CLO_0034828
DR Coriell; AG04431
RX PubMed=9724752;
CC Characteristics: Senesces at 54 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J98 ! AG04432
SX Female
CA Finite cell line
//
ID AG04432
AC CVCL_0J98
DR CLO; CLO_0034827
DR Coriell; AG04432
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J97 ! AG04431
SX Female
CA Finite cell line
//
ID AG04433
AC CVCL_0J99
DR CLO; CLO_0034826
DR Coriell; AG04433
RX PubMed=9724752;
CC Characteristics: Senesces at 30-36 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0K00 ! AG04434
SX Male
CA Finite cell line
//
ID AG04434
AC CVCL_0K00
DR CLO; CLO_0034825
DR Coriell; AG04434
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J99 ! AG04433
SX Male
CA Finite cell line
//
ID AG04438
AC CVCL_2A81
DR CLO; CLO_0034824
DR Coriell; AG04438
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04439
AC CVCL_2A82
DR CLO; CLO_0034823
DR Coriell; AG04439
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E74 ! AG12605
SX Male
CA Finite cell line
//
ID AG04440
AC CVCL_L023
DR CLO; CLO_0034822
DR Coriell; AG04440
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04441
AC CVCL_2A83
SY AG04441B
DR CLO; CLO_0034821
DR Coriell; AG04441
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 37-38 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F63 ! AG13156
SX Male
CA Finite cell line
//
ID AG04442
AC CVCL_2A84
DR CLO; CLO_0034820
DR Coriell; AG04442
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04443
AC CVCL_2A85
DR CLO; CLO_0034819
DR Coriell; AG04443
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04444
AC CVCL_2A86
DR CLO; CLO_0034829
DR Coriell; AG04444
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04445
AC CVCL_2A87
SY AG-4445
DR CLO; CLO_0034836
DR Coriell; AG04445
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04446
AC CVCL_2A88
DR CLO; CLO_0034835
DR Coriell; AG04446
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 37 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E80 ! AG12851
SX Male
CA Finite cell line
//
ID AG04447
AC CVCL_2A89
SY AG04447A
DR CLO; CLO_0034838
DR Coriell; AG04447
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E73 ! AG12602
SX Male
CA Finite cell line
//
ID AG04449
AC CVCL_F485
DR CLO; CLO_0034837
DR Coriell; AG04449
DR ENCODE; ENCBS003ENC
DR ENCODE; ENCBS667XPG
DR GEO; GSM510528
DR GEO; GSM510530
DR GEO; GSM945187
DR GEO; GSM945176
RX PubMed=9724752;
RX PubMed=23325432;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG04449_Stam_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Characteristics: Senesces at 31 PDL (PubMed=9724752).
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F486 ! AG04450
SX Male
CA Finite cell line
//
ID AG04450
AC CVCL_F486
DR CLO; CLO_0034832
DR EFO; EFO_0006270
DR Coriell; AG04450
DR ENCODE; ENCBS004ENC
DR ENCODE; ENCBS008ENC
DR ENCODE; ENCBS485QDY
DR GEO; GSM510532
DR GEO; GSM510534
DR GEO; GSM945169
DR GEO; GSM945177
DR GEO; GSM1010912
DR GEO; GSM1010913
DR GEO; GSM1010914
DR GEO; GSM2072418
DR GEO; GSM2072419
DR GEO; GSM2072446
DR GEO; GSM2072447
RX PubMed=23325432;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG04450_Stam_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F485 ! AG04449
SX Male
CA Finite cell line
//
ID AG04451
AC CVCL_0N53
DR CLO; CLO_0034831
DR Coriell; AG04451
RX PubMed=9724752;
CC Characteristics: Senesces at 57 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N54 ! AG04452
SX Female
CA Finite cell line
//
ID AG04452
AC CVCL_0N54
DR CLO; CLO_0034834
DR Coriell; AG04452
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N53 ! AG04451
SX Female
CA Finite cell line
//
ID AG04453
AC CVCL_2A90
DR CLO; CLO_0034833
DR Coriell; AG04453
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D34 ! AG10047
OI CVCL_2G30 ! AG14048
SX Male
CA Finite cell line
//
ID AG04454
AC CVCL_2A91
SY AG04454B
DR CLO; CLO_0034830
DR Coriell; AG04454
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F32 ! AG13076
SX Male
CA Finite cell line
//
ID AG04455
AC CVCL_2A92
DR CLO; CLO_0034679
DR Coriell; AG04455
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B47 ! AG05414
SX Male
CA Finite cell line
//
ID AG04456
AC CVCL_2A93
DR CLO; CLO_0034677
DR Coriell; AG04456
DR GEO; GSM244113
DR GEO; GSM244114
RX PubMed=18631391;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G36 ! AG14251
SX Male
CA Finite cell line
//
ID AG04457
AC CVCL_2A94
DR CLO; CLO_0034659
DR Coriell; AG04457
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B34 ! AG05248
SX Male
CA Finite cell line
//
ID AG04458
AC CVCL_2A95
SY AG04458A
DR CLO; CLO_0034660
DR Coriell; AG04458
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C89 ! AG09158
SX Male
CA Finite cell line
//
ID AG04459
AC CVCL_2A96
DR CLO; CLO_0034661
DR Coriell; AG04459
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Discontinued: Coriell; AG04459; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E19 ! AG11693
SX Male
CA Finite cell line
//
ID AG04460
AC CVCL_2A97
DR CLO; CLO_0034662
DR Coriell; AG04460
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04461
AC CVCL_2A98
DR CLO; CLO_0034664
DR Coriell; AG04461
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G03 ! AG13345
SX Male
CA Finite cell line
//
ID AG04462
AC CVCL_L626
SY AG04462A
DR CLO; CLO_0034666
DR Coriell; AG04462
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L627 ! AG11556
SX Male
CA Finite cell line
//
ID AG04475
AC CVCL_X790
DR CLO; CLO_0034668
DR Coriell; AG04475
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0448
AC CVCL_8B65
DR ECACC; 91100410
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG0449
AC CVCL_8B66
DR ECACC; 91100411
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG04525
AC CVCL_X791
SY AG 4525
DR CLO; CLO_0034669
DR Coriell; AG04525
RX PubMed=9724752;
CC Characteristics: Senesces at 27-36 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X792 ! AG04526
SX Male
CA Finite cell line
//
ID AG04526
AC CVCL_X792
DR CLO; CLO_0034698
DR Coriell; AG04526
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X791 ! AG04525
SX Male
CA Finite cell line
//
ID AG04551
AC CVCL_2A99
DR CLO; CLO_0034697
DR Coriell; AG04551
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C99 ! AG09270
OI CVCL_2D60 ! AG11019
SX Male
CA Finite cell line
//
ID AG04552
AC CVCL_2B00
SY AG04552A
DR CLO; CLO_0034694
DR Coriell; AG04552
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 22 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F61 ! AG13152
SX Male
CA Finite cell line
//
ID AG04553
AC CVCL_2B01
DR CLO; CLO_0034682
DR Coriell; AG04553
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04554
AC CVCL_2B02
DR CLO; CLO_0034683
DR Coriell; AG04554
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04555
AC CVCL_2B03
DR CLO; CLO_0034680
DR Coriell; AG04555
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04556
AC CVCL_2B04
DR CLO; CLO_0034681
DR Coriell; AG04556
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F94 ! AG13297
SX Male
CA Finite cell line
//
ID AG04557
AC CVCL_2B05
DR CLO; CLO_0034687
DR Coriell; AG04557
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04558
AC CVCL_2B06
DR CLO; CLO_0034688
DR Coriell; AG04558
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04559
AC CVCL_2B07
DR CLO; CLO_0034685
DR Coriell; AG04559
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04560
AC CVCL_H789
SY AG4560; AG 4560
DR CLO; CLO_0034912
DR Coriell; AG04560
RX PubMed=3745952;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04645
AC CVCL_X786
DR CLO; CLO_0034914
DR Coriell; AG04645
DI NCIt; C111802; Dyskeratosis congenita
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X787 ! AG04646
SX Male
CA Finite cell line
//
ID AG04646
AC CVCL_X787
DR CLO; CLO_0034913
DR Coriell; AG04646
DI NCIt; C111802; Dyskeratosis congenita
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X786 ! AG04645
SX Male
CA Finite cell line
//
ID AG04654
AC CVCL_2B08
DR CLO; CLO_0034916
DR Coriell; AG04654
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C45 ! AG07724
SX Male
CA Finite cell line
//
ID AG04655
AC CVCL_2B09
SY AG 4655
DR CLO; CLO_0034915
DR Coriell; AG04655
DR GEO; GSM426262
RX PubMed=3745952;
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E67 ! AG12588
SX Male
CA Finite cell line
//
ID AG04656
AC CVCL_2B10
SY AG 4656
DR CLO; CLO_0034919
DR Coriell; AG04656
RX PubMed=3745952;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F31 ! AG13075
SX Male
CA Finite cell line
//
ID AG04657
AC CVCL_2B11
DR CLO; CLO_0034917
DR Coriell; AG04657
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04658
AC CVCL_2B12
DR CLO; CLO_0034922
DR Coriell; AG04658
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04659
AC CVCL_2B13
DR CLO; CLO_0034920
DR Coriell; AG04659
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B43 ! AG05283
OI CVCL_2D83 ! AG11243
SX Male
CA Finite cell line
//
ID AG04660
AC CVCL_2B14
DR CLO; CLO_0034899
DR Coriell; AG04660
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04661
AC CVCL_2B15
DR CLO; CLO_0034885
DR Coriell; AG04661
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04662
AC CVCL_2B16
SY AG04662D
DR CLO; CLO_0034884
DR Coriell; AG04662
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04676
AC CVCL_2I15
SY AG 04676
DR CLO; CLO_0034892
DR Coriell; AG04676
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Female
CA Finite cell line
//
ID AG04677
AC CVCL_2I16
SY AG 04677A
DR CLO; CLO_0034891
DR Coriell; AG04677
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Female
CA Finite cell line
//
ID AG04762
AC CVCL_2I17
SY AG04762A
DR CLO; CLO_0034890
DR Coriell; AG04762
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_2I22 ! AG07680
SX Male
CA Finite cell line
//
ID AG04765
AC CVCL_2I18
DR CLO; CLO_0034889
DR Coriell; AG04765
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex ambiguous
CA Spontaneously immortalized cell line
//
ID AG0479
AC CVCL_8B67
DR ECACC; 91102207
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG04823
AC CVCL_X788
DR CLO; CLO_0034898
DR Coriell; AG04823
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG04907
AC CVCL_2I19
DR CLO; CLO_0034897
DR Coriell; AG04907
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID AG05012
AC CVCL_0J83
SY AG5012
DR CLO; CLO_0034895
DR Coriell; AG05012
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05013
AC CVCL_X812
DR CLO; CLO_0034893
DR Coriell; AG05013
DI NCIt; C3335; Rothmund-Thomson syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05024
AC CVCL_X789
DR CLO; CLO_0035183
DR Coriell; AG05024
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05025
AC CVCL_F252
SY AG 5025
DR CLO; CLO_0001683
DR CLO; CLO_0035181
DR CLDB; cl255
DR Coriell; AG05025
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Finite cell line
//
ID AG05055
AC CVCL_2I20
DR CLO; CLO_0035182
DR Coriell; AG05055
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Finite cell line
//
ID AG05056
AC CVCL_2I21
SY AG 05056
DR CLO; CLO_0035176
DR Coriell; AG05056
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Finite cell line
//
ID AG05095
AC CVCL_2B17
DR CLO; CLO_0035177
DR Coriell; AG05095
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05096
AC CVCL_2B18
SY AG05096A
DR CLO; CLO_0035174
DR Coriell; AG05096
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 34 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F55 ! AG13129
SX Male
CA Finite cell line
//
ID AG05097
AC CVCL_2B19
DR CLO; CLO_0035175
DR Coriell; AG05097
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05098
AC CVCL_2B20
DR CLO; CLO_0035179
DR Coriell; AG05098
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05099
AC CVCL_2B21
DR CLO; CLO_0035180
DR Coriell; AG05099
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C98 ! AG09269
SX Male
CA Finite cell line
//
ID AG05100
AC CVCL_2B22
DR CLO; CLO_0035178
DR Coriell; AG05100
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05101
AC CVCL_2B23
DR CLO; CLO_0035190
DR Coriell; AG05101
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05102
AC CVCL_2B24
DR CLO; CLO_0035191
DR Coriell; AG05102
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05103
AC CVCL_2B25
DR CLO; CLO_0035192
DR Coriell; AG05103
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E72 ! AG12599
SX Male
CA Finite cell line
//
ID AG05120
AC CVCL_X865
DR CLO; CLO_0035193
DR Coriell; AG05120
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X866 ! AG05121
SX Female
CA Finite cell line
//
ID AG05121
AC CVCL_X866
DR CLO; CLO_0035184
DR Coriell; AG05121
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X865 ! AG05120
SX Female
CA Finite cell line
//
ID AG05139
AC CVCL_X813
DR CLO; CLO_0035185
DR Coriell; AG05139
DI NCIt; C3335; Rothmund-Thomson syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X814 ! AG05140
SX Male
CA Finite cell line
//
ID AG05140
AC CVCL_X814
SY AG05140B
DR CLO; CLO_0035186
DR Coriell; AG05140
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3335; Rothmund-Thomson syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X813 ! AG05139
SX Male
CA Transformed cell line
//
ID AG05186
AC CVCL_2B26
SY AG05186A
DR CLO; CLO_0035187
DR Coriell; AG05186
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E08 ! AG11561
OI CVCL_2G11 ! AG13369
SX Male
CA Finite cell line
//
ID AG05188
AC CVCL_2B27
DR CLO; CLO_0035188
DR Coriell; AG05188
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B53 ! AG05805
OI CVCL_2F28 ! AG13065
SX Male
CA Finite cell line
//
ID AG05189
AC CVCL_2B28
DR CLO; CLO_0035189
DR Coriell; AG05189
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05190
AC CVCL_2B29
DR CLO; CLO_0035163
DR Coriell; AG05190
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05191
AC CVCL_2B30
DR CLO; CLO_0035161
DR Coriell; AG05191
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05192
AC CVCL_X832
SY AG05192A
DR CLO; CLO_0035162
DR Coriell; AG05192
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X833 ! AG09844
OI CVCL_X834 ! AG12587
SX Male
CA Finite cell line
//
ID AG05229
AC CVCL_X835
SY AG05229B
DR CLO; CLO_0035159
DR Coriell; AG05229
DR GEO; GSM1184268
DR GEO; GSM1184269
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X836 ! AG12799
OI CVCL_X837 ! AG12800
SX Male
CA Finite cell line
//
ID AG05231
AC CVCL_U312
DR Coriell; AG05231
CC Discontinued: Coriell; AG05231; probable.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U316 ! AG12795
SX Male
CA Finite cell line
//
ID AG05233
AC CVCL_X768
SY AG05233A; AG5233
DR CLO; CLO_0035160
DR Coriell; AG05233
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X769 ! AG12797
OI CVCL_X770 ! AG12798
SX Male
CA Finite cell line
//
ID AG05243
AC CVCL_0J84
SY AG5243
DR CLO; CLO_0035157
DR Coriell; AG05243
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05244
AC CVCL_2B31
DR CLO; CLO_0035158
DR Coriell; AG05244
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05245
AC CVCL_2B32
DR CLO; CLO_0035155
DR Coriell; AG05245
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G23 ! AG13968
SX Female
CA Finite cell line
//
ID AG05246
AC CVCL_2B33
DR CLO; CLO_0035156
DR Coriell; AG05246
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05247
AC CVCL_L605
SY AG05247D; AG05247E
DR CLO; CLO_0035154
DR Coriell; AG05247
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 45 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L607 ! AG09602
SX Female
CA Finite cell line
//
ID AG05248
AC CVCL_2B34
SY AG05248A
DR CLO; CLO_0035172
DR Coriell; AG05248
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2A94 ! AG04457
SX Male
CA Finite cell line
//
ID AG05251
AC CVCL_V973
DR Coriell; AG05251
RX PubMed=22720000;
CC Group: Non-human primate cell line.
CC Discontinued: Coriell; AG05251; probable.
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID AG05252
AC CVCL_1G38
DR Coriell; AG05252
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9600; ! Pongo pygmaeus
OI CVCL_2V04 ! PR00002
SX Male
CA Finite cell line
//
ID AG05253
AC CVCL_1G37
DR Coriell; AG05253
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Finite cell line
//
ID AG05253-iPS
AC CVCL_2Z84
SY AG05253 iPSC-2; Bonobo iPS2
DR GEO; GSM1153525
DR GEO; GSM1153526
RX PubMed=24153179;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9597; ! Pan paniscus
HI CVCL_1G37 ! AG05253
SX Male
CA Induced pluripotent stem cell
//
ID AG05265
AC CVCL_2B35
DR CLO; CLO_0035173
DR Coriell; AG05265
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05266
AC CVCL_2B36
SY AG05266B
DR CLO; CLO_0035168
DR Coriell; AG05266
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D78 ! AG11161
SX Female
CA Finite cell line
//
ID AG05270
AC CVCL_2B37
DR CLO; CLO_0035169
DR Coriell; AG05270
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E70 ! AG12597
SX Female
CA Finite cell line
//
ID AG05271
AC CVCL_2B38
SY AG05271A
DR CLO; CLO_0035170
DR Coriell; AG05271
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C47 ! AG07801
OI CVCL_2D74 ! AG11157
OI CVCL_2G05 ! AG13349
SX Male
CA Finite cell line
//
ID AG05274
AC CVCL_2B39
SY AG05274B
DR CLO; CLO_0035171
DR Coriell; AG05274
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 38 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D43 ! AG10884
SX Male
CA Finite cell line
//
ID AG05275
AC CVCL_2B40
DR CLO; CLO_0035164
DR Coriell; AG05275
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F91 ! AG13246
SX Female
CA Finite cell line
//
ID AG05277
AC CVCL_2B41
DR CLO; CLO_0035165
DR Coriell; AG05277
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05278
AC CVCL_2B42
DR CLO; CLO_0035166
DR Coriell; AG05278
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05283
AC CVCL_2B43
DR CLO; CLO_0035167
DR Coriell; AG05283
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B13 ! AG04659
OI CVCL_2D83 ! AG11243
SX Male
CA Finite cell line
//
ID AG05308
AC CVCL_2I26
DR CLO; CLO_0035216
DR Coriell; AG05308
CC Group: Non-human primate cell line.
OX NCBI_TaxID=78454; ! Saguinus labiatus
SX Female
CA Finite cell line
//
ID AG05311
AC CVCL_2I27
DR CLO; CLO_0035215
DR Coriell; AG05311
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9521; ! Saimiri sciureus
SX Female
CA Finite cell line
//
ID AG05313
AC CVCL_2I28
DR CLO; CLO_0035214
DR Coriell; AG05313
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9487; ! Saguinus fuscicollis
SX Female
CA Finite cell line
//
ID AG05322
AC CVCL_0U83
DR Coriell; AG05322
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05324
AC CVCL_0U84
DR Coriell; AG05324
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U85 ! AG05325
SX Male
CA Finite cell line
//
ID AG05325
AC CVCL_0U85
DR Coriell; AG05325
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; AG05325; probable.
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U84 ! AG05324
SX Male
CA Transformed cell line
//
ID AG05326
AC CVCL_0U86
DR Coriell; AG05326
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U87 ! AG05327
SX Female
CA Finite cell line
//
ID AG05327
AC CVCL_0U87
DR Coriell; AG05327
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U86 ! AG05326
SX Female
CA Transformed cell line
//
ID AG05356
AC CVCL_2I29
DR CLO; CLO_0035218
DR Coriell; AG05356
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9519; ! Lagothrix lagotricha
SX Female
CA Finite cell line
//
ID AG05397
AC CVCL_L780
DR CLO; CLO_0035217
DR Coriell; AG05397
RX PubMed=23716668;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05410
AC CVCL_2B44
DR CLO; CLO_0035223
DR Coriell; AG05410
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C44 ! AG07723
OI CVCL_2F65 ! AG13198
SX Male
CA Finite cell line
//
ID AG05411
AC CVCL_2B45
SY AG05411A
DR CLO; CLO_0035222
DR Coriell; AG05411
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F92 ! AG13285
SX Male
CA Finite cell line
//
ID AG05412
AC CVCL_2F95
SY AG05412A
DR Coriell; AG05412
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Discontinued: Coriell; AG05412; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F96 ! AG13299
SX Male
CA Finite cell line
//
ID AG05413
AC CVCL_2B46
DR CLO; CLO_0035221
DR Coriell; AG05413
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05414
AC CVCL_2B47
DR CLO; CLO_0035230
DR Coriell; AG05414
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2A92 ! AG04455
SX Male
CA Finite cell line
//
ID AG05415
AC CVCL_2B48
SY AG05415A
DR CLO; CLO_0035229
DR Coriell; AG05415
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Discontinued: Coriell; AG05415; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G06 ! AG13353
SX Male
CA Finite cell line
//
ID AG05416
AC CVCL_2B49
DR CLO; CLO_0035232
DR Coriell; AG05416
DR GEO; GSM426257
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D95 ! AG11364
OI CVCL_2F57 ! AG13145
SX Male
CA Finite cell line
//
ID AG05417
AC CVCL_2B50
DR CLO; CLO_0035231
DR Coriell; AG05417
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E45 ! AG11746
SX Male
CA Finite cell line
//
ID AG05419
AC CVCL_2B51
DR CLO; CLO_0035234
DR Coriell; AG05419
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05749
AC CVCL_X851
DR CLO; CLO_0035233
DR Coriell; AG05749
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG05770
AC CVCL_0J85
DR CLO; CLO_0035236
DR Coriell; AG05770
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05804
AC CVCL_2B52
SY AG05804B
DR CLO; CLO_0035235
DR Coriell; AG05804
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2A66 ! AG04353
SX Male
CA Finite cell line
//
ID AG05805
AC CVCL_2B53
SY AG05805B
DR CLO; CLO_0035238
DR Coriell; AG05805
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2B27 ! AG05188
OI CVCL_2F28 ! AG13065
SX Male
CA Finite cell line
//
ID AG05806
AC CVCL_2B54
DR CLO; CLO_0035237
DR Coriell; AG05806
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05807
AC CVCL_2B55
SY AG05807A
DR CLO; CLO_0035194
DR Coriell; AG05807
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG05809
AC CVCL_0J86
SY AG05809B
DR CLO; CLO_0035202
DR Coriell; AG05809
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05810
AC CVCL_0J87
SY AG05810D
DR CLO; CLO_0035201
DR Coriell; AG05810
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05811
AC CVCL_2B56
DR CLO; CLO_0035200
DR Coriell; AG05811
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05813
AC CVCL_2B57
DR CLO; CLO_0035199
DR Coriell; AG05813
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05836
AC CVCL_2B58
SY AG05836B
DR CLO; CLO_0035198
DR Coriell; AG05836
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05837
AC CVCL_2B59
SY AG05837B
DR CLO; CLO_0035197
DR Coriell; AG05837
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D87 ! AG11248
SX Female
CA Finite cell line
//
ID AG05838
AC CVCL_2B60
SY AG05838B
DR CLO; CLO_0035196
DR Coriell; AG05838
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E44 ! AG11745
SX Female
CA Finite cell line
//
ID AG05839
AC CVCL_2B61
SY AG05839A
DR CLO; CLO_0035195
DR Coriell; AG05839
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05840
AC CVCL_2B62
DR CLO; CLO_0035203
DR Coriell; AG05840
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG05844
AC CVCL_2B63
SY AG05844A
DR CLO; CLO_0035204
DR Coriell; AG05844
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D93 ! AG11362
OI CVCL_2F56 ! AG13144
SX Female
CA Finite cell line
//
ID AG06009
AC CVCL_2B64
DR CLO; CLO_0035213
DR Coriell; AG06009
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06010
AC CVCL_2B65
DR CLO; CLO_0035212
DR Coriell; AG06010
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06040
AC CVCL_F288
DR CLO; CLO_0035207
DR Coriell; AG06040
DI NCIt; C2903; Bloom syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06062
AC CVCL_2Y85
DR CLO; CLO_0035206
DR Coriell; AG06062
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06063
AC CVCL_6G83
DR CLO; CLO_0035209
DR Coriell; AG06063
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06064
AC CVCL_6G84
DR CLO; CLO_0035208
DR Coriell; AG06064
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06083
AC CVCL_6G85
DR CLO; CLO_0035287
DR Coriell; AG06083
DR GEO; GSM2064580
DR GEO; GSM2064582
DR GEO; GSM2064583
DR GEO; GSM2064584
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06084
AC CVCL_6G86
DR CLO; CLO_0035286
DR Coriell; AG06084
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06085
AC CVCL_6G87
DR CLO; CLO_0035289
DR Coriell; AG06085
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06086
AC CVCL_6G88
DR CLO; CLO_0035288
DR Coriell; AG06086
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06103
AC CVCL_0J88
DR CLO; CLO_0035285
DR Coriell; AG06103
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06105
AC CVCL_EF56
DR Coriell; AG06105
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9601; ! Pongo abelii
SX Female
CA Finite cell line
//
ID AG06115
AC CVCL_2I30
DR CLO; CLO_0035282
DR Coriell; AG06115
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9523; ! Callicebus moloch
SX Male
CA Finite cell line
//
ID AG06116
AC CVCL_2I31
DR CLO; CLO_0035247
DR Coriell; AG06116
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9538; ! Erythrocebus patas
SX Female
CA Finite cell line
//
ID AG06204
AC CVCL_0U88
DR CLO; CLO_0035261
DR Coriell; AG06204
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U89 ! AG06205
SX Male
CA Transformed cell line
//
ID AG06205
AC CVCL_0U89
SY AG06205C
DR CLO; CLO_0035259
DR Coriell; AG06205
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U88 ! AG06204
SX Male
CA Finite cell line
//
ID AG06209
AC CVCL_2I39
DR Coriell; AG06209
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9601; ! Pongo abelii
SX Female
CA Finite cell line
//
ID AG06234
AC CVCL_2B66
SY AG06234C; AG 6234
DR CLO; CLO_0035258
DR Coriell; AG06234
RX PubMed=3745952;
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 22-26 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F62 ! AG13153
SX Male
CA Finite cell line
//
ID AG06235
AC CVCL_2B67
DR CLO; CLO_0035257
DR Coriell; AG06235
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F60 ! AG13151
SX Male
CA Finite cell line
//
ID AG06236
AC CVCL_2B68
DR CLO; CLO_0035256
DR Coriell; AG06236
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D56 ! AG11014
SX Male
CA Finite cell line
//
ID AG06237
AC CVCL_2B69
DR CLO; CLO_0035254
DR Coriell; AG06237
DR GEO; GSM426263
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06239
AC CVCL_2B70
DR CLO; CLO_0035253
DR Coriell; AG06239
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06240
AC CVCL_2B71
SY AG 6240
DR CLO; CLO_0035252
DR Coriell; AG06240
RX PubMed=3745952;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06241
AC CVCL_H790
SY AG6241
DR CLO; CLO_0035250
DR Coriell; AG06241
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06242
AC CVCL_2B72
DR CLO; CLO_0035336
DR Coriell; AG06242
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E14 ! AG11648
SX Male
CA Finite cell line
//
ID AG06243
AC CVCL_2B73
DR CLO; CLO_0035362
DR Coriell; AG06243
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06244
AC CVCL_0J89
DR CLO; CLO_0035359
DR Coriell; AG06244
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06249
AC CVCL_2I32
DR CLO; CLO_0035338
DR Coriell; AG06249
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG06252
AC CVCL_2I33
DR CLO; CLO_0035337
DR Coriell; AG06252
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG06253
AC CVCL_2I34
DR CLO; CLO_0035340
DR Coriell; AG06253
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG06254
AC CVCL_2I35
DR CLO; CLO_0035339
DR Coriell; AG06254
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9538; ! Erythrocebus patas
SX Female
CA Finite cell line
//
ID AG06262
AC CVCL_X838
DR CLO; CLO_0035342
DR Coriell; AG06262
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06263
AC CVCL_X839
DR CLO; CLO_0035341
DR Coriell; AG06263
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06264
AC CVCL_H779
SY AG6264
DR CLO; CLO_0035345
DR Coriell; AG06264
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06265
AC CVCL_H780
SY AG6265
DR CLO; CLO_0035343
DR Coriell; AG06265
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06266
AC CVCL_F253
DR CLO; CLO_0035328
DR Coriell; AG06266
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06269
AC CVCL_0J90
DR CLO; CLO_0035325
DR Coriell; AG06269
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06276
AC CVCL_2B74
DR CLO; CLO_0035323
DR Coriell; AG06276
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06277
AC CVCL_2B75
DR CLO; CLO_0035310
DR Coriell; AG06277
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06278
AC CVCL_X752
SY AG 6278
DR CLO; CLO_0035309
DR Coriell; AG06278
RX PubMed=16126733;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06279
AC CVCL_2B76
SY AG06279A
DR CLO; CLO_0035308
DR Coriell; AG06279
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06280
AC CVCL_2B77
DR CLO; CLO_0035307
DR Coriell; AG06280
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06281
AC CVCL_2B78
DR CLO; CLO_0035314
DR Coriell; AG06281
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06282
AC CVCL_2B79
DR CLO; CLO_0035313
DR Coriell; AG06282
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F93 ! AG13292
SX Male
CA Finite cell line
//
ID AG06283
AC CVCL_2B80
DR CLO; CLO_0035311
DR Coriell; AG06283
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06284
AC CVCL_2B81
SY AG 6284
DR CLO; CLO_0035501
DR Coriell; AG06284
RX PubMed=3745952;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F98 ! AG13308
SX Male
CA Finite cell line
//
ID AG06285
AC CVCL_2B82
SY AG06285A
DR CLO; CLO_0035502
DR Coriell; AG06285
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 26-29 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06287
AC CVCL_2B83
DR CLO; CLO_0035499
DR Coriell; AG06287
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F27 ! AG13018
SX Male
CA Finite cell line
//
ID AG06288
AC CVCL_2B84
SY AG06288A
DR CLO; CLO_0035500
DR Coriell; AG06288
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D51 ! AG10944
SX Male
CA Finite cell line
//
ID AG06289
AC CVCL_2B85
DR CLO; CLO_0035505
DR Coriell; AG06289
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06290
AC CVCL_2B86
DR CLO; CLO_0035506
DR Coriell; AG06290
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06291
AC CVCL_2B87
SY AG06291A; AG 6291
DR CLO; CLO_0035503
DR Coriell; AG06291
RX PubMed=3745952;
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 19 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06292
AC CVCL_2B88
DR CLO; CLO_0035504
DR Coriell; AG06292
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06294
AC CVCL_2B89
DR CLO; CLO_0035507
DR Coriell; AG06294
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D12 ! AG09697
OI CVCL_2F34 ! AG13084
SX Male
CA Finite cell line
//
ID AG06295
AC CVCL_2B90
DR CLO; CLO_0035508
DR Coriell; AG06295
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D55 ! AG11013
SX Male
CA Finite cell line
//
ID AG06296
AC CVCL_2B91
DR CLO; CLO_0035509
DR Coriell; AG06296
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D96 ! AG11365
SX Male
CA Finite cell line
//
ID AG06297
AC CVCL_H765
SY AG06297A; AG06297B; AG06297C
DR CLO; CLO_0035510
DR Coriell; AG06297
RX PubMed=12714972;
RX PubMed=16126733;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06298
AC CVCL_2A29
DR Coriell; AG06298
RX PubMed=12714972;
CC Discontinued: Coriell; AG06298; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06299
AC CVCL_L606
DR CLO; CLO_0035511
DR Coriell; AG06299
RX PubMed=12714972;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06300
AC CVCL_0J91
DR CLO; CLO_0035512
DR Coriell; AG06300
DR GEO; GSM1184270
DR GEO; GSM1184271
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06302
AC CVCL_2B92
DR CLO; CLO_0035513
DR Coriell; AG06302
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06304
AC CVCL_2B93
DR CLO; CLO_0035514
DR Coriell; AG06304
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06305
AC CVCL_2B94
DR CLO; CLO_0035515
DR Coriell; AG06305
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F90 ! AG13245
SX Male
CA Finite cell line
//
ID AG06306
AC CVCL_2B95
DR CLO; CLO_0035516
DR Coriell; AG06306
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06307
AC CVCL_2B96
DR CLO; CLO_0035517
DR Coriell; AG06307
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D48 ! AG10941
OI CVCL_2F30 ! AG13067
SX Male
CA Finite cell line
//
ID AG06308
AC CVCL_2B97
SY AG06308A
DR CLO; CLO_0035518
DR Coriell; AG06308
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C46 ! AG07725
SX Male
CA Finite cell line
//
ID AG06310
AC CVCL_2B98
SY AG06310A
DR CLO; CLO_0035523
DR Coriell; AG06310
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG0650
AC CVCL_8B68
DR ECACC; 92032522
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C101029; Atrioventricular septal defect
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG0655
AC CVCL_8B69
DR ECACC; 92050712
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG06555
AC CVCL_0N55
SY AG06555A
DR CLO; CLO_0035524
DR Coriell; AG06555
RX PubMed=9724752;
CC Characteristics: Senesces at 30-31 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N56 ! AG06556
SX Male
CA Finite cell line
//
ID AG06556
AC CVCL_0N56
DR CLO; CLO_0035521
DR Coriell; AG06556
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N55 ! AG06555
SX Male
CA Finite cell line
//
ID AG06557
AC CVCL_0N57
DR CLO; CLO_0035522
DR Coriell; AG06557
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N58 ! AG06558
SX Male
CA Finite cell line
//
ID AG06558
AC CVCL_0N58
DR CLO; CLO_0035519
DR Coriell; AG06558
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N57 ! AG06557
SX Male
CA Finite cell line
//
ID AG06559
AC CVCL_0N59
DR CLO; CLO_0035520
DR Coriell; AG06559
RX PubMed=9724752;
CC Characteristics: Senesces at 30-31 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N60 ! AG06560
SX Female
CA Finite cell line
//
ID AG0656
AC CVCL_GR82
SY AG656
DR ECACC; 04101820
DR TOKU-E; 4015
RX PubMed=14630800;
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 04101820; true.
DI NCIt; C129027; Fanconi anemia, complementation group J
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AG06560
AC CVCL_0N60
DR CLO; CLO_0035527
DR Coriell; AG06560
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N59 ! AG06559
SX Female
CA Finite cell line
//
ID AG06561
AC CVCL_0N61
DR CLO; CLO_0035528
DR Coriell; AG06561
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N62 ! AG06562
SX Female
CA Finite cell line
//
ID AG06562
AC CVCL_0N62
DR CLO; CLO_0035525
DR Coriell; AG06562
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N61 ! AG06561
SX Female
CA Finite cell line
//
ID AG06838
AC CVCL_H791
DR CLO; CLO_0035535
DR Coriell; AG06838
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H792 ! AG06839
SX Female
CA Finite cell line
//
ID AG06839
AC CVCL_H792
DR CLO; CLO_0035529
DR Coriell; AG06839
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H791 ! AG06838
SX Female
CA Transformed cell line
//
ID AG06840
AC CVCL_H793
SY AG06840B
DR CLO; CLO_0035530
DR Coriell; AG06840
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H794 ! AG06841
SX Male
CA Finite cell line
//
ID AG06841
AC CVCL_H794
SY AG06841A
DR CLO; CLO_0035531
DR Coriell; AG06841
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H793 ! AG06840
SX Male
CA Transformed cell line
//
ID AG06842
AC CVCL_H777
SY AG6842
DR CLO; CLO_0035532
DR Coriell; AG06842
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H778 ! AG06843
SX Male
CA Finite cell line
//
ID AG06843
AC CVCL_H778
DR CLO; CLO_0035536
DR Coriell; AG06843
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H777 ! AG06842
SX Male
CA Transformed cell line
//
ID AG06844
AC CVCL_F257
SY AG06844D
DR CLO; CLO_0035537
DR Coriell; AG06844
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F258 ! AG07647
SX Male
CA Finite cell line
//
ID AG06846
AC CVCL_H799
SY AG6846; AG06846A
DR CLO; CLO_0035538
DR Coriell; AG06846
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H800 ! AG06847
SX Female
CA Finite cell line
//
ID AG06847
AC CVCL_H800
SY AG06847A
DR CLO; CLO_0035465
DR Coriell; AG06847
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H799 ! AG06846
SX Female
CA Transformed cell line
//
ID AG06848
AC CVCL_D534
SY AG6848; AG06848C
DR CLO; CLO_0035464
DR ChEMBL-Cells; CHEMBL3308626
DR ChEMBL-Targets; CHEMBL614700
DR Coriell; AG06848
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F229 ! AG06849
SX Female
CA Finite cell line
//
ID AG06849
AC CVCL_F229
SY AG06849B
DR CLO; CLO_0035463
DR Coriell; AG06849
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D534 ! AG06848
SX Female
CA Transformed cell line
//
ID AG06858
AC CVCL_0N63
DR CLO; CLO_0035462
DR Coriell; AG06858
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06868
AC CVCL_0J92
SY AG06868A
DR CLO; CLO_0035469
DR Coriell; AG06868
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J93 ! AG06869
SX Female
CA Transformed cell line
//
ID AG06869
AC CVCL_0J93
DR CLO; CLO_0035468
DR Coriell; AG06869
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0J92 ! AG06868
SX Female
CA Finite cell line
//
ID AG06872
AC CVCL_X867
DR CLO; CLO_0035467
DR Coriell; AG06872
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06877
AC CVCL_2B99
DR CLO; CLO_0035466
DR Coriell; AG06877
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06878
AC CVCL_2C00
DR CLO; CLO_0035461
DR Coriell; AG06878
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06879
AC CVCL_2C01
SY AG06879A
DR CLO; CLO_0035460
DR Coriell; AG06879
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E66 ! AG12443
SX Male
CA Finite cell line
//
ID AG06880
AC CVCL_2C02
DR CLO; CLO_0035479
DR Coriell; AG06880
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06881
AC CVCL_0F99
DR CLO; CLO_0035472
DR Coriell; AG06881
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0G00 ! AG11247
SX Male
CA Finite cell line
//
ID AG06882
AC CVCL_2C03
DR CLO; CLO_0035471
DR Coriell; AG06882
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06883
AC CVCL_2C04
DR CLO; CLO_0035474
DR Coriell; AG06883
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06885
AC CVCL_2C05
DR CLO; CLO_0035473
DR Coriell; AG06885
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06886
AC CVCL_2C06
DR CLO; CLO_0035476
DR Coriell; AG06886
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06917
AC CVCL_L613
DR CLO; CLO_0035475
DR Coriell; AG06917
RX PubMed=12714972;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06922
AC CVCL_X793
DR CLO; CLO_0035478
DR Coriell; AG06922
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06929
AC CVCL_V267
SY XP23CA
DR CLO; CLO_0035477
DR Coriell; AG06929
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG06939
AC CVCL_V975
DR Coriell; AG06939
RX PubMed=22720000;
CC Group: Non-human primate cell line.
CC Discontinued: Coriell; AG06939; probable.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Finite cell line
//
ID AG06952
AC CVCL_2C07
DR CLO; CLO_0035470
DR Coriell; AG06952
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 40 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D61 ! AG11020
OI CVCL_2F33 ! AG13077
SX Female
CA Finite cell line
//
ID AG06953
AC CVCL_2C08
DR CLO; CLO_0035669
DR Coriell; AG06953
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06956
AC CVCL_2C09
DR CLO; CLO_0035670
DR Coriell; AG06956
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06957
AC CVCL_2C10
DR CLO; CLO_0035672
DR Coriell; AG06957
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F58 ! AG13146
SX Male
CA Finite cell line
//
ID AG06959
AC CVCL_2C11
DR CLO; CLO_0035674
DR Coriell; AG06959
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F99 ! AG13329
SX Male
CA Finite cell line
//
ID AG06961
AC CVCL_6G89
DR CLO; CLO_0035676
DR Coriell; AG06961
DI NCIt; C26747; Type 2 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG06962
AC CVCL_2C12
DR CLO; CLO_0035678
DR Coriell; AG06962
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F89 ! AG13244
SX Male
CA Finite cell line
//
ID AG06971
AC CVCL_V268
DR CLO; CLO_0035680
DR Coriell; AG06971
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07075
AC CVCL_0N64
DR CLO; CLO_0035649
DR Coriell; AG07075
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N65 ! AG07076
SX Female
CA Transformed cell line
//
ID AG07076
AC CVCL_0N65
DR CLO; CLO_0035648
DR Coriell; AG07076
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N64 ! AG07075
SX Female
CA Finite cell line
//
ID AG07091
AC CVCL_4N48
DR CLO; CLO_0035651
DR Coriell; AG07091
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123417; Mandibuloacral dysplasia with type A lipodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG07095
AC CVCL_0N66
DR CLO; CLO_0035652
DR Coriell; AG07095
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07096
AC CVCL_X868
DR CLO; CLO_0035659
DR Coriell; AG07096
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07098
AC CVCL_2I40
DR CLO; CLO_0035661
DR Coriell; AG07098
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07099
AC CVCL_2I41
DR CLO; CLO_0035655
DR BioSamples; SAME57934
DR Coriell; AG07099
CC Group: Non-human primate cell line.
CC Discontinued: Coriell; AG07099; probable.
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID AG07100
AC CVCL_2I42
DR CLO; CLO_0035657
DR Coriell; AG07100
CC Group: Non-human primate cell line.
CC Discontinued: Coriell; AG07100; probable.
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID AG07101
AC CVCL_2I43
DR CLO; CLO_0035613
DR Coriell; AG07101
CC Group: Non-human primate cell line.
OX NCBI_TaxID=54600; ! Macaca nigra
SX Male
CA Finite cell line
//
ID AG07102
AC CVCL_2I44
DR CLO; CLO_0035614
DR Coriell; AG07102
CC Group: Non-human primate cell line.
OX NCBI_TaxID=54600; ! Macaca nigra
SX Male
CA Finite cell line
//
ID AG07107
AC CVCL_2I52
DR CLO; CLO_0035625
DR Coriell; AG07107
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07108
AC CVCL_2I53
DR CLO; CLO_0035642
DR Coriell; AG07108
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07109
AC CVCL_2I45
DR CLO; CLO_0035641
DR Coriell; AG07109
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07110
AC CVCL_2I46
DR CLO; CLO_0035644
DR Coriell; AG07110
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07118
AC CVCL_2C13
DR CLO; CLO_0035643
DR Coriell; AG07118
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G09 ! AG13364
SX Female
CA Finite cell line
//
ID AG07119
AC CVCL_2C14
SY AG07119A
DR CLO; CLO_0035635
DR Coriell; AG07119
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07120
AC CVCL_2C15
DR CLO; CLO_0035634
DR Coriell; AG07120
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07121
AC CVCL_2C16
DR CLO; CLO_0035639
DR Coriell; AG07121
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07122
AC CVCL_2C17
DR CLO; CLO_0035637
DR Coriell; AG07122
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D70 ! AG11081
SX Female
CA Finite cell line
//
ID AG07123
AC CVCL_2C18
DR CLO; CLO_0035582
DR Coriell; AG07123
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2A53 ! AG04146
SX Male
CA Finite cell line
//
ID AG07124
AC CVCL_2C19
DR CLO; CLO_0035594
DR Coriell; AG07124
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07127
AC CVCL_2I54
DR CLO; CLO_0035592
DR Coriell; AG07127
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07128
AC CVCL_2I55
DR CLO; CLO_0035612
DR Coriell; AG07128
CC Group: Non-human primate cell line.
CC Breed/subspecies: Indian.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID AG07135
AC CVCL_L630
DR CLO; CLO_0035611
DR Coriell; AG07135
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L631 ! AG07143
OI CVCL_L629 ! AG11488
OI CVCL_L632 ! AG12788
SX Male
CA Finite cell line
//
ID AG07136
AC CVCL_2C20
DR CLO; CLO_0035610
DR Coriell; AG07136
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C25 ! AG07144
SX Male
CA Finite cell line
//
ID AG07137
AC CVCL_2C21
DR CLO; CLO_0035609
DR Coriell; AG07137
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07139
AC CVCL_2C22
DR CLO; CLO_0035608
DR Coriell; AG07139
DR GEO; GSM426264
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07140
AC CVCL_2C23
DR CLO; CLO_0035607
DR Coriell; AG07140
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07141
AC CVCL_2C24
DR CLO; CLO_0035605
DR Coriell; AG07141
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07143
AC CVCL_L631
DR Coriell; AG07143
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Discontinued: Coriell; AG07143; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L630 ! AG07135
OI CVCL_L629 ! AG11488
OI CVCL_L632 ! AG12788
SX Male
CA Finite cell line
//
ID AG07144
AC CVCL_2C25
DR CLO; CLO_0035604
DR Coriell; AG07144
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2C20 ! AG07136
SX Male
CA Finite cell line
//
ID AG07167
AC CVCL_0N67
DR CLO; CLO_0035571
DR Coriell; AG07167
DI NCIt; C36626; Trisomy 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07180
AC CVCL_2I56
DR CLO; CLO_0035573
DR Coriell; AG07180
CC Breed/subspecies: Lakeland (Lak:LVG).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Female
CA Finite cell line
//
ID AG07184
AC CVCL_2I57
DR CLO; CLO_0035572
DR Coriell; AG07184
CC Breed/subspecies: Lakeland (Lak:LVG).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Female
CA Finite cell line
//
ID AG07302
AC CVCL_2C26
DR CLO; CLO_0035574
DR Coriell; AG07302
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07303
AC CVCL_2C27
DR CLO; CLO_0035577
DR Coriell; AG07303
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07306
AC CVCL_2C28
DR CLO; CLO_0035576
DR Coriell; AG07306
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07307
AC CVCL_X753
DR CLO; CLO_0035579
DR Coriell; AG07307
DR GEO; GSM426265
RX PubMed=19727395;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X755 ! AG12493
SX Female
CA Finite cell line
//
ID AG07308
AC CVCL_X754
SY AG 7308
DR CLO; CLO_0035578
DR Coriell; AG07308
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X756 ! AG14271
SX Female
CA Finite cell line
//
ID AG07309
AC CVCL_2C29
DR CLO; CLO_0035580
DR Coriell; AG07309
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2F97 ! AG13300
SX Female
CA Finite cell line
//
ID AG07310
AC CVCL_2C30
DR CLO; CLO_0035553
DR Coriell; AG07310
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2G08 ! AG13358
SX Female
CA Finite cell line
//
ID AG07311
AC CVCL_2G53
DR CLO; CLO_0035552
DR Coriell; AG07311
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07374
AC CVCL_X840
DR CLO; CLO_0035551
DR Coriell; AG07374
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07375
AC CVCL_X841
DR CLO; CLO_0035550
DR Coriell; AG07375
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07376
AC CVCL_X842
DR CLO; CLO_0035557
DR Coriell; AG07376
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07377
AC CVCL_H803
SY AG7377
DR CLO; CLO_0035556
DR Coriell; AG07377
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07388
AC CVCL_2I58
DR CLO; CLO_0035555
DR Coriell; AG07388
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID AG07409
AC CVCL_X869
DR CLO; CLO_0035554
DR Coriell; AG07409
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07429
AC CVCL_H975
DR CLO; CLO_0035559
DR Coriell; AG07429
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_H976 ! AG07430
SX Female
CA Finite cell line
//
ID AG07430
AC CVCL_H976
DR CLO; CLO_0035558
DR Coriell; AG07430
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_H975 ! AG07429
SX Female
CA Finite cell line
//
ID AG07438
AC CVCL_X870
DR CLO; CLO_0035824
DR Coriell; AG07438
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07443
AC CVCL_0N68
DR CLO; CLO_0035827
DR Coriell; AG07443
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07454
AC CVCL_H977
DR CLO; CLO_0035828
DR Coriell; AG07454
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_H978 ! AG07455
SX Female
CA Finite cell line
//
ID AG07455
AC CVCL_H978
DR CLO; CLO_0035825
DR Coriell; AG07455
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_H977 ! AG07454
SX Female
CA Finite cell line
//
ID AG07471
AC CVCL_2C31
SY AG07471A
DR CLO; CLO_0035826
DR Coriell; AG07471
RX PubMed=9724752;
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
CC Characteristics: Senesces at 44 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E69 ! AG12596
SX Female
CA Finite cell line
//
ID AG07472
AC CVCL_2C32
DR CLO; CLO_0035821
DR Coriell; AG07472
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2E71 ! AG12598
SX Female
CA Finite cell line
//
ID AG07473
AC CVCL_2C33
DR CLO; CLO_0035822
DR Coriell; AG07473
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07475
AC CVCL_2C34
DR CLO; CLO_0035819
DR Coriell; AG07475
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07476
AC CVCL_2C35
DR CLO; CLO_0035820
DR Coriell; AG07476
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07477
AC CVCL_2C36
DR CLO; CLO_0035823
DR Coriell; AG07477
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07478
AC CVCL_2C37
DR CLO; CLO_0035833
DR Coriell; AG07478
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AG07479
AC CVCL_2C38
DR CLO; CLO_0035834
DR Coriell; AG07479
CC Part of: Baltimore Longitudinal Study of Aging (BLSA) cell collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2D59 ! AG11018
SX Female
CA Finite cell line
//
ID AG07493
AC CVCL_0Q89
SY AG07493A; AG7493
DR CLO; CLO_0035835
DR Coriell; AG07493
RX PubMed=8246632;
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0Q98 ! AG11572
SX Female
CA Finite cell line
//
ID AG07549
AC CVCL_0N69
DR CLO; CLO_0035836
DR Coriell; AG07549
DI NCIt; C26900; Turner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AG07558
AC CVCL_4N49
DR CLO; CLO_0035837
DR Coriell; AG07558
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N50 ! AG07559
SX Female
CA Transformed cell line
//
ID AG07559
AC CVCL_4N50
SY AG07559B
DR CLO; CLO_0035838
DR Coriell; AG07559
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N49 ! AG07558
SX Female
CA Finite cell line
//
ID AG07560
AC CVCL_4N51
DR CLO; CLO_0035829
DR Coriell; AG07560
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N52 ! AG07561
SX Male
CA Transformed cell line
//
ID AG07561
AC CVCL_4N52
SY AG07561A
DR CLO; CLO_0035830
DR Coriell; AG07561
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N51 ! AG07560
SX Male
CA Finite cell line
//
ID AG07562
AC CVCL_4N53
DR CLO; CLO_0035831
DR Coriell; AG07562
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N54 ! AG07563
SX Female
CA Transformed cell line
//
ID AG07563
AC CVCL_4N54
SY AG07563A
DR CLO; CLO_0035832
DR Coriell; AG07563
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N53 ! AG07562
SX Female
CA Finite cell line
//
ID AG07564
AC CVCL_4N55
DR CLO; CLO_0035808
DR Coriell; AG07564
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N56 ! AG07565
SX Male
CA Transformed cell line
//
ID AG07565
AC CVCL_4N56
DR CLO; CLO_0035806
DR Coriell; AG07565
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N55 ! AG07564
SX Male
CA Finite cell line
//
ID AG07566
AC CVCL_4N57
DR CLO; CLO_0035807
DR Coriell; AG07566
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N58 ! AG07567
SX Male
CA Transformed cell line
//
ID AG07567
AC CVCL_4N58
DR CLO; CLO_0035804
DR Coriell; AG07567
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N57 ! AG07566
SX Male
CA Finite cell line
//
ID AG07568
AC CVCL_4N59
DR CLO; CLO_0035805
DR Coriell; AG07568
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N60 ! AG07569
SX Male
CA Transformed cell line
//
ID AG07569
AC CVCL_4N60
DR CLO; CLO_0035802
DR Coriell; AG07569
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N59 ! AG07568
SX Male
CA Finite cell line
//
ID AG07570
AC CVCL_4N61
DR CLO; CLO_0035803
DR Coriell; AG07570
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N62 ! AG07571
SX Female
CA Transformed cell line
//
ID AG07571
AC CVCL_4N62
DR CLO; CLO_0035800
DR Coriell; AG07571
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N61 ! AG07570
SX Female
CA Finite cell line
//
ID AG07572
AC CVCL_4N63
DR CLO; CLO_0035801
DR Coriell; AG07572
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N64 ! AG07573
SX Male
CA Transformed cell line
//
ID AG07573
AC CVCL_4N64
DR CLO; CLO_0035799
DR Coriell; AG07573
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N63 ! AG07572
SX Male
CA Finite cell line
//
ID AG07574
AC CVCL_4N65
SY AG07574A
DR CLO; CLO_0035815
DR Coriell; AG07574
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N66 ! AG07575
SX Female
CA Transformed cell line
//
ID AG07575
AC CVCL_4N66
DR CLO; CLO_0035816
DR Coriell; AG07575
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N65 ! AG07574
SX Female
CA Finite cell line
//
ID AG07576
AC CVCL_4N67
DR CLO; CLO_0035817
DR Coriell; AG07576
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG07578
AC CVCL_4N68
DR CLO; CLO_0035818
DR Coriell; AG07578
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N69 ! AG07579
SX Female
CA Transformed cell line
//
ID AG07579
AC CVCL_4N69
SY AG07579A
DR CLO; CLO_0035811
DR Coriell; AG07579
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N68 ! AG07578
SX Female
CA Finite cell line
//
ID AG07580
AC CVCL_4N70
DR CLO; CLO_0035812
DR Coriell; AG07580
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N71 ! AG07581
SX Female
CA Transformed cell line
//
ID AG07581
AC CVCL_4N71
SY AG07581A
DR CLO; CLO_0035813
DR Coriell; AG07581
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N70 ! AG07580
SX Female
CA Finite cell line
//
ID AG07582
AC CVCL_4N72
SY AG07582A
DR CLO; CLO_0035814
DR Coriell; AG07582
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N73 ! AG07583
SX Male
CA Transformed cell line
//
ID AG07583
AC CVCL_4N73
SY AG07583A
DR CLO; CLO_0035809
DR Coriell; AG07583
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N72 ! AG07582
SX Male
CA Finite cell line
//
ID AG07584
AC CVCL_4N74
DR CLO; CLO_0035810
DR Coriell; AG07584
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AG07588
AC CVCL_4N75
DR CLO; CLO_0032866
DR Coriell; AG07588
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N76 ! AG07589
SX Female
CA Transformed cell line
//
ID AG07589
AC CVCL_4N76
DR CLO; CLO_0032865
DR Coriell; AG07589
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N75 ! AG07588
SX Female
CA Finite cell line
//
ID AG07590
AC CVCL_4N77
DR CLO; CLO_0032864
DR Coriell; AG07590
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P60 ! AG08176
SX Female
CA Transformed cell line
//
ID AG07592
AC CVCL_4N78
SY AG07592A
DR CLO; CLO_0032863
DR Coriell; AG07592
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N79 ! AG07593
SX Male
CA Transformed cell line
//
ID AG07593
AC CVCL_4N79
DR CLO; CLO_0032862
DR Coriell; AG07593
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N78 ! AG07592
SX Male
CA Finite cell line
//
ID AG07594
AC CVCL_4N80
DR CLO; CLO_0032861
DR Coriell; AG07594
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG07596
AC CVCL_4N81
DR CLO; CLO_0032889
DR Coriell; AG07596
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P59 ! AG08175
SX Female
CA Transformed cell line
//
ID AG07597
AC CVCL_4N82
DR CLO; CLO_0032891
DR Coriell; AG07597
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N83 ! AG07598
SX Male
CA Finite cell line
//
ID AG07598
AC CVCL_4N83
DR CLO; CLO_0032893
DR Coriell; AG07598
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N82 ! AG07597
SX Male
CA Transformed cell line
//
ID AG07599
AC CVCL_4N84
DR CLO; CLO_0032894
DR Coriell; AG07599
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N85 ! AG07600
SX Male
CA Finite cell line
//
ID AG07600
AC CVCL_4N85
DR CLO; CLO_0032881
DR Coriell; AG07600
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N84 ! AG07599
SX Male
CA Transformed cell line
//
ID AG07601
AC CVCL_4N86
DR CLO; CLO_0032883
DR Coriell; AG07601
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N87 ! AG07602
SX Female
CA Finite cell line
//
ID AG07602
AC CVCL_4N87
DR CLO; CLO_0032882
DR Coriell; AG07602
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N86 ! AG07601
SX Female
CA Transformed cell line
//
ID AG07603
AC CVCL_4N88
SY AG07603A
DR CLO; CLO_0032878
DR Coriell; AG07603
RX PubMed=9724752;
CC Characteristics: Senesces at 24-32 PDL (PubMed=9724752).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N89 ! AG07604
SX Female
CA Finite cell line
//
ID AG07604
AC CVCL_4N89
DR CLO; CLO_0032877
DR Coriell; AG07604
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N88 ! AG07603
SX Female
CA Transformed cell line
//
ID AG07607
AC CVCL_4N90
DR CLO; CLO_0032880
DR Coriell; AG07607
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N91 ! AG07608
SX Female
CA Finite cell line
//
ID AG07608
AC CVCL_4N91
DR CLO; CLO_0032879
DR Coriell; AG07608
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N90 ! AG07607
SX Female
CA Transformed cell line
//
ID AG07609
AC CVCL_4N92
DR CLO; CLO_0032831
DR Coriell; AG07609
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N93 ! AG07610
SX Male
CA Finite cell line
//
ID AG07610
AC CVCL_4N93
DR CLO; CLO_0032833
DR Coriell; AG07610
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N92 ! AG07609
SX Male
CA Transformed cell line
//
ID AG07613
AC CVCL_4N94
SY AG07613B
DR CLO; CLO_0032828
DR Coriell; AG07613
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N95 ! AG07614
SX Male
CA Finite cell line
//
ID AG07614
AC CVCL_4N95
SY AG07614A
DR CLO; CLO_0032823
DR Coriell; AG07614
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N94 ! AG07613
SX Male
CA Transformed cell line
//
ID AG07615
AC CVCL_4N96
SY AG07615B
DR CLO; CLO_0032821
DR Coriell; AG07615
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N97 ! AG07616
SX Male
CA Finite cell line
//
ID AG07616
AC CVCL_4N97
DR CLO; CLO_0032820
DR Coriell; AG07616
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N96 ! AG07615
SX Male
CA Transformed cell line
//
ID AG07617
AC CVCL_4N98
DR CLO; CLO_0032819
DR Coriell; AG07617
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N99 ! AG07618
SX Female
CA Finite cell line
//
ID AG07618
AC CVCL_4N99
DR CLO; CLO_0032827
DR Coriell; AG07618
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4N98 ! AG07617
SX Female
CA Transformed cell line
//
ID AG07619
AC CVCL_4P00
SY AG07619A
DR CLO; CLO_0032826
DR Coriell; AG07619
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P01 ! AG07620
SX Male
CA Finite cell line
//
ID AG07620
AC CVCL_4P01
SY AG07620B
DR CLO; CLO_0032825
DR Coriell; AG07620
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P00 ! AG07619
SX Male
CA Transformed cell line
//
ID AG07621
AC CVCL_4P02
SY AG07621B
DR CLO; CLO_0032824
DR Coriell; AG07621
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P03 ! AG07622
SX Male
CA Finite cell line
//
ID AG07622
AC CVCL_4P03
SY AG07622A
DR CLO; CLO_0032852
DR Coriell; AG07622
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P02 ! AG07621
SX Male
CA Transformed cell line
//
ID AG07623
AC CVCL_4P04
SY AG07623A
DR CLO; CLO_0032853
DR Coriell; AG07623
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P05 ! AG07624
SX Male
CA Finite cell line
//
ID AG07624
AC CVCL_4P05
SY AG07624A
DR CLO; CLO_0032840
DR Coriell; AG07624
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P04 ! AG07623
SX Male
CA Transformed cell line
//
ID AG07627
AC CVCL_4P06
SY AG07627B
DR CLO; CLO_0032844
DR Coriell; AG07627
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P07 ! AG07628
SX Female
CA Finite cell line
//
ID AG07628
AC CVCL_4P07
SY AG07628A
DR CLO; CLO_0032842
DR Coriell; AG07628
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P06 ! AG07627
SX Female
CA Transformed cell line
//
ID AG07629
AC CVCL_4P08
SY AG07629B
DR CLO; CLO_0032846
DR Coriell; AG07629
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P09 ! AG07630
SX Male
CA Finite cell line
//
ID AG07630
AC CVCL_4P09
SY AG07630A
DR CLO; CLO_0032845
DR Coriell; AG07630
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P08 ! AG07629
SX Male
CA Transformed cell line
//
ID AG07631
AC CVCL_4P10
DR CLO; CLO_0032848
DR Coriell; AG07631
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P11 ! AG07632
SX Male
CA Finite cell line
//
ID AG07632
AC CVCL_4P11
DR CLO; CLO_0032847
DR Coriell; AG07632
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P10 ! AG07631
SX Male
CA Transformed cell line
//
ID AG07634
AC CVCL_4P12
DR CLO; CLO_0032850
DR Coriell; AG07634
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG07635
AC CVCL_4P13
DR CLO; CLO_0032849
DR Coriell; AG07635
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P14 ! AG07636
SX Female
CA Finite cell line
//
ID AG07636
AC CVCL_4P14
SY AG07636A
DR CLO; CLO_0032988
DR Coriell; AG07636
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P13 ! AG07635
SX Female
CA Transformed cell line
//
ID AG07637
AC CVCL_4P15
SY AG07637A
DR CLO; CLO_0032970
DR Coriell; AG07637
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P16 ! AG07638
SX Female
CA Finite cell line
//
ID AG07638
AC CVCL_4P16
SY AG07638B
DR CLO; CLO_0032972
DR Coriell; AG07638
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P15 ! AG07637
SX Female
CA Transformed cell line
//
ID AG07639
AC CVCL_4P17
SY AG7639A
DR CLO; CLO_0032966
DR Coriell; AG07639
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P18 ! AG07640
SX Female
CA Finite cell line
//
ID AG07640
AC CVCL_4P18
SY AG07640B
DR CLO; CLO_0032968
DR Coriell; AG07640
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P17 ! AG07639
SX Female
CA Transformed cell line
//
ID AG07641
AC CVCL_4P19
DR CLO; CLO_0032962
DR Coriell; AG07641
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P20 ! AG07642
SX Female
CA Finite cell line
//
ID AG07642
AC CVCL_4P20
DR CLO; CLO_0032965
DR Coriell; AG07642
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4P19 ! AG07641
SX Female
CA Transformed cell line
//
ID AG07644
AC CVCL_4P21
DR CLO; CLO_0032960
DR Coriell; AG07644
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AG07645
AC CVCL_V148
DR CLO; CLO_0032961
DR Coriell; AG07645
CC Miscellaneous: At sampling donor was not affected with Alzheimer disease, but has a 50% risk.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V149 ! AG07646
SX Female
CA Finite cell line
//
ID AG07646
AC CVCL_V149
DR CLO; CLO_0032958
DR Coriell; AG07646
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: At sampling donor was not affected with Alzheimer disease, but has a 50% risk.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V148 ! AG07645
SX Female
CA Transformed cell line
//
ID AG07647
AC CVCL_F258
SY AG07647A
DR CLO; CLO_0032959
DR Coriell; AG07647
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F257 ! AG06844
SX Male
CA Transformed cell line
** -----------------------------------------------------------------------
** CALIPHO group at the SIB - Swiss Institute of Bioinformatics
** Geneva, Switzerland
** -----------------------------------------------------------------------
**
** Description: References file for the Cellosaurus
** Version: 24.0
** Last update: 15-November-2017
**
** -----------------------------------------------------------------------
您正在向 biovector.net 发送关于产品 细胞株2-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
免费订购电话: 400-800-2947